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Sulfasalazine and thalidomide inhibit extracellular trap formation by human neutrophils
AM Lin, R Khandpur, M Riblett and AT Bruce Department of Dermatology, University of
Michigan, Ann Arbor, MI
Neutrophil extracellular trap formation (NETosis) is a recently discovered form of cell death distinct
from necrosis or apoptosis where a lattice of DNA strands is extruded from innate immune cells.
Although ETosis is typically thought of as an antimicrobial response, recent work in our lab has
shown that mast cells and neutrophils form IL-17+ extracellular traps (ET) in human psoriasis plaques
but not in normal uninvolved skin. In autoinflammatory diseases, overproduction or insufficient
clearance of ETs may lead to inappropriately sustained stimulation of the innate immune system.
However, while several important treatments for psoriasis and other autoimmune diseases target
TNF−α, IL-17, and IL-23, drugs that inhibit ETosis have not been identified. Several drugs used today
to treat autoimmune diseases work through incompletely understood mechanisms of action. We
hypothesized that the clinical effectiveness of some these drugs may be attributed in part to their
inhibition of ETosis. Using neutrophils isolated from human donors, we investigated the effects of
various drugs on NETosis. Through immunofluorescence and assays measuring extruded ET DNA,
we demonstrate that sulfasalazine, thalidomide, and to a lesser extent DMSO, inhibit NETosis of
human neutrophils. In contrast, cyclosporine, tacrolimus, tetracycline, colchicine, hydroxychloro-
quine, cromolyn, or dapsone had no significant effect on NETosis in these experiments. The clini-
cal effectiveness of sulfasalazine and thalidomide in treatment of diseases such as psoriasis, lupus,
and pyoderma gangrenosum may therefore be attributable to blockade of NETosis. These findings
provide a clearer understanding of the mechanism of current drugs while also providing a frame-
work to test and develop novel therapies inhibiting NETosis.
1125
Identification and validation of novel immunomodulators for treatment of common warts
HL Aloor,1 M Xie,2 JJ Pouliot,2 SK You,2 AL Banka,2 AL Handlon,1 HE Hofland1 and J Therrien1 1
Center for Skin Biology, Stiefel, a GSK company, RTP, NC and 2 Anti-Viral DPU,
Glaxosmithkline, RTP, NC
Infection of skin keratinocytes by human papillomavirus (HPV) is responsible for the skin lesions of
common warts. HPV suppresses the host immune system mainly through the ability of HPV E6 and
E7 proteins to interfere with the production of STAT1 at the transcriptional level and HPV E6 pro-
tein to inhibit the phosphorylation of TYK2 and STAT1, thus inhibiting the JAK/STAT pathway. The
inhibition of the JAK/STAT pathway is essential for viral propagation and also prevents HPV infected
cells from mounting an anti-viral response. We have discovered a series of JAK/STAT activators that
function as interferon type 1 pathway agonists to activate the JAK/STAT pathway and potentially
overcome the HPV inhibition. Here we show that treatment of both normal and E6/E7 transduced
human keratinocytes with JAK/STAT activators results in phosphorylation of STAT1 and up regula-
tion of interferon-stimulated genes (OAS2, MX1) by up to 50-fold and 1 000-fold, respectively. This
activation is seen as soon as 6 hours post treatment and is maintained for 72 hours. Significant upreg-
ulation of interferon-stimulated genes and phosphorylation of STAT1 were also observed in recon-
structed human epidermis, ex vivo human, and rabbit skin treated with the JAK/STAT activators for
6 and 72 hours. The activation of the JAK/STAT pathway in rabbit skin by JAK/STAT activators sug-
gests that the cottontail rabbit papilloma virus model may serve as preclinical animal model for
proof-of-mechanism. Taken together, the results suggest that JAK/STAT activators can trigger the
host defense system in both HPV infected and non-infected human keratinocytes to treat cutaneous
viral infection.
1127
Epidermal growth factor receptor inhibitors selectively inhibit the expression of human β-
defensins induced by Staphylococci
K Park,1 R Ommori,2 K Imoto2 and H Asada2 1 Department of Dermatology, Yamato Takada
Municipal Hospital, Yamato Takada, Nara, Japan and 2 Department of Dermatology, Nara
Medical University, Kashihara, Nara, Japan
Epidermal growth factor receptor inhibitors (EGFRI) have been established in the therapy of can-
cers. EGFR is overexpressed in many cancers, and its therapeutic blockade is beneficial on cancer
growth and spread. On the other hand, cutaneous adverse effects such as follicular acneiform erup-
tions often develop in the patients who receive EGFRI therapy. These dermatologic toxicities have
led to incompliance as well as dose reduction or even cessation of the anti-EGFR therapy and have
been shown to compromise the patients’ quality of life. Yet, a mechanism of EGFRI-induced acneiform
eruptions is not fully understood. The epidermis serves as a front line of defense against the inva-
sion of pathogenic microbes and acts as a crucial site for innate immune responses. Keratinocytes
stimulated by microbial organisms secrete a variety of cytokines, chemokines and growth factors,
as well as antimicrobial peptides such as human β-defensins. We previously demonstrated S. aureus
mainly induced the expression of human β-defensin 1 and 3, while S. epidermidis induced the
expression of human β-defensin 2 and 3. In this study, we analyzed how EGFRI affect innate immune
responses in keratinocytes upon contact with the pathogen Staphylococcus aureus and the com-
mensal Staphylococcus epidermidis. We investigated the effects of EGFRI, such as gefitinib and
erlotinib, on the expression of human β-defensins and IL-8 against these microorganisms. We
found EGFRI suppressed the expression of human β-defensin 2 and 3 induced by S. epidermidis,
but did not suppress the expression of human β-defensin 1 and 3 induced by S. aureus. In contrast,
we observed EGFRI suppressed both S. epidermidis and S. aureus induced IL-8 expression in cul-
tured keratinocytes. We suggest that EGFR inhibitors may cause cutaneous adverse effects through
selectively perturbing innate immune responses induced by commensal and pathogenic bacteria.
1126
Attenuation of cutaneous inflammation in a model of atopic dermatitis by innate immune sig-
nals of non-pathogenic bacteria
T Volz, Y Skabytska, S Kaesler and T Biedermann Department of Dermatology, University
Hospital, Tübingen, Germany
Innate immunity responds to pathogenic bacteria by mounting inflammation, however, the skin har-
bors a large quantity of non-pathogenic bacteria in the absence of inflammation. Moreover, in con-
trast to pathogens, skin microbiota may favor anti-inflammatory or even tolerogenic immune
responses. We therefore hypothesized that innate immune signals from non-pathogenic bacteria
attenuate ongoing skin inflammation. Atopic dermatitis (AD) prone Nc/NgA mice were sensitized
with FITC known to induce Th2 dominated dermatitis. Following FITC challenge dermatitis was
measured by an increase of ear thickness. Topical treatment with a lysate of non-pathogenic bac-
teria Vitreoscilla filiformis (Vf) during the challenge phase significantly reduced T-cell mediated
dermatitis by about 25%. Strikingly, cutaneous exposure of FITC sensitized mice to Vf and FITC
previous to FITC challenge reduced FITC-specific dermatitis by 50% during the consecutive chal-
lenge with FITC only one week later. This demonstrates that innate immune sensing of non-patho-
genic bacteria induces immune modulation able to attenuate even already established adaptive
immunity. Indeed, analysing whole lymph node (LN) cells from skin draining LN ex vivo we found
that only T cells from mice previously exposed to non-pathogenic bacteria displayed antigen-spe-
cific production of IL-10 while controls failed to do so. Consistently, exposure to Vf signals reduced
T cell proliferation and pro-inflammatory cytokine production. Further analyses demonstrated that
innate sensing of Vf by DC induced IL-10++ DC and consecutively regulatory IL-10++ IFN-γ+ T
cells, known as Tr1 cells, that effectively suppressed the effector T cells. These data demonstrate
that signals from non-pathogenic bacteria induce Tr1 cells attenuating even ongoing adaptive immune
responses. These data indicate that cutaneous non-pathogenic bacteria are important regulators of
skin immune homeostasis and this may pave the way for new immunomodulatory therapies for
skin inflammation such as in AD.
1124
Selective induction of antimicrobial peptides from keratinocytes by staphylococcal bacteria
R Ommori, K Park and H Asada Department of Dermatology, Nara Medical University,
Kashihara, Japan
Staphylococcus aureus (S. aureus) is one of the most clinically important inflammation-inducing
pathogens and thought to be an exacerbating factor in atopic dermatitis (AD), while Staphylococ-
cus epidermidis (S. epidermidis) is nonpathogenic and hardly causes inflammation on skin. β-
defensins, antimicrobial peptides, are secreted from keratinocytes constitutively or upon induction
by various microorganisms. However, the difference between S. aureus and S. epidermidis is still
unclear in terms of their influences on the production of β-defensins. In this study, we focused on
the influences of S. aureus and S. epidermidis on the keratinocyte innate immune response. Bacte-
rial supernatants were prepared to examine the influence of substances secreted from bacteria on
keratinocytes. S. aureus and S. epidermidis were cultivated for three days at 37°C with shaking. The
bacterial supernatants were collected and separated to three fractions, that is >100 kDa, 10-100
kDa, and <10 kDa fractions. Normal human epidermal keratinocytes were cultured with the super-
natants of S. aureus and S. epidermidis for 24 hours. Then, human β-defensins (hBD) in the culture
supernatants of keratinocytes were measured by ELISA. Toll-like receptor (TLR) 2 siRNA-transfected
keratinocytes were also stimulated with the staphylococcal supernatants for 24 hours, and hBDs in
the culture supernatants were measured by ELISA. Pathogenic S. aureus mainly induced hBD1 and
hBD3, but not hBD2, and nonpathogenic S. epidermidis mainly induced hBD2. Molecular weight
fractions of >10 kDa prepared from S. aureus supernatants induced the production of hBD1 and
hBD3. On the other hand, molecular weight fraction of >100 kDa prepared from S. epidermidis
supernatants induced the production of hBD2. Furthermore, the secreted products of S. epider-
midis used the TLR2 pathway in the induction of hBD2 production. The secreted products of S.
aureus and S. epidermidis differentially induced subtypes of hBD through different receptors, which
may be associated with the difference in virulence between these two bacteria.
1128
Identification of novel, bacterial peptide-antibiotic-like, S. aureus-killing peptides in stratum
corneum
JM Schroeder, J Bartels and U Gerstel Dermatology, University Hospital, Kiel, Germany
Recent studies revealed anatomical site-dependent differences of the skin’s microbiome. Following
the hypothesis that both, host- and microbe-derived factors shape the local skin microbiome, we
analyzed S.aureus-killing activity in heel stratum corneum (SC) extracts. Whereas fatty acid-con-
taining organic solvent extracts lacked S. a.-killing activity, fractions containing cationic peptides
showed strong activity. Separation by RP-HPLC revealed three peaks of S.a.-killing activity. Further
purification, ESI-MS- and MS/MS-analyses revealed in the first peak N-terminally truncated hBD-3
and in the second peak RNase-7. In the third activity peak, which contained strongest S. a.-killing
activity, by ESI-MS several 1.2-2.5 kDa peptides were identified. A structural characterization so far
hampered because these peptides were unstable, resistant towards proteolysis and resistant towards
collision-induced MS-fragmentation. Similar biochemical properties are well known for bacteria-
derived antimicrobial peptides (AMPs) such as Grampositive-derived Lantibiotics. Therefore we ana-
lyzed propanol-extracts of S. aureus-strains, which have been cultured on agar-plates. Surprisingly,
the dominating peptide revealed an identical molecular mass, which suggests that bacteria could
be producers of these peptides. Comparison of SC-derived S. aureus-killing peptides with known
bacteria-derived lantibiotics as well as “PSMs” showed no identity or similarity. We therefore con-
clude that heel SC contains as principal host-derived S. aureus-killing factors the epithelial AMPs
hBD-3 and RNase-7, and a panel of yet unknown and structurally unrelated 1-2.5 kDa AMPs, which
might originate from heel colonizing microbiota. Our data represent a hint that - apart from host-
derived epithelial AMPs - also microbe-derived AMP could be important in shaping the local
microflora. Structural characterization of these compounds, its activity spectrum and conditions of
its production will open a new field of research to understand what shapes the skin’s microbiome.
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Skin barrier defect allows more abundant microbiota in skin and induces skin inflammation
and the expression of antimicrobial peptides independently of microbiota
K Natsuga,1,2 S Cipolat1,3 and FM Watt1,3,4 1 Cancer Research UK Cambridge Research Institute,
Cambridge, United Kingdom, 2 Department of Dermatology, Hokkaido University Graduate
School of Medicine, Sapporo, Japan, 3 Centre for Stem Cells and Regenerative Medicine,
King’s College London, London, United Kingdom and 4 Wellcome Trust Centre for Stem Cell
Research, Cambridge, United Kingdom
Cornified envelope (CE) is the outermost part of skin and serves as a skin barrier against microor-
ganisms. Envoplakin, periplakin and involucrin are the major components of CE. Our group devel-
oped Evpl/Ppl/Ivl null mice (EPI mice) and reported that EPI mice were the model of skin barrier
defect. To elucidate the effect of barrier defect on commensal bacteria, we analyzed skin micro-
biota of wild-type (wt) and EPI mice under conventional conditions. We found that EPI mice skin
had a higher amount of microbiota than that of wt mice. Pyrosequencing of 16S rRNA did not reveal
major differences of bacterial species between wt and EPI mice skin. In situ hybridization revealed
deeper bacterial signals in epidermis of EPI mice compared with that of wt. We tested the contri-
bution of skin microbiota to skin inflammation in EPI mice because EPI mice had a higher amount
of CD4+ T cells in dermis and fewer intraepidermal dendritic T-cells compared with wt. We con-
firmed the ablation of skin microbiota in EPI mice after antibiotics treatment and in the mice fos-
tered under barrier conditions. However, diminished microbiota did not affect the inflammatory
phenotypes of EPI mice. Furthermore, we investigated the expression level of antimicrobial pep-
tides (AMPs). We observed the increased expression of beta-defensins and cathelicidine-related
antimicrobial peptides in EPI mice skin compared with wt mice. Interestingly, ablation of skin micro-
biota did not influence the expression level of the major skin AMPs in EPI mice. Our results suggest
that skin commensal microbiota may not have a major role in regulating skin inflammation and
AMPs although skin microbiota is increased and more deeply localized in barrier defective mice.
1130
Nlrp3-inflammasome activation drives acute graft-versus-host disease
D Jankovic,1 J Ganesan,2 A Bouazzaoui,3 E Holler,3 LE French,1 R Zeiser2 and E Contassot1 1
Department of Dermatology, University Hospital Zürich, Zurich, Switzerland, 2 Department
of Hematology and Oncology, University Medical Center, Albert-Ludwigs-University, Freiburg,
Germany and 3 Department of Haematology and Oncology, University Hospital Regensburg,
Regensburg, Germany
The success of allogeneic hematopoietic cell transplantation (allo-HCT) is limited by acute graft-
versus-host disease (aGvHD), a severe complication accompanied by high mortality rates. Prior to
allo-HCT, recipients undergo conditioning regimen that causes tissue damage and induces pro-
inflammatory cytokine release in the host. However, the molecular events governing pro-inflam-
matory cytokine production remain poorly understood. The inflammasome initiates inflammation
upon sensing pathogen- and danger-associated molecular patterns (PAMPs/DAMPs) by regulating
the secretion of caspase-1 activation-dependent cytokines including interleukin (IL)-1. The skin is
the earliest and most frequent target in aGvHD. Therefore, we first quantified IL-1β mRNA follow-
ing total body irradiation in target tissues of GvHD. The elevated pro-IL-1β levels were found in the
skin and intestines of irradiated mice, while the depletion of the microbial flora with antibiotics
diminished IL-1βmRNA levels in both tissues. These data indicate that the initiating signal for aGvHD
originates from the intestine. Mice treated with a neutralizing anti-IL-1β antibody 24h before con-
ditioning had a prolonged survival and improved body weight whereas a later treatment (day 5)
was not effective. When inflammasome-deficient mice were used as bone marrow and T cell recip-
ients, we observed delayed GvHD-induced mortality and a lower cumulative GvHD score as com-
pared to wild-type littermates. Our results indicate that conditioning-induced release of
PAMPs/DAMPs and subsequent inflammasome-dependent IL-1β secretion in the host is a key and
very early event in GvHD pathogenesis.
1131
Murine cathelicidin-related antimicrobial peptide regulates iNOS expression via HIF-1α in
M1-like macrophages
E Sato,1,2 K Ishii,2 B Chou,2 S Imafuku,1 J Nakayama1 and K Hiromatsu2 1 Dermatology, Fukuoka
University School of Medicine, Fukuoka, Japan and 2 Microbiology and Immunology,
Fukuoka University School of Medicine, Fukuoka, Japan
Cathelicidin is an antimicrobial peptide that kills gram positive and negative bacteria directly.
However, Mycobacterium species cannot be destroyed effectively because of the thick cell wall
with mycolic acid. Production of nitric oxide (NO) by macrophages is an important factor against
mycobacterial infection in murine model. It is known that the human cathelicidin (LL-37) suppresses
the production of inflammatory cytokines such as TNF-α and NO from LPS and IFN-γ-polarized M1
bone-marrow derived macrophages (BMDM). In this study, we assessed whether the murine cathe-
licidin-related antimicrobial peptide (CRAMP) affects production of NO in GM-CSF-induced bone
marrow-derived macrophages (M1-like BMDM) in Mycobacterium marinum infection that causes
granulomatous skin lesion such as fish tank granuloma. And we revealed that CRAMP deficient mice
(KO) shows more anti-bacterial ability against M. marinum, because of the unsuppressed produc-
tion of NO. However, CRAMP KO lost weight because of the exhaustion caused by inflammatory
cytokine storm. We also revealed that CRAMP regulates HIF-1α and suppresses the iNOS signaling
in M1-like BMDM, and this phenomenon had not been confirmed in M-CSF-induced M2-like BMDM.
In conclusion, CRAMP serves as an anti-microbial peptide as well as an important regulator of the
immune system to control the production of inflammatory cytokine, thereby protecting an individ-
ual.
1132
A specific requirement for a disintegrin and metalloprotease (ADAM) 17 in protection against
cutaneous Staphylococcus aureus infection
C Simpson, M Brooke, O Marchès and D Kelsell Blizard institute, Barts and the London SMD,
QMUL, London, United Kingdom
The skin forms a protective barrier against invading pathogens. ADAM17 acts as a sheddase enzyme,
functioning in the release of various substrates including tumour necrosis factor alpha (TNFα), and
is thus important in stimulation of the immune response. ADAM17 is also responsible for shedding
many members of the epidermal growth factor (EGF) family of growth factors, and is therefore an
upstream regulator of the EGF receptor signalling pathway, important for maintenance of the epi-
dermal barrier. Loss-of-function (LOF) mutations in ADAM17 are linked to recurrent bacterial skin
infections, especially with S. aureus. The inactive rhomboid protein iRhom2 is directly required for
the maturation of ADAM17, and therefore plays a key role in ADAM17-dependent immune regu-
lation. For example, iRhom2-/- mice produce less TNFα than wild type mice and consequently
fight a Listeria infection less efficiently. Interestingly, dominantly-inherited missense mutations in
iRhom2 – which may affect its role in ADAM17 maturation – have been identified as the cause of
the skin condition Tylosis with oesophageal cancer (TOC). To investigate a link between ADAM17
expression and S. aureus infection, we treated control keratinocytes with siRNA against ADAM17.
These cells demonstrated increased susceptibility to S. aureus infection (p=0.01), mimicking the
phenotype of LOF mutations in patients. Conversely, rates of S. aureus infection were reduced in
TOC keratinocytes (p=0.04), accompanied by upregulation of secretion of Interleukin-8, an
ADAM17/TNFα downstream target and neutrophil-recruiting cytokine. This is consistent with a
hypothesis of iRhom2 mutations in these cells resulting in increased plasma membrane ADAM17
expression compared to control keratinocytes. Moreover, treating TOC keratinocytes with ADAM17
siRNA increased S. aureus infection while reducing IL-8 expression. These results thus demonstrate
a requirement for ADAM17 in mediating protection against bacterial infection, which future stud-
ies will investigate the specific details of.
1133
TNF-α regulates the vitamin D-dependent antimicrobial response in human monocytes
M Fabri,2,1 A Sommer,1 D Shin,3 S Stenger,4 E Jo3 and RL Modlin2 1 University of Cologne,
Cologne, Germany, 2 University of California LA, Los Angeles, CA, 3 Chungnam National
University School of Medicine, Daejeon, Republic of Korea and 4 University Hospital of Ulm,
Ulm, Germany
TNF-α inhibitors are frequently used for treating patients with inflammatory skin diseases. In these
patients the risk for reactivation of latent tuberculosis infection is increased, clearly indicating that
TNF-α is crucial to the immune control of tuberculosis infection. However, TNF-αmay also enhance
survival of tubercle bacilli in human macrophages. We investigated the role of TNF-α in the vita-
min D-dependent antimycobacterial pathway, which can be induced by IFN-γ, leading to upregu-
lation of the antimicrobial peptides cathelicidin and DEFB4, as well as the cathelicidin-dependent
induction of autophagy. Using primary human monocytes cultured in vitamin D sufficient sera, we
found that TNF-α induced expression of cathelicidin and DEFB4. However, TNF-α failed to induce
autophagy, suggesting the induction of cathelicidin and autophagy are not always linked. Further-
more, TNF-α inhibited the IFN-γ-mediated induction of cathelicidin and DEFB4 gene expression,
as well as autophagy. Therefore, these data further suggest the conflicting roles of TNF-α in host
defense and pathogenesis in human infectious disease, by itself upregulating the antimicrobial
peptides cathelicidin and DEFB4, but in the context of IFN-γ, inhibiting induction of these peptides
and autophagy, key parts of the vitamin D antimicrobial pathway.
1134
Small colony variants of S. aureus are less susceptible against antimicrobial peptides of the
skin
R Gläser,1 K Becker,2 U Meyer-Hoffert1 and J Harder1 1 Department of Dermatology, Venerology
and Allergology, University Hospital of Schleswig-Holstein, Kiel, Germany and 2 Institute of
Medical Microbiology, University Hospital of Münster, Münster, Germany
Human skin has the ability to produce highly effective antimicrobial peptides and proteins (AMP)
against potentially invading microorganisms. S. aureus is one of the most skin-relevant pathogenic
bacteria causing several severe skin infections. Recently, small colony variants (SCV) of S. aureus
were identified as being responsible for persistent deep skin infections (e.g. abscesses). The reasons
why SCV are less vulnerable to the host defence are not completely understood. Therefore we aimed
to investigate the hypothesis that SCV subvert innate antimicrobial skin defence through their abil-
ity to withstand the killing activity of cutaneous AMP. Standardized antimicrobial microdilution
assays were performed to test the antimicrobial activity of the skin-derived AMP human beta-defensins
(hBD)-2 and -3 as well as RNase 7 against three different SCV and their corresponding wild-type
isolates. Our results revealed a strong reduction of the killing activity of RNase 7 and hBD-2 against
all tested SCV strains when compared to the wild-type strains. In contrast to hBD-2 and RNase 7,
hBD-3 exhibited only a slight reduced killing activity against the different SCV as compared to the
wild-type strains. To further assess the physiological relevance of these findings we tested skin extracts
derived from healthy stratum corneum in different dilutions against the SCV and the corresponding
wild-type S. aureus. The skin extracts showed a strongly diminished capability to kill S. aureus-SCV.
Dilutions of the skin extracts of more than 10-fold were still more effective in killing the wild-type
strains as compared to the SCV. Taken together, our findings indicate that small colony variants of
S. aureus may bypass the potent chemical barrier of the skin leading to therapy-refractory and per-
sistent deep skin infections.
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Microbiota of Demodex mites differs between rosacea subjects and controls
N Murillo,1 J Aubert2 and D Raoult1 1 Aix Marseille Université, URMITE, UM63, CNRS 7278,
IRD 198, Inserm 1095, Marseille, France and 2 Galderma R&D, Sofia Antipolis, France
We hypothesized that differences exist between the microbiota found in Demodex mites when com-
paring rosacea patients and controls. Demodex mites were collected from either patients with ery-
thematotelangiectatic rosacea, papulopustular rosacea or no rosacea by standardized skin biopsy.
Microbiota from each mite was assessed separately by 16S rRNA clone libraries. Microbiota of
Demodex mites was compared between each group using statistical analysis. The density of mites
was increased in ETR and PPR by 2.5-fold and 6.9-fold, respectively, as compared to controls. A
total of 121 operational taxonomic units were identified with only three shared by the three groups.
The three communities were phylogenetically different as measured by UniFrac (p≤0.001) with an
increased diversity in Demodex from both erythematotelangiectatic and papulopustular rosacea.
Microbiota of Demodex from papulopustular patients showed a 2.5-fold increase in proportion of
Proteobacteria as compared to controls (p=0.035). The microbiota of Demodex mites differs between
rosacea patients and controls. Importantly, Demodex mites from papulopustular rosacea patients
harbor an increased proportion of Proteobacteria which are known to be highly immunogenic. This
and other observed differences may participate in the pathogenesis of rosacea.
1137
A case report of reactivation of tuberculosis during etanercept treatment in a psoriatic patient
D Koumaki,1,5 F Kontos,3 E Papadavid,1 M Dalamaga,4 T Pittaras2 and V Koumaki2,6 1
Dermatology and Venereology, Attikon Hospital, medical school of Athens, HAIDARI, Greece,
2 Microbiology, medical school of Athens, Goudi, Greece, 3 Clinical Microbiology, Attikon
Hospital, medical school of Athens, Haidari, Greece, 4 Clinical Biochemistry, Attikon Hospital,
medical school of Athens, Haidari, Greece, 5 Internal Medicine, 1st IKA HOPSITAL, Melissia,
Greece and 6 Microbiology, 1st IKA HOPSITAL, Melissia, Greece
Anti-tumor necrosis factor (TNF) antagonists, that have become first-line agents in the treatment of
moderate-to-severe psoriasis, cause immunosuppression. There is considerable evidence that links
reactivation of LTBI to the use of anti-TNF monoclonal antibody (mAb). A 58-year old man with a
8-year history of generalized psoriasis and psoriatic arthritis visited our department of internal
medicine because of severe recurrence of his arthritis. He had a free medical history. He was advised
to be treated with etanercept. Before the administration of the anti-TNFα agent, we performed TST
that gave a negative result. After one year of ertanecept therapy, TST was performed again. Although,
the patients’ TST finding was negative with 0 mm of induration, QuantiFERON_-TB Gold test (QFT-
G; Cellestis Ltd, Carnegie, Australia) was ordered, since the patient exhibited symptoms of reacti-
vated tuberculosis, and yielded a positive result. We suggest that QuantiFeron-TB Gold testing may
be a more appropriate primary test in patients with risk factors for false-negative TST results.
1139
Staphylococcus aureus skin colonization is promoted by barrier disruption and leads to local
inflammation
B Kraft,1 I Wanke,1 Y Skabytska,1 A Peschel,2 T Biedermann1 and B Schittek1 1 Department of
Dermatology, University of Tuebingen, Tuebingen, Germany and 2 Interfaculty Institute of
Microbiology and Infection Medicine, University of Tuebingen, Tuebingen, Germany
Experimental mouse models of bacterial skin infections that have been described show that patho-
genic microorganisms can readily invade the epidermis and dermis to produce localized infec-
tions. We used an epicutaneous mouse skin infection model to determine how the level of a bar-
rier disruption by tape-stripping correlates with S. aureus persistent skin colonization, concomitant
induction of cutaneous inflammation and infection. Furthermore, we investigated how murine skin
responds to S. aureus colonization in a physiologic setting by analyzing proinflammatory cytokines
and antimicrobial peptides in mouse skin. We show that previous cutaneous damage allows skin
inflammation to develop, favors S. aureus persistence leading to cutaneous colonization suggest-
ing an interdependence of cutaneous bacteria and skin. Our study suggests that skin barrier defects
favors S. aureus skin colonization which is associated with profound cutaneous inflammation.
1138
A novel role of ceramide metabolite, sphingosine-1-phosphate, in epidermal innate immu-
nity
K Park,1 PM Elias,1 K Shin,2 Y Lee,2 M Hupe,1 AW Borkowski,3 RL Gallo,3 J Saba,4 WM Holleran1
and Y Uchida1 1 Dermatology, University of California, San Francisco, San Francisco, CA, 2
Pharmacy, Chungbuk National University, Cheongju, Democratic People’s Republic of Korea,
3 Dermatology, University of California, San Diego, San Diego, CA and 4 Children’s Hospital
Oakland Research Institute, Oakland, CA
A variety of external perturbations can induce endoplasmic reticulum (ER) stress, followed by stim-
ulation of epithelial cells, including keratinocytes (KC), to produce an innate immune element, the
cathelicidin antimicrobial peptide (CAMP). ER stress also increases production of the pro-apoptotic
lipid ceramide (Cer) and its anti-apoptotic metabolite, sphingosine-1-phosphate (S1P). Our recent
studies elucidated that subtoxic levels of ER stress upregulates CAMP expression via a newly-iden-
tified NF-κB-C/EBPα-, rather than the well-established vitamin D receptor (VDR)-, dependent mech-
anism. We now demonstrate that S1P mediates ER stress-induced CAMP generation. Cellular Cer
and S1P levels rise in parallel with CAMP levels following addition of either thapsigargin (ER stres-
sor) or exogenous cell-permeable Cer (C2Cer), which both increase S1P production, in either cul-
tured human primary KC or mouse skin (topically). Knockdown of S1P lyase, which catabolizes S1P,
enhanced ER stress-induced CAMP production in cultured KC and mouse skin. These and additional
inhibitor/siRNA studies show that S1P is responsible for ER stress-induced upregulation of CAMP
expression. Increased CAMP expression is likely mediated via S1P dependent NF-κB-C/EBPα acti-
vation. Moreover, the S1P signal operates independently of S1P receptors located on the plasma
membrane. Finally, lysates of both ER-stressed and S1P-stimulated cells blocked growth of a viru-
lent Staphylococcus aureus (S. aureus) in vitro, and topical C2Cer and LL-37 inhibited invasion of
S. aureus into murine skin. These studies suggest that S1P-dependent CAMP production comprises
a novel regulatory mechanism of epithelial innate immunity in response to subtoxic levels of exter-
nal stresses, pointing to new therapeutic approach to enhance cutaneous antimicrobial defense.
1136
Post-septic immune-suppression following Gram positive sepsis is mediated by TLR depend-
ent induction of myeloid derived suppressor cells
M Köberle, Y Skabytska and T Biedermann Dermatology, Eberhard Karls University, Tübingen,
Germany
Systemic bacterial infection and consecutive sepsis is a leading cause of death and Gram+ bacte-
ria are a major causative agent. Treatment of acute sepsis has been improved and many patients
survive primary infection. However, severe secondary infections due to post-septic immune sup-
pression are still associated with high mortality in part because underlying mechanisms are poorly
understood. To this end, we established a mouse model of Gram+ sepsis. Mice were intravenously
infected with high doses of Staphylococcus aureus SA113. Animal weight as indicator of sepsis
severity and bacterial CFU (kidneys) were determined as well as several immune parameters at dif-
ferent time points. Importantly, the post-septic immune status was assessed by determining a cuta-
neous T-cell mediated recall response to FITC (FITC-contact hypersensitivity; CHS). Indeed, post-
septic immune suppression was established in these mice, because FITC-CHS was significantly
reduced in comparison to the uninfected control. Among several immune parameters analyzed,
the most striking finding was a massive expansion of the Gr-1+ CD11b+ so called myeloid derived
suppressor cells (MDSC) in septic mice. To assess whether MDSC induction by SA113 sepsis con-
tributes to post-septic immune-suppression, MDSC were first analyzed ex vivo: MDSC completely
blocked T-cell activation with suppressive functions of MDSC dependent on reactive oxygen species
(ROS). Next MDSC were eliminated in vivo using a depleting anti-Gr-1 antibody and, strikingly,
MDSC depletion abrogated post-septic immune suppression of FITC-CHS. MDSC induction in vivo
was independent of either IFN-γ, TNF, IL-4, or IL-10. In contrast, MDSC induction was completely
abrogated when mice deficient in TLR-adaptor protein MyD88 were infected. Further we demon-
strated that MDSC induction by Gram+ bacteria depended on both, TLR2- and TLR9-signaling, but
not NOD-2. In summary, we show for the first time post-septic immune suppression after Gram+
sepsis to be mediated by MDSC induced via MyD88 and TLR2/9 signaling.
1140
In vitro CYP inhibition and induction assessments of efinaconazole coupled with low clini-
cal systemic exposure suggest low DDI potential in topical onychomycosis
W Jo Siu,1 L Mutter,1 A Aoyama,2 H Yamanaka,2 N Sugimoto2 and R Pillai2 1 Dow Pharmaceutical
Sciences, Petaluma, CA and 2 Kaken Pharmaceutical Co., Ltd.,, Shizuoka, Japan
Efinaconazole is a novel triazole antifungal in development for topical treatment of superficial
mycoses. The metabolic drug-drug interaction (DDI) potential of efinaconazole was evaluated in
vitro by identifying the CYP enzymes involved in its metabolism and assessing the capacity for induc-
tion and inhibition of CYP activity. In human liver microsomes with CYP-selective chemical inhibitors
and in recombinant isozyme experiments, multiple CYP enzymes were involved in efinaconazole
metabolism, with CYP2C19 and CYP3A4 identified as the primary isozymes. Azole antifungals are
known to inhibit CYP enzymatic activity and as expected, efinaconazole was a potent competitive
inhibitor of CYP2C8, CYP2C9, CYP2C19 and CYP3A4 in human liver microsomes (inhibition con-
stant, ki, < 2 μM). The ki for the most sensitive isoform, CYP2C9, was 0.26 μM or 91 ng/mL, which
is more than 130-fold higher than the mean peak plasma concentration seen in onychomycosis
patients at steady state (Cmax,ss, 0.67 ng/mL). The Cmax,ss/ki ratio was well below the thresholds
for clinical DDI evaluation as recommended in regulatory guidances. Further, efinaconazole was
not an inducer of CYP1A2 or CYP3A4 activities in human hepatocytes at concentrations as high as
350 ng/mL. Considering that plasma levels in onychomycosis patients are two orders of magnitude
lower than this concentration, efinaconazole is not expected to induce CYP1A2 and CYP3A4 in
vivo. In conclusion, the in vitro CYP-dependent metabolism characteristics of efinaconazole are
similar to those of other azoles such as itraconazole and voriconazole. Based on the very low sys-
temic exposure after topical efinaconazole administration in onychomycosis patients, we conclude
that efinaconazole has limited or no potential for metabolic DDI.
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Histological evaluation of impetigo in the hamster model infected with Staphylococcus aureus
S Adams, S Chandra, H Thibodeaux, E Klymenova, D Shelton, R Willingham, D Danielson-
Borrero, S Wu, S Frey, H Hofland and J Pace Center for Skin Biology, Siefel-GlaxoSmithKline,
Durham, NC
Impetigo is a common largely uncomplicated skin infection most often encountered in children. In
the past group A Streptococcus pyogenes was the primary cause, but Staphylococcus aureus has
come to fore as the principle pathogen, and of marked concern is the increasing incidence of com-
munity-associated methicillin-resistant S. aureus (CA-MRSA). The hamster impetigo model has been
utilized to evaluate efficacy of topical antibiotics for impetigo. In this study, histological analyses of
S. aureus infected hamster tissues at various time points post-infection were evaluated. Tissues from
hamsters humanely euthanized 4, 8, 24, or 48 hrs after intradermal inoculation of CA-MRSA USA300
CDC revealed sequential progression of inflammatory changes in the dermis. Changes at 4h were
minimal with localized vascular dilation, loosely scattered influx of neutrophils in the subcutis/pan-
niculus, with expansion of the lesion at 8h due to edema, significant accumulation of neutrophils
extending to the subcutis associated with localized necrosis of dermis. At 24h, the lesion had a large
area of necrotic dermis containing clumps of bacterial colonies with a band of neutrophils on the
periphery area covered by non-viable epidermis. At 48h, the lesion was similar to that noted at 24h
and revealed a fairly well-demarcated flask-shaped lesion confined to the dermis/subcutis (resolv-
ing). Histologically, bacterial clumps (ie. colonies) were prominent at 8h and 24h after inoculation
(than at 4h or 48hrs). Histologic changes 48h after inoculation with methicillin-susceptible S. aureus
ATCC 29213 revealed an extensive area of tissue necrosis and the microscopic changes were sub-
stantially different compared to those noted in hamsters inoculated with CA-MRSA. These findings
suggest remarkable tissue involvement in impetigo greater than may be observed macroscopically
on the surface, and that differences in disease states associated with diverse pathogen lineage may
occur.
1142
Toll-like receptor 2 epidermal barrier enhancement is inhibited by Th2 cytokines found in
atopic dermatitis
I Kuo,1 T Yoshida,1 A De Benedetto,1 DY Leung2 and LA Beck1 1 Dermatology, University of
Rochester Medical Center, Rochester, NY and 2 Pediatrics, National Jewish Health, Denver,
CO
Atopic dermatitis (AD) is a Th2-driven skin disorder characterized by a defect in epidermal tight
junction (TJ). We recently found that activation of toll-like receptor 2 (TLR2) enhances epidermal TJ
integrity and AD subjects have reduced expression of TLR2 in their epidermis. We hypothesized that
Th2 cytokines inhibit the TLR2 mediated barrier repair function. Human epidermal TLR2 immunore-
activity inversely correlated with Th2 biomarkers (total IgE, r=−0.596, P=0.032; circulating eosinophil
counts, r=−0.609, P=0.027). Th2 cytokines (IL-4+IL-13, 10 and 50 ng/mL, respectively) inhibited
TLR2 protein expression in primary human keratinocytes. The TLR1/2 agonist, Pam3C enhanced TJ
barrier recovery (P<0.001) following tape-stripping of human skin explants. This recovery was blocked
by co-treatment with Th2 cytokines as demonstrated by measurement of both transepithelial elec-
trical resistance (TEER; P<0.01) and paracellular permeability (P<0.01). To confirm our hypothesis,
we evaluated barrier recovery in STAT6VT mice, which have a constitutively active mutant form of
STAT6 primarily in T lymphocytes, resulting in a hyper-Th2 immune profile. We observed that these
mice had reduced epidermal expression of TLR2 by using confocal microscopy and delayed bar-
rier recovery following tape-stripping as measured by transepidermal water loss (wild type [WT] vs
STAT6VT: 41 vs 71 g/hr/m2 at 24 h, P<0.001). Consistent with this, TLR1/2 agonist Pam3C enhanced
TJ barrier recovery measured by TEER (P<0.01) and paracellular permeability (P<0.01) in skin sam-
ples from WT but not STAT6VT mice. In summary, Th2 cytokines commonly found in AD skin reduce
epidermal TLR2 expression and barrier repair function. This finding suggests that antagonizing Th2
cytokines in AD patients may restore the TLR2 epidermal innate immune response, which will help
repair epidermal barrier defects and possibly also enhance elimination of unwanted cutaneous
pathogens.
1143
Processing of the extracellular matrix component laminin generates peptides with antimi-
crobial and chemotactic activity
I Senyuerek,1 W Kempf,1 G Klein,2 A Maurer,3 H Kalbacher,3 S Stevanovic,4 P Rousselle,5
C Garbe,1 M Schaller,1 T Biedermann1 and B Schittek1 1 Dermatology, University of Tuebingen,
Tuebingen, Germany, 2 Section for Transplantation Immunology and Immunohematology,
University of Tuebingen, Tuebingen, Germany, 3 Interfaculty Institute for Biochemistry,
Medical and Natural Sciences Research Center, University of Tuebingen, Tuebingen,
Germany, 4 Institute for Cell Biology, University of Tuebingen, Tuebingen, Germany and 5
Structure Fédérative de Recherche BioSciences Gerland-Lyon Sud, Institut de Biologie et
Chimie des Protéines, Université Lyon 1, Lyon, France
Heterotrimeric laminins play a fundamental role in basement membrane architecture and function
in human skin. The C-terminal laminin G domain-like (LG) modules of several laminin α chains are
modified by proteolysis to generate LG1-3 and secreted LG4-5 modules. Our group has previously
reported that peptides derived from the LG4 module of human laminin α4 and α5 chains exhibit a
dose-dependent antimicrobial activity against Gram-positive and Gram-negative bacteria. In the
present study, we provide evidence that human keratinocytes and fibroblasts process and secrete
biologically active peptides from the LG4-5 module of the laminin α3, α4 and α5 chain in vitro
and in vivo. Furthermore we demonstrate that also laminin LG4-derived peptides from the α3, α4
and α5 chains have potent antimicrobial activity against Gram-positive and Gram-negative bacte-
ria and feature a strong chemotactic activity towards mononuclear cells. Laminin LG4-derived
peptides enhance proliferation of human keratinocytes, suggesting that LG4 peptides could play a
crucial role in wound healing. Indeed, we found that expression and processing of laminin α3
LG4-5 module is strongly increased in skin wounds and that the expression of laminin α3 and α5
chains are increased after wound infection. These data suggest that expression and processing of
laminin α chains is tightly regulated and that processing of the LG4-5 module plays a role in inflam-
mation, wound healing and skin host defense.
1144
Resveratrol stimulates sphingosine-1-phosphate signaling of Cathelicidin Antimicrobial Pep-
tide (CAMP) production
K Park,1 PM Elias,1 M Hupe,1 AW Borkowski,2 RL Gallo,2 K Shin,3 Y Lee,3 WM Holleran1 and
Y Uchida1 1 Dermatology, University of California, San Francisco, San Francisco, CA, 2
University of California, San Diego, San Diego, CA and 3 Chungbuk National University,
Cheongju, Democratic People’s Republic of Korea
We recently discovered a novel regulatory mechanism that stimulates production of the multifunc-
tional antimicrobial peptide, cathelicidin antimicrobial peptide (CAMP). In response to subtoxic
levels of ER stress, sphingosine-1-phosphate (S1P) levels increase, activating an NFκBÇC/EBPα
dependent pathway that enhances CAMP production in cultured human keratinocytes. Since the
multifunctional stilbenoid compound, resveratrol (RESV), increases levels of ceramide (Cer, a pre-
cursor of S1P), we hypothesized and assessed here whether RESV could exploit the same pathway
to regulate CAMP production. Accordingly, RESV significantly increased Cer and S1P levels in cul-
tured keratinocytes, paralleled by increased CAMP mRNA/protein expression. Furthermore, topical
RESV also increased murine CAMP mRNA/protein expression in mouse skin. Conversely, blockade
of CerÇsphingosineÇS1P metabolic conversion, with specific inhibitors of ceramidase or sphin-
gosine kinase, attenuated the expected RESV-mediated increase in CAMP expression. In addition,
the RESV-induced increased in CAMP expression required both NF-κB and C/EBPα transactivation.
Moreover, conditioned media from keratinocytes treated with RESV significantly suppressed Staphy-
lococcus aureus (S. aureus) growth. Finally, topical RESV, but not with coapplication with a specific
inhibitor of sphingosine kinase, blocked S. aureus invasion into murine skin. These results demon-
strate that the dietary stilbenoid, RESV, stimulates S1P signaling of CAMP production through an
NF-κBÇC/EBPα-dependent mechanism, leading to enhanced antimicrobial defense against exoge-
nous microbial pathogens.
1145
Immune responses to Propionibacterium acnes
B Janela,1 P Musette,2 A Jomard3 and F Ginhoux1 1 Singapore Immunology Network, A*STAR,
Singapore, Singapore, 2 INSERM U905, Rouen University Hospital, Rouen, France and 3
Galderma R&D, Sophia-Antipolis, France
Acne Vulgaris is a common chronic skin inflammatory disorder caused, in part, by inflammation of
the hair follicles and the sebaceous glands. The presence of Propionibacterium acnes (P. acnes) and
the induction of associated pro-inflammatory responses are some of the key features seen in inflam-
matory Acne Vulgaris. In rodents, P. acnes generate granulomatous reactions when injected into the
skin, the lung or the liver, similar to granulomas found in human diseases. The precise mechanisms
by which P. acnes induce such inflammatory responses are poorly understood. In particular, the role
of cutaneous dendritic cells (DCs), professional antigen sensing and presenting cells that control
the initiation of immune responses, remains elusive. We followed, after intradermal injection of P.
acnes, the appearance of the granulomatous reactions by histology and by caliper evaluation of the
thickness of the ear. Using 11 colour flow cytometry, we also characterized the cellular composi-
tion of these granulomas and identified all the associated leucocyte populations. Injection of P. acnes
induces a significant thickening of the ear over the entire time course of 75 days with a maximum
at D9, followed by a decrease stabilizing between D15 to D30. This increased thickening was asso-
ciated with the appearance of granulomas as soon as D2. Analysis of the early innate immune
response highlighted a major neutrophil infiltration in the dermis during the 3 first days, followed
by a second wave of monocytes and inflammatory CD11b+ DCs from D4 to D9 and by a last wave
of lymphocytes, which are retained in the skin until D30. The precise nature of the lymphocytic
response is still under investigation. These findings will allow a better understanding of the immune
cell subsets and molecular pathways involved in the granulomas formation induced by P. acnes
and may offer new therapeutic targets in the treatment of the inflammatory responses seen with Acne
Vulgaris.
1146
Basic fibroblast growth factor, promoting FOXP3 expression in MT2 cells, is a bridge linking
UVR and regulatory T cells in psoriasis treatment
L Chen,1 X Yang2 and Z Shen2 1 Department of Dermatology, Daping Hospital, Third Military
Medical University, Chongqing, China and 2 Department of Dermatology, Southwest
Hospital, Third Military Medical University, Chongqing, China
Forkhead box P3 (FOXP3) is a key transcription factor in regulatory T cells. The promotion of FOXP3+
regulatory T cells by ultraviolet radiation (UVR) in psoriasis has been suggested by previous stud-
ies. But the exact bridge linking them has not been identified. In the present study, we mainly uti-
lized cell culture, ELISA, and Western blot methods. We found that the co-culture of keratinocytes
and MT2 cells (human leukemia cell line) could increase FOXP3 expression in the later. Next, we
found the supernatant of cultured keratinocytes showed similar effect on FOXP3 expression in MT2
cells and this effect could be amplified if the keratinocytes was pre-irradiated by UVR. This obser-
vation suggested some cytokine(s) in keratinocyte supernatant might play vital roles in promoting
FOXP3 expression and the secretion of the cytokine(s) should be regulated by UVR. In the follow-
ing study, we investigated the involvement of the candidate cytokine(s). We found that UVR could
increase the secretion of basic fibroblast growth factor (bFGF) by keratinocytes. In addition, the addi-
tion of bFGF into the culture of MT2 cells could increase the expression of FOXP3 in a dose-depend-
ent manner. These results showed bFGF was such a cytokine in keratinocyte supernatant that could
upregulate FOXP3 expression in MT2 cells. Our study suggests bFGF is a bridge linking UVR and
regulatory T cells via keratinocytes in psoriasis treatment. This conclusion needs further investiga-
tion in psotiatic patients.
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Differential cell intrinsic MyD88- and STAT3-signaling promote immunity against Staphylo-
coccus aureus skin infection
JS Cho,1 RI Ramos,2 Y Guo,2 JH Shahbazian3 and LS Miller3 1 Division of Dermatology,
University of California Los Angeles (UCLA), Los Angeles, CA, 2 Department of Translational
Immunology, Dirks/Dougherty Laboratory for Cancer Research, John Wayne Cancer Institute,
Santa Monica, CA and 3 Department of Dermatology, Johns Hopkins University School of
Medicine, Baltimore, MD
Humans with impaired IL-1R and TLR signaling (as a result of MyD88 or IRAK deficiency) or impaired
Th17 cell responses (as a result of the STAT3 mutations in autosomal dominant hyper-IgE syn-
drome) were found to have a selective predisposition to S. aureus infections in the skin. In mice,
we previously reported that neutrophil recruitment to a site of S. aureus skin infection is mediated
by IL-1R/MyD88 signaling and indirectly through γδT cell production of IL-17, which also required
IL-23/STAT3 activation. To determine the cell types that utilized MyD88 or STAT3 intrinsic signal-
ing for host defense against S. aureus skin infections, conditional knockout mice were generated by
crossing mice with cre expression in keratinocytes (K14-ERT2-cre mice), T cells (Lck-cre mice) or
neutrophils and monocytes/macrophages (LysM-cre mice) with MyD88flox/flox mice or STAT3flox/flox
mice. These conditional knockout mice were inoculated with a bioluminescent strain of S. aureus
into the back skin and lesion sizes and the in vivo bacterial burden were measured noninvasively
over time using digital photography/image analysis and in vivo bioluminescence imaging, respec-
tively. Mice with MyD88 or STAT3 deletion in keratinocytes and T cells had statistically and sub-
stantially increased lesion sizes and bacterial burden compared with wildtype control mice. Mice
with deletion of MyD88 but not STAT3 in neutrophils and monocytes/macrophages also had increased
lesion sizes and bacterial burden compared with wildtype control mice. Taken together, keratinocytes
and T cells utilized both MyD88 and STAT3 signaling whereas neutrophils and
monocytes/macrophages utilized MyD88 but not STAT3 to promote an effective immune response
against a S. aureus skin infection.
1149
IL-33 KO mice exhibit the reduced immediate type contact hypersensitivity
Y Imai,1 T Haneda,1 K Yasuda,2 T Yoshimoto,3 K Nakanishi2 and K Yamanishi1 1 Dermatology,
Hyogo College of Medicine, Nishinomiya, Japan, 2 Immunology and Medical Zoology, Hyogo
College of Medicine, Nishinomiya, Japan and 3 Laboratory of Allergic Diseases, Institute for
Advanced Medical Sciences, Hyogo College of Medicine, Nishinomiya, Japan
IL-33, a member of IL-1 family cytokine is a ligand of ST2. IL-33 stimulates Th2 cells, basophils,
mast cells and type II innate lymphoid cells. We recently reported that ragweed-induced allergic
rhinitis was not observed in IL-33 KO mice (JACI, 130:184.e11, 2012). In this study, to elucidate the
pathological role of IL-33 in dermatitis, we examined an immediate type contact hypersensitivity
of skin induced in IL-33 KO and ST2 KO mice. Mice were sensitized and repeatedly challenged
with DNFB on the left ear every other week. The ear thickness was measured before and after each
challenge. No immediate reaction occurred after the 1st challenge, however, wild-type mice showed
immediate reaction after the 3rd challenge. In contrast, both in IL-33 KO and ST2 KO mice, the
immediate reaction was not induced. Plasma histamine levels were significantly lower in IL-33 KO
and ST2 KO mice than in wild type mice. The number of mast cells of the skin increased in wild
type mice, but not in IL-33 KO or ST2 KO mice. In contrast, no difference was seen in the number
of basophils between wild-type and IL-33 KO and ST2 KO mice. By using real-time PCR and immuno-
histochemistry, we found that IL-33 expression significantly increased 6 hour after DNFB adminis-
tration. From these results, we propose the following mechanism. IL-33 is secreted from keratinocytes
in response to stimulation such as allergens or excoriation. IL-33 acts as alarmin and recruits ST2-
positive mast cells into the skin. The large amount of histamine was released by antigen stimulation
due to large number of mast cells infiltrating in dermis. This is how immediate contact hypersensi-
tivity was triggered. In conclusion, IL-33 plays an important role in the mechanism of immediate
contact hypersensitivity.
1151
Efinaconazole’s nail penetration and fungicidal activity may contribute to its therapeutic
efficacy as a topical treatment for onychomycosis
K Sugiura,1 S Hosaka,2 N Sugimoto,2 Y Tatsumi1 and W Jo Siu3 1 Kaken Pharmaceutical Co., Ltd.,
Kyoto, Japan, 2 Kaken Pharmaceutical Co., Ltd., Shizuoka, Japan and 3 Dow Pharmaceutical
Sciences, a division of Valeant Pharmaceuticals North America LLC, Petaluma, CA
Onychomycosis is a fungal disease of the nail in which the infection resides in the nail bed. Effi-
cacy of topical antifungal drugs is limited by their poor penetration through the nail and decreased
fungicidal activity with keratin. Efinaconazole is a novel triazole with potent in vitro antifungal activ-
ity. The in vitro nail penetration, fungicidal activity in the presence of keratin, and in vivo efficacy
of efinaconazole were compared to existing topical onychomycosis drugs, ciclopirox and amorolfine.
Drug penetration through human nail was evaluated in Franz diffusion cells following a single appli-
cation of efinaconazole 10% solution, and ciclopirox and amorolfine lacquers. Efinaconazole pen-
etrated through the nail plate faster than ciclopirox and amorolfine. Cumulative penetration after
14 days (6.53±8.15 μg/cm2, mean±SD) was comparable to ciclopirox (4.57±6.89 μg/cm2) and higher
than amorolfine (below the detection limit). In a 20% keratin media mimicking the nutritional envi-
ronment of the nail, efinaconazole at ≥1.25 μg/ml showed comparable fungicidal activity to
amorolfine against Trichophyton mentagrophytes and was superior to ciclopirox. In a guinea pig
onychomycosis model with T. mentagrophytes infection, efinaconazole 10% solution significantly
reduced nail fungal viable counts (2.41±0.48, mean log CFU±SD) after 28 days compared with
infected control (4.64 ± 0.30, p<0.001). The viable cell counts of the efinaconazole group were sig-
nificantly lower than those of the ciclopirox and amorolfine lacquers (3.17±0.77, p<0.01 and
3.99±0.48, p<0.001, respectively). In conclusion, the superior in vivo efficacy of efinaconazole is
likely to relate to a combination of its greater nail penetration, low keratin affinity and potent fun-
gicidal activity.
1150
Suppressive CD14dimCD16+ monocytes contribute defective anti-viral immune responses in
eczema herpeticum
R Takahashi1,2 and T Shiohara2,1 1 Division of FlowCytometry, Kyorin University Graduate
School of Medicine, Mitaka, Japan and 2 Department of Dermatology, KYORIN University,
School of Medicine, Mitaka, Japan
Eczema herpeticum (EH) is a severe viral superinfection of the skin lesions in atopic dermatitis (AD)
by herpes simplex virus (HSV)-1 associated with severe systemic illness. We have recently found
that functional regulatory T cells (Tregs) were expanded at onset and contracted upon resolution in
ADEH. This expansion was associated with impaired IFN-γ and TNF-α production by CD8 T and
NK cells. Furthermore, we previously demonstrated a profound reduction in TLR2-mediated proin-
flammatory cytokines in proinflammatory monocytes (MO) from AD patients. Recently, paired
immunoglobulin-like type 2 receptor α (PILRα) has been identified as a glycoprotein B receptor for
HSV-1 and we have found that PILRαwas preferentially expressed on CD14dimCD16+ MOs. There-
fore, we investigated whether this selective impairment could be related to onset of ADEH and could
be restored coincident with a contraction of Tregs and CD14dimCD16+ MOs after clinical resolu-
tion. To demonstrate that IFN-γ production by HSV-1 specific CD8 T cells could be abrogated by
expanded Tregs at onset, we analyzed the effects of depletion of Tregs on IFN-γ production by HSV-
1 specific CD8 T cells from these patients. IFN-γ production by HSV-1 specific CD8 T cells was
restored upon depletion of Tregs from PBMCs obtained from ADEH at onset: surprisingly, Treg deple-
tion resulted in a 2-fold increase in the frequency of HSV-1-specific CD8 T cells producing IFN-γ.
Proinflammatory cytokine production from CD14dimCD16+PILRα++ MOs in response to TLR2 was
significantly reduced in the onset of ADEH. In contrast, IL-10 production in response to TLR2 was
significantly increased in the onset of ADEH. Importantly, this population at the onset of ADEH was
characterized by increased IL-10R expression. These results indicate that suppressed TLR2-medi-
ated protective immunity against the HSV-1 infection by suppressive CD14dimCD16+ MOs and
expanded functional Tregs may contribute defective anti-viral immune responses in ADEH.
1148
HPV in male genital lichen sclerosus, penile carcinoma-in-situ and penile squamous cell car-
cinoma
T Shim,1,2 M de Koning,3 A Muneer,2 S Minhas,2 N Francis,1 CF Jameson,2 M Dinneen,1 KJ Purdie,4
SI Goolamali,1 CA Harwood4 and CB Bunker1,2 1 Chelsea and Westminster Hospital, London,
United Kingdom, 2 University College Hospital, London, United Kingdom, 3 DDL, Rijswijk,
Netherlands and 4 Queen Mary University, London, United Kingdom
Male genital lichen sclerosus (MGLSc) is an acquired cutaneous disease of uncertain aetiology. It
causes acute and chronic inflammation (balanoposthitis) and scarring that can result in sexual dys-
function, urological morbidity and an increased risk of squamous cell carcinoma (SCC) of penis.
Penile carcinoma-in-situ (PCIS) describe three distinctive premalignant clinical entities: erythro-
plasia of Queyrat (EQ), Bowen’s disease of the penis (BDP) and bowenoid papulosis (BP). The
aetiopathogenesis of MGLSc and PCIS is unknown. Human papillomavirus (HPV) has been impli-
cated. This study addresses the role of HPV in MGLSc, PCIS and penile SCC. 40 cases have been
evaluated: 25 MGLSc, 9 PCIS (8 BDP, 1 BP), 6 SCC. DNA was extracted from paraffin-embedded
sections using the QiAmp DNA mini kit (Qiagen). Broad spectrum PCR combined with a reverse
hybridization assay was used to identify all known HPV types. HPV was found in 8/25 MGLSc, 8/9
PCIS (7/8 BPD, 1/1 BP) and 4/6 penile SCC. HPV sub-types 1, 2, 6, 16, 24, 27, 43, 51, 52, 53 and
74 were observed in MGLSc. HPV subtypes 1, 6, 16, 18, 31, 33, 56 and 58 were seen in BDP,
whereas subtype 16 was seen in the case of BP. HPV subtypes 16, 31, 43, 52 and 74 were detected
in penile SCC. Some of these HPV subtypes are previously unreported: 1, 2, 6, 24, 27, 43, 52, 53
and 74 in MGLSc; 1, 18, 31, 33, 56 and 58 in BDP. Co-infection with multiple HPV types was seen
in 50% cases of MGLSc and PCIS. One case of penile SCC had multiple sub-types. A high preva-
lence of HPV 16 has been shown as has several previously unreported HPV sub-types. Analysis of
more case samples is in progress.
1152
Strong induction of AIM2 expression in human epidermis in acute and chronic inflammatory
skin conditions
HD de Koning,1,2,3 JG Bergboer,1,4 EH van den Bogaard,1,3,4 IM van Vlijmen-Willems,1 D Rodijk-
Olthuis,1 A Simon,2,3 PL Zeeuwen1,3,4 and J Schalkwijk1,3,4 1 Dermatology, Radboud University
Nijmegen Medical Centre, Nijmegen, Netherlands, 2 Internal Medicine, Radboud University
Nijmegen Medical Centre, Nijmegen, Netherlands, 3 Nijmegen Institute for Infection,
Inflammation and Immunity, Nijmegen, Netherlands and 4 Nijmegen Centre for Molecular
Life Sciences, Nijmegen, Netherlands
Absent in melanoma 2 (AIM2) is a double-stranded DNA receptor and its activation initiates an inter-
leukin-1 beta processing inflammasome. AIM2 is implicated in host defense against several pathogens,
but could hypothetically also contribute to autoinflammatory or autoimmune diseases. Here, we
aimed to investigate AIM2 expression in inflammatory skin conditions and AIM2 induction in vitro,
and to develop an AIM2 antibody suitable for immunohistochemistry. Epidermal mRNA and pro-
tein levels of AIM2 were assessed in several inflammatory skin conditions; primary human ker-
atinocytes were stimulated with various cytokines; and AIM2 induction in a human reconstructed
epidermis was studied. We found strong epidermal upregulation of AIM2 in several acute and chronic
inflammatory skin disorders, such as psoriasis, atopic dermatitis, venous ulcera, contact dermatitis,
and experimental wounds. In normal skin, Langerhans cells and melanocytes were the primary
AIM2-expressing cells. We also studied AIM2 expression in in vitro models of human epidermis. In
all conditions, AIM2 seemed to be predominantly induced by interferon-gamma and in proliferat-
ing keratinocytes, which may provide a link between its functions in inflammation and in its puta-
tive role in growth control. In inflammatory skin conditions AIM2 expression is strongly induced in
the epidermis, and interferon-gamma is the strongest inducer in primary human keratinocytes.
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Programmed cell death induced by CAPS-associated mutant NLRP3 features necrosis that
leads to in vivo neutrophilic inflammation
T Satoh, N Kambe and H Matsue Dermatology, Chiba University, Chiba, Japan
Cryopyrin-associated periodic syndrome (CAPS), clinically characterized by neutrophil-rich urticar-
ial rash, is associated with missense mutations in NLRP3. NLRP3 is a pattern recognition receptor
in the cytoplasm of cells and structurally related to plant resistance proteins, which detect pathogen
or danger associated signals, leading to programmed cell death and hyper response at the local
site. In mammals, activated NLRP3 forms inflammasome, which orchestrates the early inflamma-
tory process via IL-1β activation, but the contribution of the cell death to inflammatory response is
unknown. We have established a system in which programmed necrotic cell death was induced by
the expression of CAPS-associated gain-of-function mutant of NLRP3, using a tetracycline-inducible
expression (Tet-on) system. In this system, administration of doxycycline without LPS pretreatment
induced only necrotic cell death but not IL-1β secretion. Therefore, we can evaluate the contribu-
tion of NLRP3-mediated necrotic cell death on neutrophilic inflammation in vivo, independently
of IL-1β, using a mouse air-pouch model. Upon oral administration of doxycycline, injection of LPS-
pretreated cells harboring mutant NLRP3, but not wild type NLRP3, showed necrotic cell death in
addition to IL-1β release, resulting in the significant increase in numbers of neutrophils in the air-
pouch on the back skin of mice. Interestingly, non-pretreated mutant cells, which showed necrotic
cell death without mature IL-1β release, also induced neutrophil infiltration, though smaller in num-
ber relative to neutrophil infiltration induced by LPS-pretreated mutant cells. These results indicate
that necrotic cell death in itself can cause and exacerbate the neutrophilic inflammatory response,
suggesting a putative role of the necrotic cell death of NLRP3-expressing inflammatory cells in
urticarial rash.
1154
The alarmin IL-33 derived from HSV-2-infected keratinocytes triggers mast cell-mediated
antiviral innate immunity
R Aoki,1 T Kawamura,1 F Goshima,2 Y Nishiyama2 and S Shimada1 1 Dermatology, University of
Yamanashi, Yamanashi, Japan and 2 Virology, Nagoya University Graduate School of
Medicine, Nagoya, Japan
The essential contribution of mast cells (MCs) to bacterial host defense has been well established;
however, little is known about their role in viral infections in vivo. We have previously reported that
MCs were critically involved in host defense at herpes simplex virus 2 (HSV-2)-infected sites through
TNF-α and IL-6 production using a MC knock-in mouse model. Interestingly, HSV did not directly
induce TNF-α or IL-6 production by bone marrow-derived MCs (BMMCs), whereas supernatants
from HSV-infected keratinocytes induced production of these cytokines by BMMCs. Therefore, we
examined which factor derived from HSV-infected keratinocytes induced TNF-αand IL-6 produc-
tion by BMMCs. In vivo cytokine screening in HSV-infected skin indicated that the protein level of
IL-33, known as an “alarmin” in innate immune responses, was peaked at day 1 p.i., and IL-33 pro-
tein kinetics paralleled the kinetics of HSV titer in the skin, suggesting that productive viral repli-
cation promotes IL-33 release in the skin. Immunohistochemical staining for IL-33 in HSV-infected
skin showed that IL-33 was expressed in the nucleus of epidermal keratinocytes at day 1 p.i. More-
over, IL-33 was found to be selectively expressed on damaged Pam 212 cells and secreted by these
cells after in vitro HSV exposure. The frequency of IL-33-expressing cells was increased in a MOI
dependent manner. Importantly, we found that TNF-α and IL-6 production by BMMCs in response
to the supernatants from HSV-treated Pam 212 cells was significantly reduced by blockade of the
IL-33 receptor using the T1/ST2 antibody. Furthermore, we confirmed that rIL-33 stimulated TNF-α
and IL-6 production by BMMCs. These results indicate that IL-33 derived from HSV-infected ker-
atinocytes acts as an alarmin and triggers TNF-α and IL-6 production by mast cells.
1155
Inhibitory effects of Helicobacter pylori-derived antimicrobial peptide HPA3NT3 against Pro-
pionibacterium acnes in the skin
S Ryu,1 Y Park,2 B Kim,3 S Cho,4 C Gurley,1 K Song,1 CA Armstrong1 and PI Song1 1 Dermatology,
University of Arkansas for Medical Sciences, Little Rock, AR, 2 Biochemistry, Chosun
University School of Medicine, Gwangju, Republic of Korea, 3 Dermatology, Chung-Ang
University College of Medicine, Seoul, Republic of Korea and 4 Functional Food and Nutrition
Division, National Academy of Agricultural Science, Rural Department Administration,
Suwon, Republic of Korea
An effective treatment strategy for acne vulgaris is the reduction of Propionibacterium acnes (P.
acnes). In this study, we examined the role of Helicobacter pylori (H. pylori)-derived synthetic antimi-
crobial peptide (AMP) HPA3NT3 against P. acnes in the skin. HPA3NT3 is a previously reported α-
helical antibiotic peptide with enhanced hydrophobicity and positive charge which promotes potent
antibacterial effects against gram positive and negative bacteria such as Staphylococcus aureus and
Escherichia coli. The minimal inhibitory concentration (MIC) of HPA3NT3 against P. acnes was 0.4
μM, which is similar to the MIC determined for clindamycin (0.2 μM). HPA3NT3 showed no cyto-
toxicity in vitro against normal human keratinocytes (HK) even at concentrations 10-fold higher than
those needed for biologic activity. Treatment of HK with HPA3NT3 after incubation with P. acnes
significantly decreased the expression of IL-8 and the rapid fluctuation of intracellular calcium
through blocking of activated NF-κB signaling pathways associated with TLR2, which are induced
by P. acnes. Intradermal injection of HPA3NT3 effectively decreased the number of P. acnes in an
established model of P. acnes-induced inflammation in ICR mouse ears. P. acnes-induced ear swelling
and the histologic inflammatory infiltrate was also significantly reduced by HPA3NT3 but not by
clindamycin. Taken together, our data suggest that HPA3NT3 may represent a new therapeutic
approach to acne vulgaris due to its enhanced bactericidal and anti-inflammatory actions.
1156
Alarmin function of cathelicidin antimicrobial peptide LL37 through IL-36s induction and
p38 MAPK pathway in keratinocytes
N Li, S Fukushi-Takahashi, R Shimada-Omori, M Asano, R Saito, K Yamasaki and S Aiba
Dermatology, Tohoku University Graduate School of Medicine, Sendai, Japan
Several dermatoses including psoriasis, atopic dermatitis, and rosacea alter the expression of innate
immune effecter human cathelicidin antimicrobial peptide (CAMP). To elucidate consequence of
aberrant CAMP in dermatoses, we performed the cDNA array analysis in CAMP-stimulated human
epidermal keratinocytes, which are primary cells in response of innate immunity and a major source
of CAMP LL37 in skin. Among LL37-inducible genes, IL-1 cluster genes, particularly IL-36s, are of
interest since we observed that the coordinate increases in CAMP and IL-36s in lesional skin of pso-
riasis whereas virtually no CAMP and IL36s was observed in non-lesional skin and normal skin. Real
time RT-PCR, western blotting and ELISA confirmed that LL37 increases IL-36γ and IL-36β as well
as IL-1 cluster genes in keratinocytes. Production and release of IL-36γ increase more in differenti-
ated than undifferentiated keratinocytes up to 20 to 30 ng/ml. As an alarmin, LL37 induces chemokines
including CXCL1, CXCL8/IL-8, CXCL9, CXCL10/IP-10 and CCL20/MIP3a in keratinocytes. 10 to 100
ng/ml of IL-36s (α, β and γ) augmented these chemokines production by LL37, and p38 MAPK
inhibitor SB203580 suppressed the CXCL1, CXCL8/IL-8, CXCL10/IP-10 and CCL20/MIP3a pro-
duction by LL37 and IL36s. Pretreatment of siRNA for IL-36β suppressed LL37-dependent CXCL1
and CXCL10/IP-10 production, and siRNA for IL-36γ partially suppressed CXCL1 and CXCL8/IL-8
production by LL37 in keratinocytes. IL-36s siRNA did not alter CCL20 induction by LL37. Along
with the previous observation of increase in these chemokines in psoriasis epidermis, our findings
suggested that alarmin functions of CAMP are at least partially through IL-36s induction and p38
MAPK pathway in keratinocytes. Since CAMP is induced in innate stimuli such as infection and
wounding, this would explain the mechanism of occasional exacerbation of psoriasis, and innate
immune axis would be an option of therapeutic targets.
1157
Hippo pathway mediates the inhibitory signal on epidermal γδ T cells
Y Uchida, K Kawai, A Ibusuki and T Kanekura Dermatology, Kagoshima University Graduate
School of Medical and Dental Sciences, Kagoshima, Japan
Resident murine epidermal γδ T cells, known as dendritic epidermal T cells (DETCs), constitutively
express E-cadherin. We have shown that E-cadherin acts as an inhibitory receptor on DETCs, but
the signaling pathway that mediates the inhibitory signal through E-cadherin has not been deter-
mined. In this study, we analyzed expression levels of known signaling molecules, which mediate
inhibitory signals through other lymphocyte inhibitory receptors or through E-cadherin on epithe-
lial cells, before and after cross-linking of E-cadherin on DETCs. Quantitative RT-PCR analysis showed
no significant up-regulation of SHP-1, SHP-2, SHIP-1, BATF, or PTEN expression after the cross-link-
ing of E-cadherin on DETCs. Previously, we have shown that E-cadherin is down-regulated upon
activation of DETCs during wound healing in vivo. In the periwound activated DETCs, a transcrip-
tion coactivator, Yes-associated protein (YAP) translocated to the nucleus. YAP in short-term DETC
lines also translocated to the nucleus on activation in vitro. These results suggest possible involve-
ment of Hippo signaling pathway, which mediates contact inhibition in epithelial cells, in the
inhibitory signal through E-cadherin on DETCs.
1158
Correlation of rosacea lesions with distribution of skin microflora in face
R Shimada-Omori, N Li, K Yamasaki and S Aiba Dermatology, Tohoku University Graduate
School of Medicine, Sendai, Japan
Aberrant innate immune responses have been emerged into the pathogenesis of rosacea. Rosacea
and rosacea-like dermatitis induced by corticosteroid and tacrolimus showed increase in TLR2 and
cathelicidin antimicrobial peptide in lesional skin. Since these molecules are inducible by microbe
stimuli and common rosacea lesion sites are relatively limited to malar, forehead and mandibular
region, we examined the amount and composition of bacterial flora in face of 7 individuals with
rosacea and 6 healthy controls. Microflora were determined by PCR of extract from tape-strip sam-
ples (6.9 cm2) from 7 points in the face; forehead, lower eyelid, cheek, nose, nasolabial fold, philtrum,
and mandibular. VISIA™ Evolution scored skin redness and porphyrin amounts reflecting P.acnes.
The over all ratio of detected bacteria was P.acnes 79.87 ± 35.86%, S.epidermidis 6.47 ± 13.61%,
MRSA 1.3 ± 3.18%, and MSSA was undetectable. Average amount of bacteria (CFU/cm2, mean ±
SD) in rosacea skin was 1.79 ± 2.07 in forehead, 0.72 ± 0.92 in lower eyelid, 1.27 ± 1.63 in cheek,
7.29 ± 8.09 in nose, 2.72 ± 3.09 in nasolabial fold, 5.80 ± 6.41 in philtrum, 2.19 ± 2.26 in mandibu-
lar. The bacteria amounts in each site of rosacea group were not significantly different from control.
The redness scores of rosacea were higher than control (14.92 ± 5.38 and 4.517 ± 3.37, respec-
tively), but no correlation was observed between redness and the amount of bacteria. The por-
phyrin scores positively correlated with the amount of P.acnes, and no correlation between redness
and porphyrin score was observed in both rosacea and control group. A rosacea individual that
improved redness 14% in the course of treatments showed more than 90% decrease in both the
porphyrin score and P.acnes amount. The results suggested that the microflora did not correlate
with the severity of skin redness in rosacea though improvement of symptom was accompanied with
the decrease in P.acnes. Thus, increased sensitivity to innate immune stimuli by aberrant TLR2 expres-
sion would be more associated with rosacea pathogenesis than altered microflora.
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Proteomic diversity of five types of Propionibacterium acnes strains isolated from human skin
I Dekio,1,2 R Culak,1 M Fang,1 D Rajendram,1 E Morita,2 S Gharbia1 and HN Shah1 1 Department
for Bioanalysis and Horizon Technologies, Health Protection Agency, London, United
Kingdom and 2 Department of Dermatology, Faculty of Medicine, Shimane University, Izumo,
Japan
Objectives: Propionibacterium acnes, an abundant commensal of human skin, is also known as an
opportunistic pathogen of acne vulgaris (common acne), sarcoidosis, prostate cancer, prosthetic hip
joint infection, and other infectious diseases. Recently, investigations using sequence data of sev-
eral housekeeping genes (multilocus sequence typing, MLST) has revealed that the species consists
of five distinct genotypes, types IA1, IA2, IB, II, and III. Our previous report showed that all five types
exist on human skin both in Europe and Japan. In order to investigate the possible association into
either of these subtypes and disease, the biochemical profiles of various subtypes have been inves-
tigated by other groups, but so far the underlying basis for their distribution have remained elusive.
Methods: In the present study, 21 strains of P. acnes isolated from healthy humans and patients with
atopic dermatitis, which have been confirmed their genotypes using an MLST scheme, were analysed.
These were cultured in aerobic, microaerophilic, and anaerobic conditions. The proteins were
extracted from cultured cells, and were analysed using SELDI-TOF Mass Spectrometer (Bio-Rad),
high resolution capillary gel electrophoresis (deltaDOT), and LC-MS/MS using a ThermoFisher Sci-
entific Orbitrap Mass Spectrometer. Results: The 21 strains formed three groups that correspond to
types IA1- IA2-IB group, type II, and type III, based on their characteristic mass ions. Each of these
groups were shown to be robust and were not influenced by differences in culture conditions. Con-
clusion: The present study revealed good congruence between genomic and proteomic data sug-
gesting that the microenvironment of each subtype may influence protein expression in a very pre-
cise manner. Further studies are in progress to characterize some of these biomarkers to shed light
on the basis for their selection.
1161
Dermal adipose tissue participates in skin defense against bacterial infection
L Zhang and R Gallo Dermatology, University of California San Diego, San Diego, CA
The immunologic function of adipose tissue has not been extensively studied in skin despite its abun-
dance, capacity to secrete bioactive adipokines and location as the deepest boundary before sys-
temic dissemination of cutaneous microorganisms. We show here for the first time that dermal
adipocytes produce an antimicrobial peptide (AMP) and actively participate in resisting bacterial
skin infections. Primary cultures of mouse preadipocytes (3T3L1) were observed by qPCR to increase
expression of cathelicidin (Camp) mRNA by ~80 fold during differentiation. In contrast, other AMPs,
including Defa3/5/17 and Defb1/2/3/4/14 were not detected. The abundance of cathelicidin pro-
tein produced by adipocytes exceeded that of keratinocytes and was secreted into the culture medium
by an ER-endosome pathway. Camp mRNA and protein was also detected by qPCR, western blot
and immunostaining of fat in vivo. Cathelicidin was maximal in adipose tissue of young mice and
was influenced by diet as a high-fat diet led to elevated expression of Camp in serum and in adi-
pose from dermis or bone marrow. CAMP was also detected in human dermal adipose tissue, and
serum concentrations were higher in subjects with BMI>25 (p=0.01, n=19/group). Adipocyte cathe-
licidin was functional since protein lysates from adipose exhibited direct antimicrobial activity that
was impaired when derived from the fat of Camp-/- mice. Furthermore, dermal adipocytes responded
to infection by group A Streptococcus or Staphylococcus aureus as we observed preadipocyte stem
cells transiently expanded and greatly increased production of cathelicidin in fat adjacent to bac-
teria. Dermal adipose tissue expansion during infection was blocked by adipogenesis inhibitor
BADGE, leading to loss of CAMP induction in fat cells and impaired bacterial clearance. Together,
these observations show for the first time that cathelicidin is produced by adipocytes. The function
of cathelicidin as a molecule capable of killing microbes and promoting inflammation in disorders
such as psoriasis and rosacea suggest that the role of adipocytes in skin immunity warrants further
study.
1163
Appearance of eczematous id reactions to molluscum contagiosum virus in children is a har-
binger sign for resolution of primary lesions
E Netchiporouk1 and B Cohen2 1 Dermatology, McGill University Health Centre, Montreal,
QC, Canada and 2 Dermatology, The Johns Hopkins School of Medicine, Baltimore, MD
Molluscum contagiosum (MC) is a self-limiting cutaneous viral eruption that is very common in chil-
dren. MC infection can trigger an eczematous reaction around molluscum papules known as a
hypersensitivity or an id reaction. In addition, a hypersensitivity reaction can occasionally occur at
sites distant from the primary molluscum papules. These eczematous reactions are often asympto-
matic or minimally pruritic. In the current work we analyze disease course in patients from our
clinic. Our findings indicate that id reactions represent an immunologically mediated host response
to MC virus and a harbinger of regression. Therefore, these reactions often do not require treatment
other than emollients. Moreover, topical steroids or immunomodulators may suppress this process
and potentiate the spread of the primary MC infection. However, in symptomatic patients, treatment
should not be withheld and short-course treatments of topical corticosteroids may be used.
1162
Inflammatory caspase dependent release of interleukin-1α from herpes simplex virus 1 infected
keratinocytes implicates pyroptosis in secondary zosteriform blistering
M Uribe-Herranz, K Milora and LE Jensen Microbiology & Immunology, Temple University
School of Medicine, Philadelphia, PA
Pyroptosis is a recently discovered novel type of leukocyte cell death aimed at exposing and elim-
inating intracellular bacterial pathogens. Like apoptosis, pyroptosis is a form of programmed cell
death, specifically caspase-1 dependent. However, pyroptosis is distinct from apoptosis in that it
promotes inflammation by releasing the inflammatory mediators interleukin-1β (IL-1β) and IL-18.
We recently reported that the double stranded RNA analogue poly(I:C) induces pyroptosis in ker-
atinocytes. Since herpes simplex virus-1 (HSV-1) produces double stranded RNA during its lifecy-
cle and is cytotoxic to epithelial cells, the present study is aimed at testing the hypothesis that HSV-
1 triggers pyroptosis in keratinocytes and that this response is part of the pathology of secondary
blistering. Initial cell culture experiments revealed that poly(I:C) induced a 4-fold (p<0.05) increase
in IL-1α mRNA expression as determined by real-time PCR. In a similar manner both intra- and
extra-cellular levels of IL-1α protein, as determined by ELISA, increased approx. 4-fold (p<0.05) 24
hours post-treatment. These responses could be blocked by a caspase-1/4 inhibitory peptide. Extra-
cellular release of IL-1α protein was also observed 24 hours after HSV-1 infection. Furthermore,
HSV-1 triggered activation of inflammatory caspase-1/4 as determined using fluorescence labeled
peptides. The physiological in vivo role of IL-1α signaling and pyroptosis is currently investigated
in a mouse model involving: 1) primary infection through scratch inoculation of flank skin, 2) spread
to sensory nerves and subsequent retrograde axonal transport to the dorsal root ganglion, 3) sec-
ondary shingles-like blistering around nerves infected through antrograde migration of virus from
the dorsal root ganglion, and 4) ultimately encephalitis. Pyroptosis and IL-1 signaling may repre-
sent promising therapeutic targets for preventing shingles-like reoccurrence and encephalitis.
1160
Potent and persistent activity of a nucleoside reverse transcriptase inhibitor, 4′-ethynyl-2-flu-
oro-2′-deoxyadenosine, against HIV-1 infection in Langerhans cells
T Matsuzawa,1 T Kawamura,1 Y Ogawa,1 R Aoki,1 Y Koyanagi,2 A Blauvelt,3 H Mitsuya4 and
S Shimada1 1 Dermatology, University of Yamanashi, Yamanashi, Japan, 2 Laboratory of Viral
Pathogenesis, Institute for Virus Research, Kyoto University, Kyoto, Japan, 3 Oregon Medical
Research Center, Portland, OR and 4 Hematology, Kumamoto University, Kumamoto, Japan
Because of the absence of a prophylactic vaccine, new strategies that reduce sexual transmission
of HIV are urgently needed. A recent clinical trial has shown that vaginal application of tenofovir
(TDF); a nucleotide reverse transcriptase inhibitor (NRTI), reduces the probability of sexual trans-
mission of HIV-1 by an estimated 39% overall. To deliver and demonstrate more potent anti-HIV
activity of microbicides, we have recently developed a novel NRTI; 4′-Ethynyl-2-Fluoro-2′-
Deoxyadenosine (EFdA). Because Langerhans cells (LCs) are suspected to be initial cellular targets
for HIV following sexual exposure to virus, we compared anti-HIV activity of TDF and EFdA in LCs.
Strikingly, preincubation with EFdA (100-5000 nM) completely blocked HIVBa-L infection in mono-
cyte-derived LCs (mLCs) without cytotoxicity, while preincubation with TDF partially inhibited HIVBa-
L infection in mLCs, and the mean inhibition values with 100, 1000, or 5000 nM TDF was 28%,
37%, and 59%, respectively. In addition, in an ex vivo skin explant model, when skin explants
were preincubated with each drug, similar blocking effects were observed for epidermal LCs.
Moreover, preincubation of mLCs as well as skin explants with EFdA (100 -5000nM) completely
blocked subsequent HIV transmission from LCs to cocultured CD4+ T cells, while TDF partially
inhibited the transmission. Similar blocking effect of EFdA was observed when LCs were exposed
to R5 HIV primary isolates; JR-FL and AD8. In addition, although complete blocking effect of EFdA
against HIVBa-L infection in mLCs persisted for 3 days, TDF gradually lost the anti-HIV activity depend-
ing on culture periods. Taken together, our data suggest that EFdA may be useful as a topical micro-
bicide to block sexual transmission of HIV.
1164
Interplay between basophils and eosinophils is essential in the development of skin inflam-
mation
C Nakashima, A Otsuka, K Kabashima and Y Miyachi Dermatology, Kyoto University Graduate
School of Medicine, Kyoto, Japan
Skin inflammation is a result of a complex interplay among inflammatory cells, including mast cells,
basophils, lymphocytes, dendritic cells, and eosinophils. These cells produce multiple inflamma-
tory mediators, including lipids, cytokines, chemokines and reactive oxygen species. Recently, it
has been reported that basophils and eosinophils colocalize in a number of skin diseases. However
the relationship between basophils and eosinophils and their roles in cutaneous immunity remain
unknown. To clarify this issue, we used an irritant dermatitis model via topical application of cro-
ton oil. As expected, both basophils and eosinophils were detected in inflamed skin lesions 3-6
hours after applying croton oil, but basophils infiltrated the skin earlier than eosinophils. In addi-
tion, depletion of basophils in vivo with anti-FcεR1α (Mar-1) antibody decreased the number of
eosinophils in the inflamed skin. These results suggest that basophils promote eosinophil infiltra-
tion into the skin. Next we evaluated whether basophils attract and modulate the functions of
eosinophils. Co-cultivation of eosinophils with bone marrow (BM)-derived basophils for 24 hours
significantly increased the expression levels of CD69, CD86, CD11b and ICAM-1 as an activation
marker of eosinophils. In addition, we revealed that basophils produced a large amount of RANTES
which attracts eosinophils, and that the chemotaxis of eosinophils using transwells was signifi-
cantly enhanced when BM-derived basophils were added to the lower chamber. These findings
suggest that basophils attract and activate eosinophils in the skin. Lastly, we have demonstrated that
skin inflammation was significantly attenuated in eosinophil-depleted ΔdblGATA-1 mice and was
enhanced in IL-5 transgenic mice in a reactive oxygen species dependent manner at least in part.
Taken together, our study proposes a new concept that the interplay between basophils and
eosinophils is essential in the development of skin inflammation.
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The immune atlas – a topographical three-dimensional study of the skin immune system using
multiphoton microscopy and multi-parameter flow cytometry
PL Tong,1,2,3 R Jain,1 B Roediger1 and W Weninger1,2,3 1 Centenary Institute, Newtown, NSW,
Australia, 2 Discipline of Dermatology, University of Sydney, Camperdown, NSW, Australia
and 3 Department of Dermatology, Royal Prince Alfred Hospital, Camperdown, NSW,
Australia
The composition and localization of immune cells in the skin has been studied extensively using
histology and flow cytometry, however the precise three-dimensional (3D) distribution of distinct
leukocytes at different sites in the body has not been analysed. This is important, as the quality of
the ensuing immune response against invading microbes potentially depends on their exact entry
point. In this study, we have used intravital multiphoton microscopy in conjunction with fluores-
cent reporter mice that enable the direct visualisation of leukocyte subpopulations to generate a
3D atlas of mouse skin. Microscopy was complemented by quantitative flow cytometry using opti-
mized protocols for the release of skin resident immune cells. Using this approach, we detail for
the first time the anatomical location of T cells, mast cells, macrophages and dendritic cells (DCs)
within the 3D microenvironment of the skin, and how this varies from site to site (ear, tail, back,
foot pad). Dermal macrophages were the most populous and in absolute terms outnumbered Langer-
hans cells in the epidermis. This was followed by mast cells and collectively they represent more
than 75% of the resident leukocyte population in the dermis. Furthermore, mast cells and dermal
T cells were found to reside predominantly in the superficial dermis whilst only macrophages and
a small proportion of dermal DCs were found greater than 100μm away from the dermo-epidermal
junction. Finally, we demonstrate that higher densities of mast cells were found in peripheral sites
(ear, tail) rather than centrally (back) whilst in contrast, the highest density of dermal DCs was
found in back skin. Such immune variation may have functional consequences in the setting of infec-
tion as well as in the pathogenesis of inflammatory skin conditions.
1166
Attenuated neutrophil axis in atopic dermatitis (AD) compared to psoriasis reflects Th17 path-
way differences between these diseases
N Dhingra,1,2 M Suarez-Fariñas,1 J Fuentes-Duculan,1 JK Gittler,1 A Shemer,3 JG Krueger1 and
E Guttman-Yassky2,1 1 Laboratory for Investigative Dermatology, The Rockefeller University, NY,
NY, 2 Department of Dermatology, Mount Sinai School of Medicine, NY, NY and 3
Department of Dermatology, Tel-Hashomer, Tel-Aviv, Israel
AD and psoriasis are the most common inflammatory skin diseases. Both are T-cell-driven and share
some common features, but have different immune and barrier phenotypes. AD is Th2/Th22-polar-
ized with an attenuated Th17 axis and is associated with an impaired barrier, low levels of antimi-
crobial peptides (AMPs), and increased infections (particularly S. aureus/SA). Psoriasis is Th1/Th17-
driven and has no increased infections. The Th17-cytokine IL-17 is a key inducer of AMPs and
neutrophil chemoattractants; its attenuation results in decreased AMPs and might explain the increased
infections in AD. There is no clear understanding of the role of neutrophils in AD inflammation and
infection responses. Using genomic profiling by microarrays and protein expression by immuno-
histochemistry, we performed a large-scale evaluation of neutrophils and their associated molecules
in non-lesional and lesional AD (n=15) and psoriasis (n=19) skin. A broad genomic comparison of
IL-17- and neutrophil-associated factors revealed significant increases in psoriatic lesional (PL) com-
pared with atopic lesional (AL) skin, including defensin β2, lipocalin 2 (LCN2), IL-8, and CCL20.
Immunohistochemistry of AL and PL biopsies with neutrophil markers (neutrophil elastase and LCN2)
revealed significantly higher neutrophilic infiltrates in PL compared to both acute or chronic AL skin
(p=0.007 and 0.005, respectively). Interestingly, the only AD patients with high neutrophil counts
exhibited epidermal serum crusts and were confirmed to have SA in the crust and dermis using a
GFP-tagged biotinylated binding domain. Our data suggest that in the absence of super-infection,
AD demonstrates a significantly attenuated neutrophil axis in parallel with a decreased IL-17 path-
way and AMP activity compared to psoriasis.
1167
Extracellular superoxide dismutase (EC-SOD) inhibits mast cell activation and allergic responses
Y Lee and T Kim Dermatology, The Catholic University of Korea, Seoul, Republic of Korea
Extracellular superoxide dismutase (EC-SOD), also known as SOD3, is an enzyme that is present in
the extracellular matrix and catalyzes the dismutation of superoxide anions. It is a multi-functional
molecule, containing reactive oxygen species scavenging, anti-angiogenic, anti-inflammatory,
anti-chemotatic, and anti-tumoric activity. Recently, we demonstrated that EC-SOD inhibited oval-
bumin-induced allergic airway inflammation in mice. However, the role of EC-SOD in mast cell
activation, which is important for allergic responses was not well studied. In this study, we demon-
strated whether EC-SOD could inhibit mast cell activation and allergic responses using primary
mouse mast cells generated from bone marrow cells of wild type, EC-SOD transgenic, and knock-
out mice. The expression of pro-inflammatory cytokines increased in EC-SOD KO mast cells and
decreased in EC-SOD over-expressing mast cells. Consistent results were obtained in the secretion
of pro-inflammatory cytokines. EC-SOD KO mast cells also showed increased histamine release
after antigen/IgE stimulation or PMA/A23187, suggesting that EC-SOD inhibits mast cell activation.
A passive cutaneous anaphylaxis experiment showed more blood leakage from EC-SOD KO mouse
ear skin, implying that the lack of EC-SOD increases allergic responses. These results suggest that
an altered expression of EC-SOD could cause allergic diseases.
1168
Effects of human β-defensins on interleukin-37 production by human keratinocytes
R Smithrithee, F Niyonsaba, C Kiatsurayanon, T The Nguyen, T Akiyama, H Ushio, S Ikeda,
K Okumura and H Ogawa Atopy Research Center and Dept. Dermatology, Juntendo Univ.
Graduate Sch. Med., Tokyo, Japan
Interleukin (IL)-37 is the most recently identified IL-1 member, and has 5 variants, namely IL-37a-
IL-37e, with IL-37b being the largest isoform. Contrasting other IL-1 members, IL-37 is an inhibitor
of innate immunity. Human β-defensins (hBDs) are host defense peptides mainly produced by epithe-
lial cells, including keratinocytes, and exhibit both antimicrobial and immunomodulatory activi-
ties. In keratinocytes, hBDs induce cell migration, proliferation, wound healing and
cytokine/chemokine production, including IL-1 member, IL-18. Hence, we envisaged that hBDs
might also affect IL-37 production by human keratinocytes. IL-37 gene and protein expression lev-
els were analyzed by real-time PCR and Western blotting, respectively. MAPK, NF-κB and caspase
inhibitors were used to study the signaling pathways by which hBDs stimulate keratinocytes. Cas-
pase activity was assessed using specific assay kits. Among hBD-1~-4 used in this study, only hBD-
3 markedly enhanced both IL-37 gene and protein expression levels. Furthermore, we found that
various cytokines and TLR ligands also increased IL-37 expression, however; only the combination
of hBD-3 and poly (I:C) synergistically elevated IL-37 expression levels. Because pre-treatment of
cells with MAPK and NF-κB inhibitors suppressed hBD-3-mediated IL-37 protein expression, we
assumed that hBD-3 stimulated keratinocytes via MAPK and NF-κB activation. Moreover, hBD-3-
induced IL-37 expression was under the control of both caspase 1 and 4, as evidenced by the
inhibitory effects of caspase 1 and 4 specific inhibitors, and the ability of hBD-3 to increase both
caspase 1 and 4 activity. IL-37 had no significant effect on cytokine/chemokine production by ker-
atinocytes, as assessed by specific ELISAs. In conclusion, the finding that hBD-3 induced keratinocyte
expression of an anti-inflammatory cytokine IL-37 suggests novel evidence of the contribution of
host defense peptides in the regulation of skin innate immunity.
1169
Perivascular macrophages are key regulators of neutrophil recruitment during skin infection
and are targeted by a Staphylococcus aureus virulence factor
R Jain,1 A Abtin,1 B Roediger,1 AJ Brzoska,2 AJ Mitchell,1 LG Ng,3 LL Cavanagh,1,4 UH von
Andrian,5 N Firth2 and W Weninger1,6 1 The Centenary Institue, Newtown, NSW, Australia, 2
School of Biological Sciences, University of Sydney, Sydney, NSW, Australia, 3 Singapore
Immunology Network, Biopolis, Singapore, 4 Sydney Medical School, Sydney, NSW, Australia,
5 Immune Disease Institute, Harvard Medical School, Boston, MA and 6 Discipline of
Dermatology, Sydney Medical School, Sydney, NSW, Australia
Neutrophils are important defenders against bacterial infections. Upon bacterial entry into the skin,
neutrophils migrate rapidly into the inflamed dermis. The intravascular events that mediate neu-
trophil adhesion to inflamed dermal vessels are well understood. Here we report the unexpected
finding that perivascular macrophages are essential regulators of neutrophil homing following infec-
tion with the pathogen Staphylococcus aureus (S. aureus). Using real-time multiphoton intravital
microscopy in a novel transgenic mouse strain, we show that neutrophils extravasate from inflamed
dermal venules in close physical contact with perivascular macrophages. The latter are a major
source of chemokines, in particular CXCL1 and 2, implicated in neutrophil homing. Strikingly, the
S. aureus virulence factor alpha-hemolysin selectively targets perivascular macrophages, but not
other cells, resulting in their lysis in an inflammasome-dependent manner. Consequently, neutrophil
recruitment is delayed, leading to increased bacterial survival and tissue necrosis. These findings
reveal a previously unrecognized, perivascular cell-dependent guidance mechanism for extravasa-
tion of blood-borne leukocytes into inflamed tissues. Furthermore, the specific killing of perivas-
cular macrophages by a bacterial product provides novel insight into the mechanisms of immuno-
evasion by an important human pathogen.
1170
Characterization of virus recognition receptors: RIG-I-like receptors (RLRs) of mast cells
M Takeuchi,1,3 M Fukuda,2 H Ushio,1 J Kawasaki,1,3 F Niyonsaba,1 K Okumura,1 S Ikeda1,3 and
H Ogawa1 1 Atopy (Allergy) Research Center, Juntendo University School of Medicine, Tokyo,
Japan, 2 Department of Infection Control Science, Juntendo University School of Medicine,
Tokyo, Japan and 3 Department of Dermatology, Juntendo University School of Medicine,
Tokyo, Japan
It is becoming evident that mast cells play important roles in innate immune responses by express-
ing various receptors to recognize pathogen-derived molecular patterns (PAMP) and being activated
to release inflammatory cytokines and chemokines. The mechanisms of mast recognition against
invading bacteria are well understood, however, those against virus are not fully investigated. In
this study, to investigate the precise mechanisms of virus recognition by mast cells, we examined
the expression and functional characteristics of virus recognition receptors that lead to mast cell
activation. Our in vivo results using mast cell-deficient mice suggest that mast cells are partly respon-
sible for the early production of antiviral cytokines and chemokines upon vesicular stomatitis virus
(VSV) infection. Analysis of the expression of double stranded RNA (dsRNA) recognition receptors
in murine bone marrow-derived mast cells (BMMCs) revealed that BMMCs express melanoma dif-
ferentiation-associated gene 5 (MDA5), protein kinase RNA-activated (PKR), retinoic acid-inducible
gene-I (RIG-I) and Toll-like receptor 3 (TLR3). The expression levels of these receptors were found
to increase upon stimulation of mast cells with VSV as well as synthetic dsRNA: polyinosinic-poly-
cytidylic acid. Moreover, small interfering RNA analysis to identify the receptors responsible for
mast cell activation by VSV revealed that both RIG-I and MDA5 were involved in cytokine pro-
duction but not in the degranulation of mast cells. Our results suggest that mast cells may con-
tribute to antiviral responses in the early infection stage by recognizing viruses via RIG-I and MDA5.
These results provide additional novel information that improves our understanding of antiviral
innate responses that involve mast cells.
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The activation of TLR3 regulates keratinocyte differentiation via the induction of S100A7 in
wound repair
L Hu, Y Wang, H Li, C Li and Y Lai East China Normal University, Shanghai, China
S100 proteins are involved in many biological processes. Human S100A7 (psoriasin) is highly
expressed in psoriasis and other inflammatory diseases; however, the physiological function of
S100A7 in wound healing remains largely unknown. We observed that S100A7 was highly expressed
in mouse wounded skin and significantly induced by Toll-like receptor 3 ligand polyinosinic-poly-
cytidylic acid (poly(I:C)) in normal human epidermal keratinocytes. The induction of S100A7 by
poly(I:C) was dependent on p38 MAPK as the inhibitor of p38 MAPK significantly decreased the
expression of S100A7. Furthermore, we found that poly(I:C) induced keratinocyte differentiation via
the induction of S100A7 to induce loricrin as knockdown of S100A7 abrogated the expression of
loricrin by poly(I:C). The induction of loricrin by S100A7 was through activation of p38 MAPK- cas-
pase 1- p63 signaling pathway. Taken together, our results suggest that the activation of TLR3 induce
keratinocyte differentiation via the induction of S100A7 during wound repair, thus promoting epi-
dermal stratification.
1173
Eradication of cutaneous herpesvirus infections by nucleic acid sensors and cytotoxic T lym-
phocyte-mediated apoptotic processes
Y Hirai,1 T Yamamoto,1,2 S Morizane,1 T Miyake,1 T Takiguchi1 and K Iwatsuki1 1 Department of
Dermatology, Okayama University Graduate School of Medicine, Dentistry and
Pharmaceutical Sciences, Okayama, Japan and 2 Department of Dermatology, Kawasaki
Medical School, Okayama, Japan
[Background] No precise mechanism has been clarified about host defense mechanisms against
herpesvirus infections such as herpes simplex (HS) and herpes zoster (HZ). [Purpose] We have exam-
ined 1) the differences in cellular and molecular events in cutaneous HS and HZ between immuno-
competent and immunocompromised hosts, and 2) epidermal antiviral activity induced by viral
nucleic acid sensing mechanism. [Results] We confirmed that apoptotic cells determined by TUNEL
and cleaved caspase 3 were detected in the cutaneous HS and HZ lesions, but not in the herpesvirus-
infected cultured cells. Many cytotoxic T lymphocytes (CTLs) expressing granzyme B, TIA-1 and
granulysin were present in HS and HZ lesions in immunocompetent hosts, but the numbers were
less in the immunocompromised hosts. Apoptotic signals related to bax/bcl-2 and Fas/FasL path-
ways were implicated in HS and HZ lesions of immunocompetent hosts. The up-regulation of TLR3
expression was observed in the lesional epidermis of HS and HZ. Type 1 interferon was markedly
produced in cultured human keratinocytes by co-stimulation with poly(I:C) and LL37, and the stim-
ulated keratinocytes showed antiviral activities in virus plaque forming assay using HSV. [Conclu-
sions] These observations indicate that unlike in culture study, the virus-infected keratinocytes in
vivo were eradicated by CTL-mediated apoptotic processes including granule-exocytosis mecha-
nism, and bax/bcl-2 and Fas/FasL pathways. Furthermore, the lesional epidermis inhibited further
viral spreading by production of type 1 interferon via a nucleic acid sensor, or TLR3-mediated innate
immunity.
1175
The murine skin microbiome is regulated independently of innate and adaptive immunity
F Scholz,1 BD Badgley,2 MJ Sadowsky2 and DH Kaplan1 1 Department of Dermatology, Center
for Immunology, University of Minnesota, Minneapolis, MN and 2 Department of Soil, Water,
and Climate, University of Minnesota, Minneapolis, MN
Immunologically active barrier surfaces such as the intestinal lining and skin are colonized by a
diverse community of commensal microorganisms. Recently, it has been shown that these micro-
biota influence innate and adaptive immune responses by inducing expression of specific antimi-
crobial peptides, generating Th17 CD4+ T cells and promoting T regulatory CD4+ cells. Although
these commensal microorganisms clearly impact the host immune system, whether the immune
system also shapes the commensal community is poorly understood. To test whether immune defects
can alter the microbiome we employed 16S rDNA deep sequencing of skin swabs and stool sam-
ples from 1) huLangerin-DTA mice that lack Langerhans cells (LC), 2) Myd88/TRIF-/- mice that have
defective innate immunity and 3) Rag1-/- mice that have defective adaptive immunity. To avoid
parental and housing issues, all genotypes were intercrossed to C57BL/6 allowing the use of wild-
type littermates as controls. As expected, the commensal communities of the gut and skin were
highly divergent. Despite the intimate contacts that LC make with the upper epidermis, we did not
observe any alterations in the density, diversity, or composition of the skin microbiome in individ-
ual huLangerin-DTA mice. The skin microbiome was also unaffected in MyD88/TRIF-/- and Rag1-
/- mice. Similarly, we observed that microbial density, diversity and composition in the gut were
unaffected in MyD88/TRIF-/- mice. In contrast, we observed altered community composition in the
gut of Rag1-/- mice, which consisted primarily of an increase in Lachnospiraceae . This phenotype
is reminiscent of that seen in mice with defective humor immunity (i.e. AID-/-) and suggests that
IgA affects the gut microbiome. Thus, we conclude that the immune system has a greater influence
on modulating the microbial composition of the gut microbiome relative to the skin, revealing a
major distinction between these two barrier sites.
1174
Expression of toll-like receptor 2 but not 1, 4, 5 or 6 is increased by interferon γ in primary
human keratinocytes in a concentration and time dependent manner
A Ljulkina, E Proksch and R Panzer Clinic for dermatology, University clinics Schleswig-
Holstein, campus Kiel, Kiel, Germany
The innate immune system supports the physical skin barrier in antimicrobial defense. Human ker-
atinocytes constitutively express various members of the toll-like receptor (TLR) family important
for innate immunity including TLR1, TLR2, TLR4, TLR5 and TLR6. TLR1 recognizes triacyl-lipopep-
tides. TLR2 detects gram-positive bacteria via their lipoteichoic acid. TLR4 recognizes lipopolysac-
charide, a cell wall component of gram-negative bacteria. The ligand of TLR5 is flagellin, a protein
expressed in flagellated bacteria. TLR6 detects diacyl-lipopeptides. We asked whether TLR1, TLR2,
TLR4, TLR5 and TLR6 expression is stimulated by cytokines in human keratinocyte culture in vitro.
The expression of human TLR1, TLR2, TLR4, TLR5 an TLR6 was assessed by realtime PCR analysis
and subsequent gel electrophoresis for verification. Keratinocytes were stimulated by cytokines
which have been described to be involved either in Th1 or Th2 dominated immune responses:
interleukin (IL)-1β, IL-4, IL-5, IL-6, IL-13, IL-15, IL-17, IL-18, IL-20, IL-31, interferon (IFN) γ, tumor
necrosis factor (TNF) α and tissue derived growth factor (TGF)α. We found a significant upregula-
tion of TLR2 expression especially by stimulation with IFNγ. The effect of IFNγ stimulation was con-
centration an time dependent with a maximum response after stimulation with 40 nm/ml about 24
h after stimulation. Interestingly neither TLR1 or TLR6 expression was induced by IFNγ at any time
point or concentration tested. As both receptors are thought to be act as heterodimers with TLR2
when detecting their ligand this suggests that TLR2 dominates the innate immune reaction of the
skin although other receptors are alsoe expressed. As IFNγ is a typical Th1 cytokine it may be respon-
sible for the induction of TRL2 expression seen in psoriatic skin.
1172
CD16+ patrolling monocytes (pMO) sensing HSV negatively control regulatory T cell (Treg)
responses in severe drug eruptions
Y Ushigome, R Takahashi and T Shiohara Depertment of Dermatology, Kyorin University
School of Medicine, Tokyo, Japan
CD16+ monocytes are specialized for the protection against viruses by patrolling blood vessels and
selectively detecting virally infected cells: they can produce higher TNF-α and expand under infec-
tious conditions. Indeed, our recent study indicates that pMO preferentially expresses paired
immunoglobulin-like type 2 receptor-α (PILRα) and herpesvirus entry mediator (HVEM), which can
specifically bind to glycoprotein B (gB) and glycoprotein D(gD) of herpes simplex virus (HSV),respec-
tively. Here, we demonstrated preferential elimination of pMO sensing HSV at the early stage of
drug-induced hypersensitivity syndrome (DiHS)/drug reaction with eosinophilia and systemic symp-
toms (DRESS), which represents the polar end of a spectrum of severe drug eruptions and is char-
acterized by sequential herpesvirus reactivation and the subsequent development of autoimmune
diseases. In contrast, pMO was detected in normal frequency in patients with Stevens-Johnson syn-
drome, which represent another end of a spectrum of severe drug eruptions and in which no viral
reactivations were detected. We then asked whether the pMO could have an impact on number
and function of circulating Treg and be responsible for herpesvirus reactivation. To this end, patients
with DiHS/DRESS were divided into two groups, steroid-treated (ST) and non-steroid-treated(NST),
because of the different outcomes depending on the treatment: herpesvirus reactivations were
more frequent in ST except for EB virus. Surprisingly, in NST, preferential elimination of pMO was
transient and rapidly restored to normal levels, while in ST elimination of pMO persisted for ≥2
months. Although elimination of pMO was associated with expansions of Treg at the acute stage of
DiHS regardless of treatment, the subsequent rapid restoration of pMO in NST resulted in a decrease
in Treg responses, leading to autoimmune outcomes. pMO play a critical role in negatively con-
trolling Treg responses,and cross-talk between pMO and Treg would determine the course and out-
come of severe drug eruptions.
1176
The innate immune defect in atopic dermatitis includes a deficiency in antimicrobial activ-
ity produced by the skin microbiome
T Nakatsuji, DT MacLeod, AM Two, F Shafig, T Hata and RL Gallo Dermatology, University of
California, San Diego, San Diego, CA
Innate immune defense is mediated in part by antimicrobial peptides (AMPs) such as cathelicidins
and beta-defensins produced by the host, and by AMPs produced by commensal bacteria. Skin from
patients with Atopic Dermatitis (AD) produce less cathelicidin and beta-defensins upon injury, a
defect that leads to enhanced susceptibility to infection. In this study we hypothesized that the abnor-
mal microbiome present on AD skin may exacerbate the disorder. To test this we conducted a high-
throughput screen of antimicrobial activity produced by commensal skin bacteria, measuring activ-
ity from individual isolates of coagulase-negative Staphylococcus species present on lesional and
non-lesional skin of AD patients and normal subjects. 31.0±3.6% of isolates from healthy skin inhib-
ited growth of Staphylococcus aureus (S. aureus) by >99%. In AD skin, significantly fewer bacteria
obtained by skin swabbing were antimicrobial, only 6.25±7.6% (p<0.05) or 8.5± 5.5% (p<0.05)
were active from lesional or non-lesional sites, respectively. When bacteria from normal skin with
antimicrobial activity were applied to mouse skin, these mice could eliminate a subsequent surface
application of pathogens S. aureus or Group A Streptococcus within 3 hours. Full-length, Sanger
sequencing of 16S rRNA identified 81.8% of the antimicrobial active clones as Staphylococcus
hominis (S. hominis). The antimicrobial activity produced by S. hominis was heat stable and pro-
tease-sensitive, and purification by strong cationic exchange, reverse-phase HPLC and mass spec-
trometry identified two AMPs (3152.2 Da and 3550.7 Da) with cyclic structures. These peptides
were potently active against S. aureus and killed synergistically. Thus, our data have identified new
AMPs on human skin, show for the first time that S. hominis contributes to innate immune defense,
and suggest a lack of such mutualistic interactions with our microbiome may contribute to suscep-
tibility of AD skin to infection.
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Regulation of cutaneous inflammation by skin-resident type 2 innate lymphoid cells
B Roediger,1 R Kyle,2 K Yip,3 T Guy,1 N Sumaria,1 A Mitchell,1 R Jain,1 E Forbes-Blom,2 X Chen,4
P Tong,1 H Bolton,1 W Paul,4 B Fazekas de St. Groth,1 M Grimbaldeston,3 G Le Gros2 and
W Weninger1,5,6 1 Centenary Institute, Sydney, NSW, Australia, 2 Malaghan Institute of Medical
Research, Wellington, New Zealand, 3 Centre for Cancer Biology, Adelaide, SA, Australia, 4
National Institutes of Health, Bethesda, MD, 5 Discipline of Dermatology, University of
Sydney, Sydney, NSW, Australia and 6 Department of Dermatology, Royal Prince Alfred
Hospital, Sydney, NSW, Australia
Type 2 immunity is critical for the defense against cutaneous infections, but also underlies the devel-
opment of allergic skin diseases, such as eczema. Here we report the identification, phenotype and
function of a unique type 2 innate lymphoid cell (ILC2) subset resident in normal murine dermis,
which depends on IL-7 and constitutively produces IL-13 in an age-dependent manner. Using intrav-
ital multiphoton microscopy, we reveal that dermal ILC2 specifically contact skin-resident mast cells
using a unique migratory pathway confined to the dermis. Moreover, we describe a novel model of
dermatitis, in which increased numbers of activated dermal ILC2 promote type 2 inflammation char-
acterized by epidermal hyperplasia and dermal leukocyte infiltrate. The skin lesions in this model
are further characterized by high levels of IL-5 and IL-13, eosinophilic influx and reactive mast cells.
Our data uncover a novel interactive pathway between two innate immune cell populations impli-
cated in the regulation of type 2 immunity, and demonstrate that ILC2 can promote inflammation
of the skin.
1178
Tumour necrosis factor (TNF)-α-dependent and –independent langerhans cell mobilisation
during skin sensitisation
A Metryka,1 LH Eaton,1 I Kimber,1 R Roberts2 and RJ Dearman1 1 Faculty of Life Sciences,
University of Manchester, Manchester, United Kingdom and 2 Safety Assessment Alderley
Park, AstraZeneca, Macclesfield, United Kingdom
Langerhans cells (LC) are epidermal dendritic cells (DC) that together with other dermal DC, play
important roles in the initiation and regulation of skin immune responses. In response to encounter
with allergen LC migrate from the epidermis via afferent lymphatics to regional lymph nodes. Pre-
vious studies have suggested that the mobilisation of LC by chemical allergens is dependent upon
signals provided by both TNF-α and interleukin 1β. In the present investigations we have examined
whether TNF-α signalling is a universal requirement for mobilisation of LC by chemical allergens.
For this purpose two unrelated chemical allergens, 2,4-dinitrochlorobenzene (DNCB) and oxazolone
(Ox), have been compared. The activity of TNF-αwas blocked either by topical application of native
human lactoferrin (nLF;0.5μg), or by intradermal injection of neutralising anti-TNF-α antibody (10μg)
and after 2h the same site was treated topically with 0.5% Ox or with 1% DNCB. Four h later the
frequency of LC in epidermal sheets was determined by staining for MHC class II. Application of
Ox or DNCB in each case resulted in approximately 20% decrease in LC numbers; the proportion
of LC that mobilise rapidly in response to migratory stimuli. Prior topical treatment with nLF inhib-
ited Ox- but not DNCB-mediated LC migration (1% and 17%, respectively). Administration of neu-
tralising anti-TNF-α antibody also inhibited completely Ox triggered migration, but was without
effect on DNCB mediated LC mobilisation (20%). Furthermore, in mice deficient in TNF-R2 (the
only TNF-α receptor expressed by LC), DNCB stimulated levels of LC migration equivalent to those
provoked in wild type mice. These data demonstrate that DNCB-induced LC migration is inde-
pendent of TNF-α signalling. The implication is that DNCB is an exceptional allergen as to date all
stimuli that cause LC mobilisation have been shown to require TNF-α.
1179
Basal levels of IgE are physiological regulators of innate-type immune responses mediated by
connective–tissue mast cells
Y Mizukawa and T Shiohara Dermatology, Kyorin University School of Medicine, Mitala, Japan
Although increased serum IgE levels observed in allergic diseases are thought to be detrimental to
the host, no information is available about the effect of basal levels of IgE normally present in ani-
mals. Our hypothesis was that basal levels of IgE may be of considerable biological significance. To
test this, we have recently established a simplified in vivo experimental system that allows dissec-
tion of innate immune responses and IgE-mediated allergic immune responses to the same hapten:
single exposure to hapten at the footpad induces TLR2-dependent immediate-type hypersensitivity
(ITH)-like responses, which are mediated by degranulation of connective tissue-type mast cells
(CTMC) stimulated with keratinocyte-derived neuropeptide. In contrast, repeated hapten exposure
caused hapten-specific IgE-mediated ITH responses, which are mediated by cross-linking of IgE/FcεRI
on MC. The innate-type ITH was inhibited by pretreatment of Ig-deficient (μ-/-) mice with basal lev-
els (0.02-0.1μg/ml) of IgE regardless of its hapten specificity. The innate-type degranulation in vitro
was detected in WT CTMC, but not TLR2-/- CTMC, stimulated with the neuropeptide and the for-
mer was inhibited by pretreatment of WT CTMC with basal levels of IgE, but not IgG. MC-deficient
mice reconstituted with WT CTMC, but not BMMC, showed the innate-type ITH upon single expo-
sure to hapten, which was inhibited by pretreatment of the CTMC with basal levels of IgE. The IgE
per se never induced degranulation of CTMC or BMMC. In contrast, IgE/FcεRI-mediated degranu-
lation was preferentially observed in BMMC and was enhanced by high levels( > 0.5μg/ml) of IgE.
Our findings indicate that basal levels of IgE may be evolutionally needed to efficiently downregu-
late excessive innate-type activation of CTMC resident in the skin, thereby limiting tissue damage.
However, if the levels exceed the threshold by excessive or repeated stimulation with hapten, the
pathological levels of IgE could ultimately mediate detrimental outcome.
1180
Deficiency in mouse beta-defensin 14 leads to a delay in wound healing
N Graumann,1 C Neumann,1 C Walker,2 J Harder,1 W Müller2 and E Proksch1 1 Dermatology,
University of Kiel, Kiel, Germany and 2 Faculty of Life Sciences, Manchester, United Kingdom
β-Defensins are antimicrobial peptides of the innate immune system produced in the skin by vari-
ous stimuli including proinflammatory cytokines and bacterial infection. The innate immunity bar-
rier supports the permeability barrier in the defense against bacterial infection. Mouse beta-defensin
14 (mBD-14), the mouse orthologue of human beta-defensin 3, has a broad antimicrobial activity
including activity against S. aureus. We previously showed that a disruption of the physical barrier,
a superficial wound, which presumably increased invasion of microbes, leads to an upregulation
of the expression of several antimicrobial proteins including mBD-14. Deep wounds show a com-
plete loss in skin barrier function and are therefore prone to bacterial infection. Here we asked
whether wound healing is impaired in mBD-14 deficient mice. Full thickness wounds were made
on one flank of mBD-14 deficient mice and control mice. Repair of the skin barrier was monitored
by measuring the size of the wound, wound contraction and reepithelization during wound heal-
ing over time. mBD-14-deficient mice exhibited a significant delay in wound healing at 6 – 12 days
after wounding as compared to wild-type mice. Also, a delay in wound contraction occurred in the
deficient mice. Topical application of a solution of 1% recombinant mBD-14 in isopropanol/propy-
lenglycol (3/7) reversed the delay in wound healing, wound contraction and reepithelization in
mBD-14 deficient mice. Topical application of mBD-14 was ineffective in the wild type mice. Appli-
cation of the vehicle did neither affect the speed of wound healing in mBD-14 deficient nor in wild
type mice. mBD-14 seems to be involved not only in antimicrobial defence, but also in wound
repair. Recently, it has been shown that mBD-14 exhibits immunomodulatory activities such as
chemotactic activity. Since it is known that inflammatory signals are important for wound healing,
mBD-14-mediated modulation of specific inflammatory signals might be a reason for the delayed
wound healing in mBD-14 deficient mice.
1181
Could Merkel cell polyomavirus and other human polyomaviruses play a role in primary cuta-
neous T-cell lymphomas?
A Du-Thanh,1,3 V Foulongne,2,3 B Guillot1,3 and O Dereure1,3 1 Dermatology, University
Montpellier 1, Montpellier, France, 2 Virology, University Montpellier 1, Montpellier, France
and 3 Unit 1058, INSERM, Montpellier, France
As viruses have been suggested as potentially causative or associated agents in primary cutaneous
T-cell lymphomas (CTCL), we investigated the presence of 5 newly described skin-targeted human
polyomaviruses (Merkel cell polyomavirus (MCPyV), Human polyomaviruses 6, 7 and 9 (HPyV 6,
7, 9) and Trichodysplasia spinulosa-associated polyomavirus (TSPyV)) in lesional and non lesional
skin from 36 patients with Mycosis Fungoides (MF) and 6 with Sézary syndrome (SS). Real-time PCR
was performed on genomic DNA from 86 fresh-frozen skin biopsy and from 39 blood samples. 22
skin samples from healthy individuals were used as controls. MCPyV DNA was detected in 14/37
(37.8%) versus 3/17 (17.6%) in lesional and non lesional skin respectively (p=0.13). HPyV6 DNA
was detected in 7/39 (17.9%) versus 4/16 (25%) in lesional and non lesional skin respectively (p=0.7),
and HPyV7 in 3/35 (8.5%) versus 2/16 (12.5%) cases respectively (p=1). MCPyV DNA was signif-
icantly more frequently detected in MF lesional skin than in skin from healthy individuals (p=0.03)
but no difference was identified in classical versus folliculotropic MF lesional skin (p=0.3), nor in
CTCL non lesional skin versus skin from healthy individuals (p=1). None of polyomaviruses under
focus was detected in SS skin samples or in blood from any CTCL patients. TSPyV and HPyV9 DNA
were detected in no skin or blood sample. Higher detection rate of MCPyV DNA in MF lesional
skin compared to skin from healthy individuals, and, although not reaching a significant level, to
non lesional skin of MF patients must be interpreted with caution as hair follicles, monocytes and
lymphocytes are potential reservoirs for MCPyV. Nevertheless, these results reinforce differences
between MF and SS and lead to further questions regarding the non univocal, perhaps versatile roles
of viruses in MF, especially in particular subsets of CTCL such as folliculotropic MF.
1182
Microbial skin and nares communities are markedly different in children and adults
J Oh,1 S Conlan,1 E Polley,2 JA Segre1 and HH Kong3 1 Genetics and Molecular Biology Branch,
NHGRI, NIH, Bethesda, MD, 2 Biometric Research Branch, Division of Cancer Treatment and
Diagnosis, NCI, NIH, Bethesda, MD and 3 Dermatology Branch, Center for Cancer Research,
NCI, NIH, Bethesda, MD
Characterizing the diversity of the microbial collective (microbiome) inhabiting healthy human
skin established a reference for studying host-microbial interactions. Physiologic changes occur in
skin as humans mature from infancy to adulthood and pediatric microbiomes might be consider-
ably different from those in adults. Differences between pediatric and adult microbiomes might be
relevant when considering pediatric disorders such as atopic dermatitis or issues such as sites of
microbial carriage. The objective of this study was to determine if microbial communities at several
body sites differed significantly between children and adults. Using 16S-rRNA gene sequencing
technology, we characterized and compared the bacterial communities of four body sites in rela-
tion to Tanner stage of human development of 28 healthy individuals ranging in age from 2 to 40
years. Bacterial communities in the nares of children differed strikingly from those in/on adults. Fir-
micutes (Streptococcaceae), Bacteroidetes, and Proteobacteria (β, γ) were overrepresented in chil-
dren compared to adults, where Corynebacteriaceae and Propionibacteriaceae predominated. The
most marked microbial differences were observed in the nares, a site that can harbor pathogenic
species, including Staphylococcus aureus and Streptococcus pneumonia. Significant shifts in the
microbiota associated with progressive sexual maturation as measured by Tanner staging suggest
that puberty-dependent shifts in the skin and nares microbiomes may have significant implications
regarding prevention and treatment of pediatric disorders involving microbial pathogens and col-
onization.
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Type I IFN suppresses Type II IFN triggered human antimicrobial responses in leprosy skin
lesions
R Teles and RL Modlin Dermatology, UCLA, Los Angeles, CA
The immune mechanisms that control resistance vs. susceptibility to infection in humans were inves-
tigated by studying leprosy skin lesions, the site where the battle between the host and the pathogen
is joined. Using an integrative genomics approach, we found an inverse correlation between IFN-
β and IFN-γ gene expression programs at the site of disease. The Type II IFN, IFN-γ and its down-
stream vitamin D-dependent antimicrobial genes were preferentially expressed in the lesions from
patients with the self-healing tuberculoid form of the disease and mediated antimicrobial activity
against the pathogen, Mycobacterium leprae, in vitro. In contrast, the Type I IFN, IFN-β, and its
downstream genes, including IL-10, were induced in monocytes by M. leprae in vitro, and were
preferentially expressed in the lesions of disseminated and progressive lepromatous form. The IFN-
γ-induced macrophage antimicrobial response was inhibited by IFN-β and IL-10, by a mechanism
involving blocking the generation of bioactive 1,25-dihyroxyvitamin D as well as inhibiting induc-
tion of antimicrobial peptides cathelicidin and DEFB4. The ability of IFN-β to inhibit the IFN-γ-
induced vitamin D pathway including antimicrobial activity was reversed by neutralization of IL-
10. These data suggest that the ability of IFN-β to downregulate protective IFN-γ responses provides
one general mechanism by which some bacterial pathogens of humans evade protective host
responses and contribute to pathogenesis.
1185
Zinc chloride exposure modulates cytokine expression and induces heme oxygenase-1 in
human keratinocytes
E Emri, E Miko, G Boros, E Remenyik and G Emri Department of Dermatology, University of
Debrecen MHSC, Debrecen, Hungary
Zinc is an important trace element, which is also used therapeutically, particularly in the treatment
of inflammatory skin diseases, although the molecular basis of the anti-inflammatory effect is less
known. We have recently published that the expression of metallothionein, which is involved in
the regulation of zinc homeostasis, is linked to aggressive behaviour of primary melanomas and to
defective antitumor immune response. Furthermore, we demonstrated that in human keratinocytes
non-toxic amount of zinc reduces UVB-induced DNA damage, affects the outcome of UVB-asso-
ciated cell death and changes the UVB-induced transcriptional response including genes involved
in DNA repair (POLB, RAD52, RAD51, CCNF), DNA damage response (AKT) and immune response
(TRIM26, CYP1B1, heme-oxygenase-1 (HMOX-1)). In the present study we aimed to examine fur-
ther the immune-modulatory role of the zinc homeostasis in human keratinocytes. Therefore, gene
expression changes of various cytokines, COX-2 and HMOX-1 were detected in HaCaT keratinocytes
exposed to non-toxic amounts of zinc chloride using quantitative RT-PCR. ROS production as pos-
sible mediator of zinc chloride effects was tested by CM-H2DCFDA fluorimetric assay. Zinc treat-
ment increased the gene expression level of HMOX-1 15-fold (p= 0,0413) compared to the control
at the 4th hour-treatment. In addition, in time kinetics experiments we found that zinc exposure
significantly reduced the gene expression level of IL-8 (p= 0,0216), IL-6 (p= 0,0113) and COX-2
(p= 0,0187) at early time points of treatment, but did not affect the expression of IL1-beta and IL-
18. Our results suggest that zinc homeostasis has role not only in the regulation of the inflamma-
tory response after UVB irradiation of the skin, but also in the function of human keratinocytes as
immune-modulatory cells.
1187
A unique TTC repeat base pair loss mutation in cases of pure neural leprosy: A survival strat-
egy of Mycobacterium Leprae?
A De1 and A Sarda2 1 Dermatology, Institute of Post Graduate Medical Education and
Research, Kolkata,West Bengal, India and 2 Dermatology, KPC Medical college, Kolkata,West
Bengal, India
Genomic reduction helps obligate intracellular microbes to survive difficult host niches. Adapta-
tion of M.leprae in cases of pure neural leprosy (PNL) in the intracellular niche of peripheral nerves
can be associated with some gene loss. Recently a stable but variable number of tandem repeats
(TTC) have been reported in strains of M.leprae. FolP and rpoB genes are other two common muta-
tion sites which deal with the susceptibility of the bacteria to drugs. We attempted to find if genomic
reduction of M.leprae in context of these TTC repeats or mutations in folP1 and rpoB can be the
reason for the restriction of M.leprae in the nerves in PNL. DNA extracts taken from fine needle
aspiration of affected nerves of 24 PNL cases were studied for tandem repeats with 21TTC primer
in multiplex-PCR. Mutations were also studied by PCR Amplification of SRDR (Sulphone Resist-
ance Determining Region) of the folP1 and multiple primer PCR amplification refractory mutation
system (MARS) of the rpoB. Of the 24 PNL, only one patient showed mutation in the rpoB gene and
none in folp1 gene. Studying the mutation in TTC region of the M.leprae gene we found that all the
cases have a loss a few bases in the sequence. We can conclude that there is consistent loss in the
bases in the TTC region in all cases of pure neural Hansen and we postulate that it may be an adap-
tive response of the bacteria to survive host niche resulting in its restriction to peripheral nerves.
1186
TSLP elicits IL-33–independent innate lymphoid cell responses to promote skin inflamma-
tion
BS Kim,1 MC Siracusa,3,2 SA Saenz,3,2 M Noti,3,2 LA Monticelli,3,2 GF Sonnenberg,3,2
MR Hepworth,3,2 AS Van Voorhees,1 MR Comeau5 and D Artis2,3,4 1 Dermatology, Perelman
School of Medicine at the University of Pennsylvania, Philadelphia, PA, 2 Institute for
Immunology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia,
PA, 3 Microbiology, Perelman School of Medicine at the University of Pennsylvania,
Philadelphia, PA, 4 Pathobiology, University of Pennsylvania School of Veterinary Medicine,
Philadelphia, PA and 5 Inflammation Research, Amgen, Seattle, WA
Innate lymphoid cells (ILCs) are a recently identified family of heterogeneous immune cells that
can be divided into three groups based on their differential developmental requirements and expres-
sion of effector cytokines. Among these, group 2 ILCs produce the type 2 cytokines IL-5 and IL-13
and promote type 2 inflammation in the lung and intestine. However, whether group 2 ILCs reside
in the skin and contribute to skin inflammation has not been characterized. Here, we identify for
the first time a population of skin-resident group 2 ILCs present in healthy human skin that are
enriched in lesional human skin from atopic dermatitis (AD) patients. Group 2 ILCs were also
found in normal murine skin and were critical for the development of inflammation in a murine
model of AD-like disease. Remarkably, in contrast to group 2 ILC responses in the intestine and lung,
which are critically regulated by IL-33 and IL-25, ILC responses in the skin and skin-draining lymph
nodes were independent of these canonical cytokines but were critically dependent on thymic
stromal lymphopoietin (TSLP). Collectively, these results demonstrate an essential role for IL-33–
and IL-25–independent group 2 ILCs in promoting skin inflammation.
1184
Antimicrobial peptide LL-37 produced by HSV-2-infected keratinocytes enhances HIV infec-
tion of Langerhans cells
Y Ogawa,1 T Kawamura,1 T Matsuzawa,1 R Aoki,1 K Yamasaki,2 A Blauvelt3 and S Shimada1 1
Dermatology, University of Yamanashi, Yamanashi, Japan, 2 Dermatology, Tohoku University
Graduate School of Medicine, Sendai, Japan and 3 Oregon Medical Research Center,
Portland, OR
Herpes simplex virus (HSV)-2 shedding is associated with increased risk for sexually acquiring HIV.
Because Langerhans cells (LCs) are suspected to the initial target cells infected by HIV following
sexual exposure, we examined whether HSV-2 modulates HIV susceptibility of LCs by using an ex
vivo skin explant model. Epidermal sheets obtained from suction blister roofs were exposed to
HSV-2 strain G, and then exposed to HIV-1BaL. Pre-incubation with HSV-2 significantly increased
the percentage of HIV p24+ LCs approximately 3-fold. However, relatively few HSV-2/HIV co-
infected (HIV-1 p24+ / HSV-2 gD+) LCs were detected, suggesting that HSV may not directly mod-
ulate HIV susceptibility in LCs. We found that HSV-2 induced production of antimicrobial peptides
(AMPs) from normal human epidermal keratinocytes (NHEKs), including human β defensin (hBD)2,
hBD3, hBD4 and LL-37, however, exclusively LL-37 strongly enhanced HIV susceptibility in mono-
cyte-derived LCs (mLCs). Moreover, condition medium of NHEKs culture exposed to HSV-2 enhanced
HIV susceptibility in mLCs, and this effect was significantly abrogated by blocking LL-37 produc-
tion. Surface expression of CD4 and CCR5 on mLCs was significantly up-regulated by LL-37, whereas
LL-37 did not affect CD4 expression, and decreased CCR5 and DC-SIGN expression and HIV sus-
ceptibility, in monocyte-derived dendritic cells (mDCs). In line with these findings, pre-incubation
of mLCs with LL-37 significantly enhanced subsequent HIV transmission from mLCs to CD4+ T cells,
while pre-incubation of mDCs with LL-37 decreased the transmission. Given these data, we hypoth-
esize that HSV-2 enhances HIV susceptibility in LCs via LL-37 production by keratinocytes, pro-
viding one biologic explanation to explain why HSV-2 increases the risk of HIV acquisition.
1188
Use of fine needle aspiration cytology DNA PCR in the diagnosis of pure neural hansens dis-
ease-A pilot study
A Sarda1 and A De2 1 Dermatology, KPC Medical College, Kolkata,West Bengal, India and 2
Dermatology, Institute of Post Graduate Medical Education and Research, Kolkata,West
Bengal, India
Pure neural Hansen disease, though constitutes about 10% of all leprosy cases, is till now a sub-
jective phenomenon. The criteria for diagnosis, proposed by Jardim et.al, are largely unpopular as
it is too complicated and involves invasive nerve biopsy and sophisticated PGL-1 detection. To
address this issue we conducted a study using fine needle aspiration cytology coupled with DNA
PCR specific for M.leprae; for a non invasive objective diagnosis of PNL. Thirteen patients of PNL
diagnosed by two independent consultants were included in the study. Fine needle aspiration was
done on the affected nerve and aspirates were evaluated for cytology, acid fast staining and DNA
PCR. Nerve conduction study was done in all patietns. Out of 13 suspected PNL cases Fine Nee-
dle Aspiration Cytology (FNAC) showed 5 cases positive for Acid Fast Bacilli (AFB) and 9 cases
were found positive for Mycobacterium leprae by molecular diagnosis by multiplex PCR. Only 3
cases had characteristic epitheloid infiltration whereas 8 others showed nonspecific infiltration in
cytology. With the use of FNAC and NCS we could exclude two cases as non PNL cases. Clearly,
our study establishes FNAC coupled with DNA PCR as an effective, simple and non-invasive alter-
native to nerve biopsy in the diagnosis of PNL. We propose this simple technique should be widely
practised to decrease the ambiguity inn diagnosis and treatment of neural Hansen which may
strengthen our “final push” towards disease elimination.
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Complement modulates host-microbe interactions of the skin
C Chehoud,1 S Rafail,2 A Tyldsley,1 JD Lambris2 and EA Grice1 1 Department of Dermatology,
University of Pennsylvania, Philadelphia, PA and 2 Department of Pathology and Laboratory
Medicine, University of Pennsylvania, Philadelphia, PA
Those factors that modulate the colonization of the skin by commensal microbiota remain unknown.
We hypothesize that complement, an innate immune surveillance system with far-reaching effects
on immunological and inflammatory processes, is a key factor in host-microbe interactions of the
skin. To determine the role of complement in modulating microbial colonization of the skin, we
treated mice with a complement C5a receptor antagonist (C5aRa) to inhibit signaling of the potent
C5a anaphylatoxin. A control group of mice was treated with an inactive control. This longitudinal
design, where each mouse is its own control, was selected because our data demonstrates that mater-
nal transmission has profound effects on the skin microbiota. By sampling the skin microbiota before
and after treatments, followed by deep sequencing of bacterial 16S ribosomal RNA genes, we iden-
tified changes in bacterial relative abundance that were specific to treatment with C5aRa, but not
with the control treatment. These changes included greater proportion of Actinobacteria (P=0.018),
specifically the genus Propionibacterium (P=0.025) on skin of C5aRa-treated mice in 2 independ-
ent experiments. Significant overall microbial community structure and membership changes were
also identified to be specific to C5aRa treatment. Expression of antimicrobial peptide and other
immune-related genes were decreased in the skin upon C5aRa treatment. Furthermore, coloniza-
tion of germ free mice with commensal skin microbiota induced expression of complement genes
in the skin. Taken together, our data demonstrate an unprecedented role for complement in host-
microbe interactions at the skin surface, and could have considerable implications for the treat-
ment of cutaneous disorders, especially those of an inflammatory and/or microbial nature.
1190
Mast cells control wound healing in skin wound infections with Pseudomonas aeruginosa
C Sieber, D Tröltzsch, F Siebenhaar and M Maurer Department of Dermatology and Allergy,
Charité - Universitätsmedizin Berlin, Berlin, Germany
Pseudomonas aeruginosa (PA), a ubiquitous environmental Gram-negative bacterium, is one of the
leading causes of severe nosocomial skin wound infections. Due to increasing resistance to com-
mon antibiotics, this pathogen poses a major threat, especially to immunocompromised patients
therefore new therapeutic approaches are needed. Since mast cells (MC) are situated at the borders
to the external environment, like the skin, their localisation allows them to be among the first inflam-
matory cells to encounter and act against invading pathogens. The aim of the present study was to
examine the effects of MCs on bacterial skin wound infections with PA. We found that MCs are
beneficial for wound healing and clearance of PA in a model of full thickness skin wound infec-
tions. Using MC-deficient mice (KitW/KitW-v) we detected an 15-fold increase of PA numbers in wound
tissues 24h post infection and a reduced wound healing resulting in delayed wound closure with a
maximum at day 4 post infection (26.2% ± 8.6 p<0.05) as compared to wild type mice. Reconsti-
tution of KitW/KitW-v mice with bone marrow-derived MCs before wounding resulted in normalisa-
tion of wound healing. To analyse the molecular mechanisms responsible for these antibacterial and
wound healing promoting effects of MCs, we looked at MC-PA interaction in vitro and found only
a minor direct antibacterial capacity of MCs. Moreover, MC-dependent recruitment of neutrophils
as well as macrophages was not altered between MC-deficient and wild type mice. The described
phenotype points towards a crucial interaction between MCs and cells of the epidermal skin com-
partment resulting in the reduction of bacterial burden and an amelioration of the wound healing
capacity. These findings present the importance of MCs in the wound healing process of PA infected
skin wounds in a clinically relevant model.
1191
Altered skin microbiome profiles in patients with primary immunodeficiency and eczema
J Oh,1 S Conlan,1 A Freeman,2 N Program,1 F Candotti,1 SM Holland,2 JA Segre1 and HH Kong3 1
Genetics and Molecular Biology Branch, NHGRI, NIH, Bethesda, MD, 2 Laboratory of Clinical
Infectious Diseases, NIAID, NIH, Bethesda, MD and 3 Dermatology Branch, CCR, NCI, NIH,
Bethesda, MD
Interactions between the skin microbiome and the human immune system are incompletely char-
acterized. To gain insights into regulatory mechanisms by which immunity might influence the com-
position of the human skin microbiome, we surveyed patients with several monogenic primary
immunodeficiencies (PID) and eczema. We studied the skin microbiomes of 41 individuals with
Hyper IgE, Wiskott-Aldrich, and Dedicator of Cytokinesis 8 (DOCK8)-deficiency syndromes and
compared them with those in typical atopic dermatitis (AD) patients and healthy controls at skin
sites characteristically affected by eczema, a control site, and a site of pathogen carriage (nares).
We found that skin in PID patients was colonized by Enterobacteriaceae that were not present in
healthy controls or AD patients. We also observed that the skin bacterial communities in PID patients
demonstrated less skin site specificity and decreased temporal stability as compared to those in
healthy or AD controls. Using linear modeling, we determined that disease severity and selected
immunological markers (IgE) were correlated with prevalence of Staphylococcus, Corynebacterium,
and other less abundant taxa. Although Staphylococcus aureus, a known pathogen, was most strongly
correlated with disease severity, other staphylococci such as S. haemolyticus and S. epidermidis
were also significantly overrepresented in the PID individuals. This study documents that patients
with primary immunodeficiencies have skin microbiomes that have unique characteristics, sug-
gesting that additional studies of these rare individuals will significantly inform our understanding
of host-microbiome interactions.
1192
MyD88 plays a role in deciding between apoptotic and necroptotic cell death after UV irra-
diation
E Harberts,1,2 R Fishelevich,2 J Liu,2 SP Atamas3 and AA Gaspari1,2 1 Microbiology and
Immunology, Univ. of MD, Baltimore, MD, 2 Dermatology, Univ. of MD, Baltimore, MD and
3 Medicine, Univ. of MD, Baltimore, MD
Ultraviolet irradiation (UV) induced cellular damage is classically associated with apoptosis and
known to result in systemic immunosuppression. How the cell fate decision to undergo apoptosis
is made following UV irradiation is not fully understood. Our previous finding that toll-like recep-
tor (TLR) signaling regulates DNA repair and cell survival after UV led us to hypothesize that a cen-
tral mediator of TLR signaling, MyD88, contributes to determining cell fate after UV. Survival fol-
lowing UV of immortalized bone marrow-derived macrophages (BMM) from MyD88
germline-deficient mice (MyD88-/-) was significantly higher than that of wild-type (WT) BMM. UV-
induced apoptotic morphology was less pronounced in MyD88-/- BMM than in WT. DNA from
peritoneal macrophages (PM) and epidermis of MyD88-/- animals, compared to WT, showed decreased
UV-induced DNA laddering. In MyD88-/- PM, decreased cleavage of a pro-necroptotic protein RIP1,
suggests that necroptosis rather than apoptosis has been initiated. Furthermore, mRNA levels of RIP1
and RIP3 were elevated and TNF-α production increased in MyD88-/- PM compared to WT PM, fur-
ther suggesting necroptotic rather than apoptotic fate. In vivo studies using UV-irradiated mice
showed significantly less TUNEL-positive cells and more profound inflammation in skin sections of
MyD88-/- than in WT animals. Using a contact sensitization model, MyD88-/- mice, compared to
WT, are also found to be resistant to UV-induced immunosuppression. Considering that MyD88
participates in multiple TLR pathways, TLR2-/-, TLR4-/-, and WT BMM were compared for evidence
of UV-induced apoptosis. Only TLR4-/- BMM had a similar phenotype to MyD88-/-, suggesting that
the TLR4-MyD88 axis importantly contributes to cell fate decision. Our study begins to describe a
new cellular consequence of MyD88 signaling after UV-irradiation, and may provide rationale for
the development of a MyD88 modulating therapy that could potentially be used to mitigate UV-
induced immunosuppression.
1193
Analysis of distribution patterns of Propionibacterium acnes phylotypes and Peptostrepto-
coccus species identified by PCR-based techniques in association with clinical characteris-
tics of acne vulgaris
D Suh,1,2 H Kwon,1,2 J Yoon,2 S Park1,2 and S Min1,2 1 Dermatology, Seoul National University
College of Medicine, Seoul, Republic of Korea and 2 Acne Research Laboratory, Seoul
National University Hospital, Seoul, Republic of Korea
Precise roles of Propionibacterium acnes (P. acnes) and other anaerobic bacteria in the pathogen-
esis of acne are still unclear. Recent studies have shown that P. acnes can be further classified into
several phylotypes with distinct phenotypes and virulences, while their correlation with clinical
characteristics of acne has been rarely demonstrated. To analyze relationships between distribution
patterns of two major anaerobic bacteria and clinical acne manifestations, we identified P. acnes
phylotypes and Peptostreptococcus species from various acne lesions. A total of 370 samples from
acne patients and 65 samples from healthy controls was investigated. Three P. acnes phylotypes
and Peptostreptococcus species were identified by practical PCR-based methods including the use
of type-specific primers and restriction fragment polymorphism analysis, respectively. Distribution
patterns were analyzed from the perspectives of disease severity, subtypes of lesions, and sebum
production. Proportions of type IA P. acnes and Peptostreptococcus species were higher in acne
patients compared with healthy controls. Parallel distribution patterns were observed among acne
patients as the disease severity aggravated. In addition, type IA P. acnes and Peptostreptococcus
species comprised higher proportions in papules and pustules compared with comedones and skin
surface. Finally, there was no significant difference in sebum output between patients infected with
type IA P.acnes and the other patients. Type IA P. acnes and Peptostreptococcus species are likely
more closely associated with acne inflammation. These findings might partly clarify the functional
contradiction between pathogens and ubiquitous inhabitants, providing insight into the develop-
ment of new acne therapeutics.
1194
Detection of factor XIII subunit A distinguishes dendritic cells and tissue macrophages in non-
infectious granulomatous skin lesions
D Torocsik,1 H Bardos,2 Z Hatalyak,2 B Dezso,3 I Veres,1 L Paragh,1 Z Peter,1 M Balazs,2
E Remenyik1 and R Adany2 1 Department of Dermatology, University of Debrecen, Medical
and Health Science Centre, Hungary, 2 Department of Preventive Medicine, University of
Debrecen, Medical and Health Science Centre, Hungary and 3 Department of Pathology,
University of Debrecen, Medical and Health Science Centre, Hungary
Factor XIII subunit A (FXIII-A) is applied in the diagnostics of a wide range of dermatological dis-
eases. In the present study we aimed to gain information on the cells showing immunohistochem-
ical reaction for FXIII-A and answer the question whether macrophages and/or dendritic cells are
labeled for FXIII-A. We carried out our studies on samples of granuloma annulare (GA) and necro-
biosis lipoidica (NL), the prime examples for granulomatous skin lesions with a non-infectious back-
ground where extracellular matrix remodeling is a key feature without any sign of malignant trans-
formation. Using markers for macrophages and dendritic cells in combination with the detection
of FXIII-A in double labeling immunohistochemical reactions we demonstrated that FXIII-A posi-
tivity clearly distinguishes macrophages (CD163+/FXIII-A+) from dendritic cells (CD11c+/FXIII-A-
) not only in normal dermis as previously described by Zaba et al. (J Clin Invest 117: 2517-25), but
also under pathological conditions of GA and NL samples. Variable expression of mannose recep-
tor and DC-SIGN molecules on FXIII-A+ macrophages confirmed that FXIII-A is present in the alter-
natively activated macrophages, but suggested that these macrophages do not represent a homog-
enous population.
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Impact of isotretinoin on the expression of antimicrobial peptides in skin of patients having
acne vulgaris
A Borovaya,1,2 Y Dombrowski,1 S Zwicker,1 O Olisova,2 R Wolf,1 T Ruzicka,1 J Schauber1 and
M Sardy1 1 Dermatology and Allergology, Ludwig Maximilian University, Munich, Germany
and 2 Department of Dermatology and Venerology, I.M. Sechenov First Moscow State
Medical University, Moscow, Russian Federation
Cutaneous antimicrobial peptides (AMPs) represent an integral part of innate immunity. They have
a broad-spectrum activity against bacteria including P. acnes. To date, more than 20 individual pro-
teins and polypeptides have been identified as AMPs. It has not been fully understood which of them
play a pathogenic role in acne vulgaris. Our study aimed to investigate which human AMPs are
expressed in the skin of acne vulgaris patients compared to healthy controls before and after treat-
ment with isotretinoin. In order to determine expression of 14 different AMPs, total RNA was pre-
pared from serial biopsies of 13 patients having acne vulgaris before, during and after isotretinoin
treatment, together with 11 healthy controls. The relative expression was measured using quantita-
tive real-time PCR with porphobilinogen deaminase as a housekeeping gene. We found that the
relative expression of cathelicidin, β-defensin-2, lactoferrin, lysozyme, psoriasin, and RNAse-7
was increased, while that of α-defensin was decreased compared to the controls. The relative expres-
sion levels of β-defensin-2, S100A7, and lactoferrin stayed upregulated even after 6 months of
isotretinoin therapy. The relative cutaneous expression of granulysin, RANTES (CCL5), perforin,
CXCL9, substance P, chromogranin B, and dermcidin did not show any significant change in acne
patients compared to healthy controls. In conclusion, some AMP genes are upregulated in acne vul-
garis compared to healthy individuals, and the upregulation of some AMPs is not completely reversed
by isotretinoin therapy. More studies are needed to explore which AMPs play a relevant role in the
defense against P. acnes in acne vulgaris.
1197
The proteomic profiling of TSLP-activated iNKT cells
J Shin,1 C Park,1 J Kim,3 S Noh,1 S Jin,1,2 N Lee,1,2 J Lee,1 H Kim,1 Y Lee1 and K Lee1 1 Department
of Dermatology and Cutaneous Biology Research Institute, Yonsei University College of
Medicine, Seoul, Republic of Korea, 2 Brain Korea 21 Project for Medical Science, Yonsei
University College of Medicine, Seoul, Republic of Korea and 3 Korea Basic Science Institute,
Daejeon, Republic of Korea
In AD, innate immune mechanisms such as pattern recognition receptors and antimicrobial pep-
tides have been investigated in detail, but recently, epidermis-derived cytokines, namely thymic stro-
mal lymphopoietin (TSLP), IL-25 and IL-33, were shown to participate in innate immune reactions
independently of adaptive immunity. In addition to conventional innate cells, such as mast cells,
basophils and eosinophils, Th2 cytokine-producing invariant natural killer T (iNKT) cells, can par-
ticipate in innate immune modulation in AD. To understand the role of iNKT cells in atopic der-
matitis in the view of innate immunity, we used comparative approaches to analyze proteomic pro-
filing of iNKT cells with and without stimulation of TSLP. In our study, iNKT cells were isolated from
human PBMCs using the anti-iNKT MicroBeads (Microbeads conjugated to monoclonal anti-human
Vα24-Jα18 antibodies), a LS Column, and a Midi MACS™Separator. We used a quantitative mass
spectrometry-based proteomics experiments with stable-isotope-containing isobaric tags (TMT),
which produce differentially labeled peptide ions that are indistinguishable in full mass spectra.
Initially, we identified about one thousand and four hundred proteins in TSLP-treated and TSLP-non-
treated iNKT cells. Then we attempted to identify proteins that either increased or decreased depend-
ing on time after stimulation with TSLP. Finally, we identified 28 proteins for further investigation.
We found 26 down regulated proteins and 2 up regulated proteins including chemokine receptors
and others. Our method allows the quantitative comparison of biologically distinct data sets with
high confidence and this can be utilized for differential protein expression analysis in the newly
developing research field of innate immune system in atopic dermatitis.
1199
The role of 9-HODE in Propionibacterium acnes-induced inflammation
A Park,1 M Qin,1 A Pirouz,1 L Hisaw,1 G Agak,1 W Zhu,1 H Garban1 and J Kim1,2 1 Medicine,
Division of Dermatology, David Geffen School of Medicine at UCLA, Los Angeles, CA and 2
Dermatology, David Geffen School of Medicine at UCLA, Los Angeles, CA
Oxidized lipids have been shown to play an important role inducing inflammation in various dis-
eases. In acne, sebum lipids are thought to contribute to disease pathogenesis by inducing inflam-
mation. Here we investigated the mechanism linking lipids found in sebum and inflammation in
response to Propionibacterium acnes. To mimic sebaceous follicular rupture during acne develop-
ment in vitro, we treated SEB-1 sebocytes with varying doses of P. acnes. The sebum from this
model was then used to treat human monocytes, cells important in inducing inflammatory response
in acne. We found that P. acnes-treated sebum induced monocytes to secrete inflammatory cytokines
IL-1β, ΙL-6, and IL-8 (n=3, p<0.05), as opposed to untreated sebum. Using gas chromatography, we
found that P. acnes-induced sebum contains higher levels of 9- and 13-hydroxyoctadecadienoic
(HODE), and 15-hydroxyeicosatetraenoic acid (HETE), all oxidized derivatives of the abundant
sebum fatty acid linoleic acid. 9-HODE alone induced significant upregulation of IL-1β in mono-
cytes at both mRNA and protein levels while 13-HODE and 15-HETE had no effect. We next ana-
lyzed the expression of G2A, a stress-inducible G protein-coupled receptor and a receptor for 9-
HODE. Low concentrations of 9-HODE induced high G2A expression but at higher concentrations
of 9-HODE, G2A expression was downregulated, suggesting a biphasic relationship between 9-
HODE and G2A. The role of sebum in acne pathogenesis has long been theorized but seldom inves-
tigated. Our data provides evidence to suggest an inflammatory pathway of the oxidative stress
caused by P. acnes through 9-HODE.
1198
Regulation of IL-6 by the inflammasome in ultraviolet B-irradiated human keratinocytes
LD Hisaw,1,2 M Qin,1 A Park1 and J Kim1,3 1 Department of Medicine, Division of Dermatology,
David Geffen School of Medicine at UCLA, Los Angeles, CA, 2 School of Medicine, University
of California Irvine, Irvine, CA and 3 Dermatology, Greater Los Angeles Healthcare System
Veterans Affairs, Los Angeles, CA
Keratinocytes are the major immunologically competent component of human skin, providing the
initial barrier and response against environmental dangers such as ultraviolet B (UVB) irradiation.
UVB-irradiated human keratinocytes have been shown to secrete potent inflammatory cytokines
including IL-1β, IL-6, and IL-18. In this study, we investigate the innate immune response in UVB-
induced inflammation in human keratinocytes; specifically, we focus on how inflammasome-medi-
ated cytokines IL-1β and IL-18 regulate IL-6 secretion and gene expression changes of Nod-like
receptors (NLRs). In our study, UVB induced significant IL-6 secretion in immortalized human ker-
atinocyte (HaCaT) cell line but not IL-1β or IL-18 (n=3, p<0.05). Because IL-1β and IL-18 are rap-
idly activated by the inflammasome when exposed to stress, they may be early signals that amplify
pro-inflammatory cytokines like IL-6. Treatment of HaCaTs with IL-1β alone induced IL-6 secretion
while IL-18 did not. Together, UVB and IL-1β had a synergistic effect on IL-6 production. Caspase-
1 inhibitor diminished UVB-induced IL-6 secretion suggesting caspase-1 (involved in inflamma-
some activation) is required for IL-6 secretion. These data suggest indirect involvement of the inflam-
masome pathway in UVB-induced IL-6 secretion in human keratinocytes. We used qPCR to analyze
NLR gene expression after exposing HaCaTs to varying UVB doses. Our preliminary data show sig-
nificant dose-dependent up regulation of NLRP3 (UVB-induced inflammasome). Additionally, our
data show significant dose-dependent down regulation of NLRP2, NLRP12, and NLRP14 and dose-
dependent up regulation of NLRP7 (significance yet unknown) (n=3, p<0.05). Better understand-
ing of UVB-induced inflammasome activation and subsequent regulation of IL-6 in keratinocytes
could lead to novel ways of manipulating the inflammatory response caused by UVB.
1196
Human mast cells kill vaccinia virus when stimulated with commensal bacteria byproduct
LTA
Z Wang, DT MacLeod and A Di Nardo Medicine-Dermatology, university of California San
Diego, La Jolla, CA
Mast cells (MCs) have been reported to be effector cells in skin viral infections in mice. However,
this capacity was never described for human MCs.. In this study, we demonstrate that human cord
blood CD34+ cells derived MCs can kill vaccinia virus (VV) by the release of LL-37 cathelicidin
antimicrobial peptide, which is induced by the activation of TLR2 ligands (lipoteichoic acid) pro-
duced by commensal bacteria at the epithelial surface. Our research shows that signaling through
TLR2 increases the production of LL-37 in human MCs, thereby enhancing their capacity to fight
vaccinia virus, while increasing the MC recruitment at the skin interface. TLR2 is a main inducer of
LL-37 in mast cells and does not require vitD as a cofactor. Furthermore, we proved that the mech-
anism of MCs kill VV by degranulation using a membrane-activated pathway that leads to antimi-
crobial peptide discharge and virus inactivation. Taken together, our findings reveal that the expres-
sion and control of antimicrobial peptides and TLR signaling on human MCs are key in fighting
viral infection. Our findings also provide new insights into the pathogenesis of skin infections and
suggest potential roles for MCs and TLR2 ligands in antiviral therapy.
1200
Strain specific and dose dependent effect of various Propionibacterium acnes strains on the
cellular functions of HPV-KER cells
G Tax,1 B Bolla,1 L Erdei,1 E Urbán,3 L Kemény1,2 and K Szabó1 1 Department of Dermatology
and Allergology, University of Szeged, Szeged, Hungary, 2 MTA-SZTE Dermatological
Research Group, Szeged, Hungary and 3 Institute of Clinical Microbiology, University of
Szeged, Szeged, Hungary
The Propionibacterium acnes (P. acnes) bacterium is a member of the commensal flora, but under
special circumstances it can affect the cellular properties of human skin cells, causing inflamma-
tion as seen in acne lesion formation. To investigate this phenomenon in more detail we monitored
the effect of three P. acnes strains (889, 6609, ATCC 11828) - belonging to various phylogenetic
groups - on the proliferation and viability of immortalized keratinocytes (HPV-KER) using the xCEL-
Ligence system. The P. acnes 6609 strain had no measurable effect on the cellular functions of
HPV-KER cells regardless of its dose. At the same time, the P. acnes 889 strain was the only one
applied at high doses (multiplicity of infection, MOI = 200, 300) that induced cell proliferation,
monitored by Ki67 mRNA expression. The P. acnes 889 and ATCC 11828 strains applied at high
doses resulted in the death of HPV-KER cells. According to the light microscopic analysis, dying
cells exhibited an altered morphology. We hypothesize that the differential effects of the P. acnes
strains might be due to the strain-specific expression of secreted toxins (CAMP factors) possibly exert-
ing the cytotoxicity on the HPV-KER cells. Next we investigated whether we can detect any dose
dependent or strain specific signaling differences in HPV-KER cells and found that the mRNA expres-
sions of key pro-inflammatory cytokines (TNFα, IL-1α) increased parallel with the elevating P.
acnes 889 doses at 6 hours after the bacterial treatment. In parallel with this, we could demonstrate
a dose dependent NF-κB nuclear translocation in the cells. These results suggest that assorted P.
acnes strains have different effects on the proliferation and viability of keratinocytes. These strain
specific differences can also be important determinants of the severity of individual inflammatory
acne symptoms.
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Identification of negative regulatory elements counteracting the Propionibacterium acnes-
induced signaling pathways in in vitro cultured immortalized keratinocytes
K Szabó,1 G Tax,2 L Erdei,2 B Bolla,2 E Urbán3 and L Kemény1,2 1 MTA-SZTE Dermatological
Research Group, Szeged, Hungary, 2 Department of Dermatology and Allergology, University
of Szeged, Szeged, Hungary and 3 Institute of Clinical Microbiology, University of Szeged,
Szeged, Hungary
The human skin harbors a specialized microbial flora that is crucial for the maintenance of the epi-
dermal homeostasis, but under special circumstances it can also contribute to the pathogenesis of
skin diseases, such as Propionibacterium acnes (P. acnes) in acne. Interpretation of this dual role is
difficult. A lot of data have been gathered about the signaling events leading to the activation of
immune and inflammatory events in response to the bacterium, but little is known about the neg-
ative regulatory elements playing role in the maintenance of epidermal homeostasis. To investigate
the interplay of positive (TNFα) and negative regulatory factors (SIGIRR, TOLLIP and TNFAIP3) of
the Toll-like receptor (TLR) induced signaling cascade, we analyzed their mRNA expression changes
in response to P. acnes 889 treatment in an in vitro cultured immortalized keratinocyte cell line, the
HPV-KER. We found that all the analyzed genes were expressed in HPV-KER cells, and the expres-
sion of TNFα and TNFAIP3 changed in response to the P. acnes 889 treatment. The induced mRNA
expression changes appeared to be dose dependent both at 6 and 24 hours after the bacterial treat-
ment. Parallel to the increase in the applied P. acnes doses (multiplicity of infection, MOI = 25, 50,
100, 200, 300) the ratio of TNFα and TNFAIP3 mRNAs changed in a way that the positive signals
increasingly outgrew the negative ones. We could demonstrate the net effect of these events with
an enhanced NF-κB nuclear translocation and increased cellular activation. We hypothesize that
in the follicles - parallel with the growth of P. acnes - these events can subsequently lead to the
induction of atypical keratinocyte functions (hyperproliferation, abnormal differentiation) charac-
teristic of acne lesion development.
1202
MicroRNA-155 (miR-155) and interleukin 10 (IL-10) regulate proinflammatory cytokine
response in Orientia tsutsugamushi-infected human THP-1 macrophages
CH Chang,1,2 MH Tsai,2 YR Hong3 and TH Chuang4 1 Dermatology, Kaohsiung Medical
University, Kaohsiung, Taiwan, 2 Graduate Institute of Medicine, Kaohsiung Medical
University, Kaohsiung, Taiwan, 3 Biochemistry, Kaohsiung Medical University, Kaohsiung,
Taiwan and 4 Immunology Research Center, National Health Research Institute, Chu Nan,
Taiwan
Orientia tsutsugamushi (OT) is a Gram-negative obligate intracellular bacterium which causes scrub
typhus. OT survives and replicates inside macrophages, which are potent effector cells to kill the
pathogens. Hyper-production of cytokines is associated with host susceptibility by OT infection. The
immunoregulatory mechanisms in macrophages in response to OT are still unknown. We examined
the dose effect of OT (TW-1 strain) infection on human THP-1 macrophage. In low dose infection
(ratio of bacteria to macrophages was 2:1), OT induced IL-10 production to ten-fold and lowered
the TNF-α, IL-1β and IL-6 secretion in macrophages time dependently. In high dose infection (ratio
of bacteria to macrophages was 100:1), OT induced IL-10 production to four-fold and increased
the TNF-α, IL-1β and IL-6 secretion in macrophages time dependently. When macrophages pre-
treated with IL-10 and then exposed to high dose infection, the TNF-α production was suppressed
and cell survival rate increased. IL-10 production in macrophage is mainly via the ERK signaling
pathway. When macrophages pretreated with PD98059 to block ERK pathway and then exposed
to low dose infection, there was no IL-10 but high TNF-α production. miR155 was upregulated by
a time dependent and dose dependent way which was 10-fold increase in high dose infection com-
pared to 4-fold increase in low dose infection. When macrophages pretreated with IL-10, the miR155
response to high dose infection was abolished and TNF-α production was burst increased. When
macrophages pretreated with anti-miR155, TNF-α production was increased and no IL-10 produc-
tion during high dose infection. miR155 and IL-10 play the key roles in the immunoregulation of
OT-infected macrophages. Dysregulation of miR155 or IL-10 may contribute to the host suscepti-
bility to OT infection.
1203
Interest of I-modulia, an Aquaphilus dolomiae extract, in innate immune response of atopic
dermatitis pathology
M Aries, H Hernandez-Pigeon, C Vaissière, A Caruana, T Nguyen, S Bessou-Touya and N Castex-
Rizzi Dermo Cosmetic Department, Pierre FABRE R&D Center, Toulouse, France
Atopic dermatitis (AD) is a highly chronic relapsing inflammatory skin disease characterized by
skin barrier dysfunction occurring through both genetic and acquired mechanisms, and associated
to immune response alteration. The innate defective immune response in AD patients has been
shown to enhance susceptibility to skin infection, in particular by Staphylococcus aureus; more-
over impaired innate mechanisms such as pattern recognition receptors (PRRs) and antimicrobial
peptides (AMPs) lead to impaired recognition of microbial components. A polymorphism in the Toll-
Like Receptor-2 (TLR-2) gene with AD has been reported and linked to these functional impairments.
As well, the production of AMPs has been reported to be impaired in AD. In this way, the aim of
this study was to evaluate an original biological extract named I-modulia from culture of Aquaphilus
dolomiae, isolated from Avene Spring Thermal Water microflora, on TLRs activation and on AMPs
expression. Activation of TLR-1 to TLR-10 by I-modulia was assessed on recombinant HEK-293 cell
lines which functionally over express each TLR protein and SEAP gene reporter. Expression of
AMPs was assessed on normal human keratinocytes incubated with I-modulia before mRNA quan-
tification by Quantigene technology. Our results showed that I-modulia activated TLR-2, TLR-4 and
TLR-5. Moreover, I-modulia induced, like flagellin, a TLR-5 natural ligand, mRNA expression of
three AMPs: hBD-2, cathelicidin and psoriasin. These inductions were blocked by TLR-5 blocking
antibody. Together, the present data support the notable activity of I-modulia, an Aquaphilus dolo-
miae extract, on innate immunity by TLR-2, TLR-4, TLR-5 activation, and by AMPs induction via
mainly TLR-5 activation. This TLRs activation is highly interesting especially as strategies that boost
TLR-2 are now also reported to restore epidermal integrity in AD, besides the restoration of innate
immune response.
1204
Activation of inflammasomes by tyrosine complexes
S Oehrl, T Doebel, A Enk and K Schaekel Dermatology, University Hospital Heidelberg, 69115
Heidelberg, Germany
Inflammasomes are cytosolic protein complexes of innate immune cells that sense various danger-
associated molecular patterns (DAMPs). Activation of inflammasomes results in autocatalytic cleav-
age of caspase-1 which subsequently leads to the conversion of pro-IL-1β into its active form. The
NLRP3 inflammasome has been demonstrated to be a crucial element in the adjuvanticity of vac-
cines containing alum. However, the use of alum has raised concerns as it has the potential to induce
neurological and immunological disorders. An apparently safe compound licensed in Europe and
frequently used for the absorption of allergens for specific immunotherapy are complexes formed
of the natural amino acid tyrosine. In this study we wanted to assess whether complexes formed of
tyrosine have the capacity to activate inflammasomes and thereby may contribute to the good clin-
ical effects seen when using these products in patients. The human monocytic cell line THP-1 was
stimulated with different concentrations of tyrosine complexes (30ng/ml-300μg/ml) after differenti-
ation with PMA (300μg/ml) and priming with ultrapure LPS (100ng/ml) to induce transcription of
pro-IL-1β. Alum (200μg/ml) served as a positive control. Stimulation with 300μg/ml and 30μg/ml
of tyrosine complexes resulted in a significantly higher IL-1β secretion compared to the LPS con-
trol. The addition of a caspase-1 inhibitor (YVAD-CMK) prior to LPS stimulation blocked IL-1β secre-
tion induced by tyrosine complexes which demonstrated the critical involvement of inflammasomes
in this process. Stimulation with tyrosine did not induce additional cell death as alum does. Fur-
thermore, also primary human blood monocytes and native dendritic cells secreted IL-1β upon stim-
ulation with tyrosine complexes after LPS-priming and in analogy to THP-1 cells this stimulatory
effect could be abrogated by the caspase-1 inhibitor. We demonstrated here that tyrosine complexes
are able to induce IL-1β, likely in an NLRP3 inflammasome-dependent manner. We conclude that
tyrosine complexes function as adjuvants and may well serve as an alternative to aluminium in vac-
cines.
1205
Live Demodex mites regulate the inflammatory responses of SZ95 sebocytes
N Lacey,1 A Russell-Hallinan,1 CC Zouboulis2 and FC Powell1 1 Charles Institute of
Dermatology, University College Dublin, Dublin, Ireland and 2 Departments of Dermatology,
Venereology, Allergology and Immunology, Dessau Medical Center, Dessau, Germany
Demodex are ubiquitous mites colonising the skin of human adults. In the majority of cases they
initiate no host inflammatory response. When mite numbers are increased they may cause inflam-
matory skin changes. How these mites interact with the immune response mechanisms of the pilose-
baceous unit they inhabit is unknown. We sought to evaluate the immunostimulatory activity of
live Demodex on human SZ95 sebocytes through the Toll like receptor signalling pathway.Demodex
(n=20) were extracted from a skin surface biopsy. SZ95 sebocytes were stimulated with live mites
for 8hr, 24hr and 48hr (n=3). The secretion of inflammatory cytokines and chemokines were deter-
mined by Multi-Analyte ELISArrays. TLR Signalling Pathway PCR Arrays were utilised for gene expres-
sion analyses. The secretion of TNFα was increased 50 fold in the presence of live mites at 8hr
(p<0.05). At 24hr secretion was inhibited (p<0.01) and this inhibition continued at 48hr compared
to control cells. IL8 and GM-CSF secretion were examined and found to be increased at 8hr return-
ing to control levels by 48hr but did not reach statistical significance (p>0.05). IL6 secretion was
increased at 48hr, while IL4 was increased above controls at each time point and IL1α was inhib-
ited, but did not reach statistical significance (p>0.05). Demodex significantly down-regulated NFKB1
and CD180 mRNA expression at 8hr and 24hr respectively and up-regulated CCL2 at 48hr (p<0.05)
compared to untreated control cells. These findings indicate that live Demodex interact immuno-
logically with SZ95 sebocytes inducing an initial pro-inflammatory response. They subsequently
down-regulate the cells damaging responses, by potentially inhibiting recruitment of inflammatory
cells. The modulation of the inflammatory responses of SZ95 sebocytes in vitro suggests a pathway
of interaction of these organisms within the environment of the pilosebaceous unit.
1206
Identification of pro-inflammatory monocyte subsets in human psoriasis and a murine pso-
riasis model
JB Golden,1,2 NL Ward,2 Y Wang,3 DI Simon,3 TS McCormick2 and KD Cooper2,4 1 Pathology,
Case Western Reserve University, Cleveland, OH, 2 Dermatology, Case Western Reserve
University, Cleveland, OH, 3 Medicine, Case Western Reserve University, Cleveland, OH and
4 VA Medical Center, Cleveland, OH
Psoriasis confers an increased risk for developing and dying of cardiovascular disease (CVD). Ele-
vated levels of circulating CD14++CD16+ intermediate monocytes (Int-Mon) independently predict
MI, non-hemorrhagic stroke, and death in CVD patients. We hypothesize that increased Int-Mon in
psoriasis mechanistically links skin pathogenesis with CVD morbidity. PBMCs of psoriasis patients
(n=22) show significantly increased Int-Mon compared to healthy controls (n=21) (11.1%±1.87 vs.
5.47%±0.46, respectively; P=0.007). Human Int-Mon have been likened to murine pro-inflamma-
tory Ly6Chi cells, a subset linked to enhanced murine atherosclerosis. KC-Tie2 psoriasiform mice
are pro-thrombotic, develop aortic root vascular lesions, and have increased splenic Ly6Chi mono-
cytes (37.9%±3.14) compared to wild type controls (11.9%±4.56; P=0.002), suggesting that chronic
skin inflammation may be linked to increased Ly6Chi cells which likely mediate vascular inflam-
mation. Indeed, topical imiquimod (5% Aldara for 5 days) produced increases in Ly6Chi monocytes
in spleen (20.3%±1.32 vs 7.87%±1.14 in controls; P=0.0001) and lymph nodes (15.1%±2.56 vs
2.74%±0.70; P=0.0136); however no increase in thrombosis was found in this short term model.
Elimination of skin inflammation via gene repression or IL-6 deletion reversed aortic root vascular
lesions and thrombosis and decreased splenic Ly6Chi cells by 10% (P=0.044). Together these data
suggest that both acute and chronic skin inflammation elicits monocytosis, whereas chronic inflam-
mation is required for thrombosis promotion. Demonstrating therapeutic promise, elimination of
skin inflammation reduces these monocytes, returning thrombotic clotting times to control levels.
Thus, pro-inflammatory Int-Mon may provide a cellular link between pathogenic skin inflamma-
tion seen in psoriasis and increased CVD risk.
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Staphylococcus aureus interaction with the epidermis regulates T cell priming by cutaneous
dendritic cells
ME Polak, E Swindon, D Davies, E Healy and MR Ardern-Jones Clinical and Experimental
Sciences, University of Southampton, Southampton, United Kingdom
Staphylococcus aureus (SA) is implicated in mediating inflammation in atopic dermatitis (AD), poten-
tiating antigen presentation and cytokine release in inflamed keratinocytes (KC), yet the precise link
with the Th2 profile of acute lesions remains unclear. To assess the role of SA on priming of skin
immune responses we used a 3D organotypic skin model derived from primary human KCs. Epi-
dermal cultures were infected with live SA for 72h before antibiotic treatment. Skin programming
of primary human cutaneous or control dendritic cells (DCs) was modelled by co-culture with SA-
exposed or control epidermis, TNFα or TSLP before phenotyping and priming of naïve human CD4
T cells. SA infection induced activation of KC measured by up-regulation of MHC class II mole-
cules. DC exposure to SA-infected epidermal sheets induced up-regulation of DC surface activa-
tion markers: CD40, CD80 and CD86. DCs exposed to SA-infected epidermis showed enhanced
priming of both Th1 and Th2 cells as compared to uninfected epidermis. Langerhans cells (LCs) were
superior inducers of Th2 priming (n=6, p=0.013), and this ability was enhanced by both TSLP (n=6,
p=0.006) and TNF-α (n=6, p=0.03). Stimulation with cytokines did not induce Th2 priming capa-
bility in dermal DCs. Memory Th2 activation was mediated by all cutaneous DC. Interestingly, TSLP
(but not TNFα) was able to further potentiate epidermal DC induction of Th2 lymphocyte cytokine
production (n=3, p=0.02). Our results indicate that bacterial interactions with the epidermis can
influence cross-talk between KCs and cutaneous DCs, most likely by altering cytokine release from
inflamed KCs. This suggests that as well as direct bacterial:DC interaction, superficial skin infection
or even colonisation may regulate cutaneous immune responses. This is likely to be important in
inflammatory skin diseases such as atopic dermatitis where the presence of bacteria is strongly impli-
cated in disease pathogenesis.
1209
No evidence for viral DNA in whole genome sequence of cutaneous squamous cell carci-
noma
M Dimon,1 HM Wood,2 W Liao,1 RJ Cho1 and ST Arron1 1 Dermatology, University of California,
San Francisco, CA and 2 Precancer Genomics, Leeds Institute of Molecular Medicine, Leeds,
United Kingdom
Multiple lines of evidence suggest a viral etiology for cutaneous squamous cell carcinoma (SCC).
Human papillomavirus (HPV) DNA has been detected at low levels in a subset of SCC, but no mech-
anism exists for viral transformation. HPV is not transcriptionally active in SCC and is present at viral
loads of only one copy to 100-10,000 cells. Our objective was to determine whether any virus is
present in the genome sequence of SCC. DNA was extracted from 12 SCC and matched normal tis-
sue. Exomes were isolated using oligonucleotide-based hybrid capture for sequencing; whole genome
libraries were prepared for three samples. Libraries were sequenced with the Illumina sequencing-
by-synthesis platform. Pathogen analysis was performed with Integrated Metagenomic Sequence
Analysis (IMSA) software; whole genome sequence from SiHa and CaSki cell lines were used as
positive controls for HPV detection. We estimated exome capture efficiency of 60%, with ample
skin flora (staphylococcus and proprionibacterium) detected in all skin samples. HPV was not detected
in the exome sequence of any of the 12 tumors sequenced; whole genome sequencing confirmed
the absence of HPV DNA. In contrast, HPV16 was readily detected in the genome sequence of CaSki
and SiHa cell lines. No other episomal or integrated virus was detected in these tumors; one tumor
and normal pair from a lung transplant recipient both carried torque teno virus, reflective of the
patient’s level of immunosuppression. In conclusion, IMSA is a fast, flexible software algorithm for
detection of pathogen sequence in high throughput datasets. We used high throughput exome and
whole genome sequence to demonstrate the absence of detectible HPV or other viral DNA in SCC.
Low-level HPV DNA detected by nested PCR in prior studies likely reflects commensalism rather
than oncogenicity of this virus.
1211
Topographical localization of antibody improves the detection limit for nanoscale biosensors
MA Lifson,1 D Basu Roy2 and BL Miller1,2,3 1 Biomedical Engineering, University of Rochester,
Rochester, NY, 2 Department of Biochemistry and Biophysics, University of Rochester,
Rochester, NY and 3 Department of Dermatology, University of Rochester, Rochester, NY
Currently available diagnostic tools such as viral cultures, immunofluorescence, and polymerase-
chain reaction are not sufficient for rapidly and accurately identifying pathogens in patients with
viral-related cutaneous conditions. There is a great deal of interest in researching nanoscale optical
biosensors due to their high sensitivities, some of which can resolve the presence of a single target
in a sample. We are developing one such nanoscale sensor, a two dimensional bandgap device (2D-
PBG), which is capable of detecting intact viruses without the need for a secondary reporter or com-
plicated sample processing. The working principle of this device is to detect the minute optical
changes that occur when biological material, such as viruses, bind to the sensor. We have demon-
strated our ability to detect human papilloma virus-like particles in serum with high specificity using
antibody-mediated recognition. We observed a detection limit for this sensor that was less sensitive
than that predicted by theory. We hypothesized that the conventional methodology by which biorecog-
nition elements were applied to nanoscale biosensor surfaces inadvertently caused analyte loss
which prevented better limits of detection from being obtained. To address this problem, we devel-
oped a novel method of nanoparticle mediated blocking, which we used to selectively localize anti-
body to topographically different portions of our ultra-sensitive biosensor. The results indicated that
blocked surfaces led to detection limits that were ten times better than unblocked surfaces and
matched expected values determined by simulation. Therefore, this method of localizing biorecog-
nition molecules substantially improved the detection limits of our biosensor and can be general-
ized to any sensor with nanoscale topographies.
1210
Propionobacterium acnes promotes monocyte-derived macrophage M2b polarization
K MyungHwa,1 M Qin,2 A Pirouz,2 F Mourad,2 S Hong1 and J Kim2 1 Department of
Dermatology, Dankook University, School of Medicine, Cheonan, Republic of Korea and 2
Division of Dermatology, Department of Medicine, David Geffen School of Medicine at
UCLA, Los Angeles, CA
Macrophages are the first line of defense against pathogens, and the mode of their activation will
determine the success or failure of the host response to pathogen aggression. Macrophages are
known to play an important role in initiating, developing and resolving stages of acne lesions. Based
on limited numbers of markers, activated macrophages can be classified as classically activated
(M1) macrophages that support microbicidal activity or alternatively activated (M2) macrophages
that are not competent to eliminate pathogens. The purpose of this study is to investigate the dom-
inant phenotypes of dermal macrophages in P. acne infected human monocyte-derived macrophage
(hMoDM). We analyzed cell surface marker, gene expression and cytokine secretion using FACs
analysis, real-time PCR and ELISA, respectively in p. acne infected hMoDM comparing with M1
and M2 polarized hMoDM. P. acne infected hMoDM revealed reduced expression of M1 markers
such as CD40, CD86, CXCL10, CCR7, and increased M2 markers such as CD163, CD204, CD206,
CXCL1, CXCL2. Furthermore, P. acnes significantly induced secretion of IL-10, an M2 marker (n=3,
P< 0.01), but not IL-12p40 and TNF-alpha which are classified M1 markers. In typical comedonal
type acne tissue, CD163 positive, CD68 positive M2 macrophages were shown to abundantly infil-
trate the pilosebaceus follicles. In order to further specify the M2 subtype involved, we analyzed
the expression of specific subtype markers accordingly. P. acnes upregulated expression of CXCL2
gene and induced secretion of IL-1b, consistent with M2b polarization (n=3, P< 0.01). There was
no induction of TGF-alpha 1 and IL-1Ra, which are classified as M2a specific markers and there
was no induction of CCL16, a specific M2c marker. Our study suggests that M2b subtype macrophages
play an important inflammatory role in acne pathogenesis.
1208
Modified vaccinia virus Ankara induces type I IFN induction in conventional dendritic cells
through a STING-mediated cytosolic DNA sensing pathway that requires IRF3, IRF7 and
IFNAR1
P Dai,2,1 W Wang,1,2 H Cao,1,2 F Avogadri,3 R Vance,5 T Merghoub,3 S Shuman2 and L Deng1,4 1
Dermatology/Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, 2 Molecular
Program, Memorial Sloan-Kettering Cancer Center, New York, NY, 3 Immunology Program,
Memorial Sloan-Kettering Cancer Center, New York, NY, 4 Dermatology, Weill Medical College
of Cornell University, New York, NY and 5 Molecular & Cell Biology, University of California,
Berkeley, Berkeley, CA
Poxviruses are large cytoplasmic DNA viruses that cause significant human and veterinary dis-
eases. Modified vaccinia virus Ankara (MVA) is a highly attenuated vaccinia strain that has been
being investigated as a vaccine vector against various infectious agents (including smallpox, HIV,
tuberculosis and malaria) as well as cancers. Understanding how MVA modulates innate immunity
in dendritic cells provides insights to vaccine designs. Here we show that MVA infection induces
the production of type I interferon (IFN) in murine bone marrow-derived conventional dendritic
cells (cDCs) but not in plasmacytoid dendritic cells (pDCs). Transcription factors IRF3/IRF7 and
type I IFN positive feedback loop mediated by IFNAR1 are required for the induction. This induc-
tion effect is modestly dependent on endosomal DNA sensor TLR9 and its adaptor MyD88, but is
independent of endosomal RNA sensors TLR7, or TLR3 and its adaptor TRIF, or cytosolic dsRNA
sensing pathway mediated by MDA5 and its adaptor MAVS. MVA induction of type I IFN is fully
dependent on STING (stimulator of interferon genes), an adaptor for cytosolic DNA sensor(s). MVA
infection triggers phosphorylation of IRF3, which is diminished in the absence of STING. Treatment
of BMDCs with inhibitors for endosomal and lysosomal acidification or lysosomal enzyme Cathep-
sin B activity attenuates MVA-induced type I IFN induction, indicating that lysosomal enzymatic
processing of virions is important for MVA sensing and type I IFN induction in cDCs. Taken together,
our results demonstrate a critical role of the cytosolic DNA sensing pathway mediated by STING/IRF3
for type I IFN induction in cDCs by MVA.
1212
HIV-1 mediated regulation of the mTOR pathway modulates autophagy flux and dendritic
cells immune function
M Czubala, JP Mitchell, FP Blanchet and V Piguet Institute of Infection and Immunity, Cardiff
University, Cardiff, United Kingdom
Our research aims to decipher the mechanism and immune consequences imposed by HIV-medi-
ated modulation of autophagy in challenged dendritic cell (DC) subsets. Autophagy is a cellular
process linked to lysosomal-mediated degradation and involved in pathogen clearance while also
regulating innate and adaptive immune responses. We use primary DC subsets as well as cell line
models phenotypically similar to langerhans cells and myeloid DC (myDC). Following infection
with HIV-1, autophagy flux in cells was monitored by western-blotting, FACS and confocal imag-
ing. We demonstrate that, alike in myDC, autophagy flux is compromised in langerhans cells after
exposure to HIV-1 envelope or infectious virus. Hence, early activation of the autophagy negative
regulator, mTOR, was detected, and could account for the autophagy flux inhibition. Intriguingly,
we have identified the cellular factor AMP-activated protein kinase (AMPK) as a novel early sig-
nalling mediator during HIV-1 infection in DC subset. This discovery is rather unexpected, as AMPK
is commonly described to antagonize mTOR activation, but strongly supported by the pronounced
effect observed on HIV-1 replication upon pharmacological modulation of this pathway. We fur-
ther aim to investigate the impact of HIV-1 infection and the role of autophagy in innate and adap-
tive immune responses of DC subsets, in particular LC.
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TLR-4 engagement of dendritic cells confers a BST-2/tetherin-mediated restriction of HIV-1
infection to CD4+ T cells across the virological synapse
FP Blanchet,1 R Stalder,2 M Czubala,1 M Lehmann,2 L Rio,2 B Mangeat2 and V Piguet1 1 Institute
of Infection and Immunity, Cardiff University, Cardiff, United Kingdom and 2 Dept
Microbiology and Molecular Medicine, Medical School of Geneva, Geneva, Switzerland
Dendritic cells and their subsets, located at mucosal surfaces, are among the first immune cells to
encounter disseminating pathogens. The cellular restriction factor BST-2/tetherin (also known as
CD317 or HM1.24) potently restricts HIV-1 release by retaining viral particles at the cell surface in
many cell types, including primary cells such as macrophages. However, BST-2/tetherin does not
efficiently restrict HIV-1 infection in immature dendritic cells. We now report that BST-2/tetherin
expression in myeloid (myDC) and monocyte-derived dendritic cells (DC) can be significantly up-
regulated by IFN-α treatment and TLR-4 engagement with LPS. In contrast to Hela or 293T cells,
infectious HIV-1 release in immature DC and IFN-α–matured DC was only modestly affected in the
absence of Vpu compared to wild-type viruses. Strikingly, immunofluorescence analysis revealed
that BST-2/tetherin was excluded from HIV containing tetraspanin-enriched microdomains (TEMs)
in both immature DC and IFN-α–matured DC. In contrast, in LPS-mediated mature DC, BST-2/teth-
erin exerted a significant restriction in transfer of HIV-1 infection to CD4+ T cells. Additionally, LPS,
but not IFN-α, stimulation of immature DC leads to a dramatic redistribution of cellular restriction
factors to the TEM as well as at the virological synapse between DC and CD4+ T cells. In conclu-
sion, we demonstrate that TLR-4 engagement in immature DC significantly up-regulates the intrin-
sic antiviral activity of BST-2/tetherin, during cis-infection of CD4+ T cells across the DC/T cell
virological synapse. Manipulating the function and potency of cellular restriction factors such as
BST-2/tetherin to HIV-1 infection, has implications in the design of antiviral therapeutic strategies.
1214
IMSA: Integrated metagenomic sequence analysis for identification of exogenous reads in a
host genomic background
M Dimon and ST Arron Dermatology, University of California, San Francisco, CA
Metagenomics, the study of microbial genomes within diverse environments, is a rapidly develop-
ing field. The identification of microbial sequences within a host organism enables the study of
human intestinal, respiratory, and skin microbiota, and has allowed the identification of novel viruses
in diseases such as Merkel cell carcinoma. Most research groups use proprietary code to “subtract”
host reads from the sequence readset by homology to the human genome. There are few publicly
available tools for metagenomic high throughput sequence analysis. We describe Integrated Metage-
nomic Sequence Analysis (IMSA), a flexible, fast, and robust computational analysis pipeline that
is available for public use. IMSA takes input sequence from high throughput datasets and uses a
user-defined host database to filter out host sequence. IMSA then aligns the filtered reads to a user-
defined universal database to characterize exogenous reads within the host background. IMSA
assigns a score to each node of the taxonomy based on read frequency, and can output this as a
taxonomy report suitable for cluster analysis or as a taxonomy map (TaxMap). IMSA also outputs
the specific sequence reads assigned to a taxon of interest for downstream analysis. IMSA was used
to analyze a variety of sequence datasets to validate our ability to detect pathogens and normal flora.
We demonstrate pathogen detection in primary human cervical cancer carrying HPV16, the HeLa
cervical cancer cell line carrying HPV18, the body-cavity-based lymphoma cell line BCBL-1 car-
rying human herpesvirus 8, and the MT4 cell line carrying human T-cell lymphotrophic virus-1. In
addition we demonstrate the ability to survey normal flora in normal cutaneous and mucosal epi-
dermis. In conclusion, IMSA delivers a flexible, comprehensive method for metagenomic analysis
of high-throughput sequence datasets. It is a valuable addition to existing tools for the rapidly
growing field of metagenomic research in dermatology.
1215
The chemokine CXCL14 acts as a modulator of CMV dissemination
J Noffke,1 S Nambiar,1 M Fiedler,2 M Schulte,1 R Kubitza,1 S Kellermann,1 U Wiesner,1 S Jeschke,2
A Zimmermann,2 H Hengel2 and B Homey1 1 Dermatology, Heinrich-Heine University
Hospital, Duesseldorf, Germany and 2 Virology, Heinrich-Heine University Hospital,
Duesseldorf, Germany
Human cytomegalovirus (HCMV) is an ubiquitous betaherpesvirus infecting between 50 and 100%
of the adult population worldwide. It is a leading cause of virus-associated birth defects and it causes
severe and fatal diseases in immune-compromised individuals, e.g. transplant recipients and HIV
patients. HCMV enters the host at epithelial surfaces, but for its persistence and latency it requires
systemic dissemination. Although these mechanisms remain largely elusive, monocytes are sus-
pected to be the main carriers of viral dissemination. Chemokines play an important role in immune
cell targeting to distinct organs. One homeostatically expressed chemokine in the skin is CXCL14,
known for its chemotatic effect on monocytes. Thus, we investigated the effect of HCMV infection
of human fibroblasts (MRC-5) and indeed could show that the expression of the chemokine CXCL14
is dramatically upregulated after infection. Therefore, we propose that HCMV hijacks the chemokine-
driven host response to infect monocytes as well as immature dendritic cells which in turn amplify
and spread HCMV progeny. To further investigate this hypothesis, we infected C57BL/6 mice intra-
dermally with mouse cytomegalovirus (MCMV) to analyze the way of infection via real-time PCR
and plaque-essays in vivo. Thereby, we discovered an altered pattern of HCMV dissemination. We
demonstrated that in the case of an intradermal injection of MCMV the virus mainly spreads into
the salivary glands. Taken together, these results suggest a novel chemokine driven mechanism of
HCMV pathogenesis and a more authentic dissemination process in vivo.
1216
STING (stimulator of interferon genes) is required for the induction of autophagy in con-
ventional dendritic cells and macrophages in response to infection by modified vaccinia virus
Ankara
W Wang,1,2 T Parikh,1,4 P Dai,2,1 N Gammoh,3 I Ganley,3 S Kim,3 R Vance,5 HW Virgin,6
M Overholtzer,3 S Shuman,2 X Jiang3 and L Deng1,4 1 Dermatology/Medicine, Memorial Sloan-
Kettering Cancer Center, New York, NY, 2 Molecular Program, Memorial Sloan-Kettering
Cancer Center, New York, NY, 3 Cell Biology Program, Memorial Sloan-Kettering Cancer
Center, New York, NY, 4 Dermatology, Weill Medical College of Cornell University, New York,
NY, 5 Molecular & Cell Biology, University of California, Berkeley, Berkeley, CA and 6
Pathology & Immunology, Washington University School of Medicine, St. Louis, MO
Autophagy is a catabolic cellular response to stress through sequestration and degradation of cel-
lular contents via the formation of autophagosomes and autolysosomes. Autophagy plays impor-
tant roles in host antiviral immune responses. Whether and how poxviruses modulate autophagy is
not well understood. The highly attenuated modified vaccinia virus Ankara (MVA) has a 31-kb
deletion of the parental genome, and is currently being developed as a vaccine vector. Here we
show that infection of macrophages and conventional dendritic cells (cDCs) with MVA but not
with live wild-type vaccinia (WT VAC) triggers autophagy induction, demonstrated by the appear-
ance of autophagosomes and autolysosomes under electron microscopy, GFP-LC3 puncta forma-
tion under confocal fluorescent microscopy, and the autophagy protein ATG5-dependent conver-
sion of LC3-I to LC3-II on western blot analysis. Time lapse imaging reveals that MVA-induced
GFP-LC3 puncta formation peaks at 4 h post infection. Co-infection of MVA with live WT VAC blocks
autophagy, indicating that vaccinia produces inhibitor(s) to evade host detection. Viral DNA repli-
cation is not required for the induction of autophagy. We find that STING (stimulator of IFN genes),
an adaptor of the cytosolic DNA sensor(s), is critical for the induction of autophagy. MVA infection
triggers GFP-STING puncta formation, which co-localizes with mCherry-LC3. Current study focuses
on the mechanisms of STING-mediated autophagy induction and viral evasion of autophagy and
innate immunity.
1217
Sphingosine 1-phosphate induces inflammatory responses in human keratinocytes and der-
mal fibroblasts through different S1P receptor subtypes
S Hamidi, M Natek, M Schäfer-Korting and G Weindl Institute of Pharmacy (Pharmacology and
Toxicology), Freie Universität Berlin, Berlin, Germany
The sphingolipid mediator sphingosine 1-phosphate (S1P) is a key regulator of diverse biological
activities such as cell migration, proliferation, differentiation and survival. Most of the effects of S1P
are mediated by five specific high-affinity G protein-coupled receptors termed S1PR1-S1PR5. S1P
inhibits proliferation and induces differentiation of keratinocytes and mediates chemotaxis of der-
mal fibroblasts. In the current study, we investigated the potential inflammatory effects of S1P on
human skin cells. Primary keratinocytes and fibroblasts showed a distinct gene expression pattern
of S1PRs, with S1PR2 and S1PR3 being predominantly expressed in fibroblasts, while all five S1PRs
were detected in keratinocytes. Exogenously applied S1P increased IL-6 and IL-8 mRNA expression
and secretion in both cell types in a time- and concentration-dependent manner. Inhibition of indi-
vidual S1PR subtypes with specific antagonists (W146, JTE-013, CAY10444) or siRNA knockdown
assays for S1PR1, S1PR2 or S1PR3, demonstrated that S1P-induced cytokine release is mediated
through S1PR2 and S1PR3 in fibroblasts. In S1P-treated keratinocytes, pharmacological blockade
of S1PR1-S1PR3 did not influence IL-6 and IL-8 secretion, suggesting the involvement of S1PR4 or
S1PR5. Moreover, exposure to S1P resulted in a concentration-dependent upregulation of TNF-α,
IL-1β and IFN-β mRNA in fibroblasts and increased IL-1α levels in keratinocytes. Collectively, we
could show that the bioactive lipid S1P induces inflammatory mediators in non-immune skin cells,
which may have important implications for the regulation of cutaneous inflammation and immu-
nity.
1218
IL-1 regulates the host immune response against cutaneous vaccinia virus infection
T Tian,1 M Jin,2 K Dubin,3 S King,1 TS Kupper1 and RC Fuhlbrigge1 1 Dermatology, Brigham and
Women’s Hospital, Boston, MA, 2 Stanford University, Stanford, CA and 3 Weill Cornell
Medical College, New York, NY
The IL-1 superfamily of cytokines and receptors has been intensively studied. However, the specific
roles of IL-1 family members in host immunity to viral infection, particularly cutaneous infection
with vaccinia virus (VACV), remains incompletely characterized. There are two forms of biologi-
cally active IL-1: IL-1α and IL-1β, both signal through type 1 receptor (IL-1R1). In a previous study,
we applied VACV by scarification to transgenic mice that overexpress IL-1α in the epidermis and
found enhanced innate and adaptive immune responses to VV. In this study, we applied VACV by
scarification to IL-1R1-/- mice and found that these mice developed markedly larger lesions with
higher virus counts in skin than wild-type (WT) mice. Their phenotype is very similar to eczema vac-
cinatum (EV), a severe side effect that may develop in atopic dermatitis (AD) patients following VV
vaccination by scarification. Importantly, the impaired cutaneous response of IL-1R1-/- mice did not
reflect a systemic immune deficiency since immunized IL-1R1-/- mice survived subsequent intranasal
challenge with a lethal dose of VACV as well as immunized WT controls. The impaired skin response
of IL-1R1-/- mice following VACV scarification was also not caused by defects of T cell activation
or T cell homing to skin. Further study revealed that VACV infection and replication after scarifica-
tion were limited to the epidermal layer of WT mice, whereas lack of IL-1R1 permitted abundant
macrophage recruitment to the dermis and these cells were vulnerable to VACA infection and
might aid in transmission of virus to adjacent skin cells, thus leading to larger skin lesions and higher
skin viral titers in IL-1R1-/- mice. These results may suggest new therapeutic strategies for treatment
of EV and inform assessment of risks in patients receiving IL-1 blocking antibodies for treatment of
chronic inflammatory disorders..
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IL-17A–producing mucosa-associated innate T cells are present in psoriatic lesions
MB Teunissen, S Chielie, PI Spuls, MA de Rie and PC Res Dermatology, Academic Medical
Center, Amsterdam, Netherlands
There is a common believe that IL-17A and IL-22 are key cytokines in the pathogenesis of psoria-
sis. We have recently shown that CD8+ T cells producing these cytokines are overrepresented in
psoriatic skin and in this study we aimed to find additional evidence that CD8+ T cells play a cen-
tral role in the pathogenesis of psoriasis. Using intracellular cytokine staining and flow cytometry,
we found that the frequency of IL-17A–producing CD8+ T cells (but not CD4+ T cells) in blood sig-
nificantly correlated with the psoriasis area and severity index. Such correlation was not found for
IL-22–producing T cells. Remarkably, the skin-homing molecule CLA was more frequently expressed
by IL-17A– and IL-22–producing CD8+ T cells (as well as CD4+ T cells) compared to their non-pro-
ducing counterparts, which appeared to be a general feature that was also observed in peripheral
blood T cells from healthy controls. It has been reported that IL-17A–producing CD8+ T cells mainly
belong to the so-called mucosa-associated innate T (MAIT) cell lineage, which is characterized by
the expression of the invariant T cell receptor Vα7.2 chain, high expression of CD161 and the pres-
ence of the IL-18Rα. Using T cells that migrated out of cultured dermal and epidermal tissue, we
demonstrated the presence of CD8+ T cells with MAIT cell characteristics in the dermis as well as
epidermis of psoriatic lesional skin and healthy skin. However, IL-17A–producing CD8+ MAIT
cells were only present in psoriatic lesional skin and therefore possibly contribute to the patho-
genesis of psoriasis. We also observed IL-17A production in a proportion of CD8+ T cells that lacked
MAIT cell characteristics. Whether these latter T cells belong to the adaptive immune system and
release IL-17 in vivo after recognition of skin exposed antigens presented by HLA molecules remains
to be investigated.
1221
Detailed longitudinal sampling of the wound microbiome reveals increased bacterial diver-
sity with antimicrobial treatment and healing
DD Sprockett, M Akhter and MS Tuttle Dermatology, Case Western Reserve University,
Cleveland, OH
A striking clinical feature of chronic wounds is their high level of microbial bio-burden. However,
prior culture-based studies on the association between specific microbes and wound healing have
been largely inconclusive. In the current study, we used culture-independent methods to prospec-
tively characterize changes in wound bacterial communities in a patient with a chronic venous leg
ulcer over a healing course of 26 weeks. The patient was sampled bi-weekly while receiving stan-
dard therapy including debridement, compression bandages, and wound dressings containing top-
ical silver, as deemed necessary by the clinician. Next generation sequencing of the 16S ribosomal
RNA bacterial gene revealed a high level of concordance in bacterial community structure regard-
less of location sampled within the wound (distal, central, and proximal wound bed). However,
superficial bacterial communities (on top of debrided tissue) were distinct from deeper tissue sam-
ples (in and under debrided tissue), with the former being less taxonomically diverse than the lat-
ter (Shannon diversity 2.07 vs. 2.76, p=0.02). These results suggest that consistent sampling depth
is more critical than sample location within the wound for future studies of wound biogeography.
Notably, we found that deep wound tissues experienced two distinct shifts in bacterial community
structure: from a community initially dominated by Acinetobacter in the first 6 weeks (average
60.96%) to a community dominated by Staphylococcus (average 48.03%), as well as a marked
increase in overall bacterial diversity during the final 8 weeks of healing (Shannon diversity 3.86
vs. 2.23, p=0.01). Antimicrobial use was associated with both of these shifts, but not with decreas-
ing wound size. These results suggest that antimicrobial treatments change wound microbial dynam-
ics, though the implications on healing are not yet understood, underscoring the need for further
longitudinal study designs when determining the microbial influence on healing outcomes in chronic
wounds.
1223
Fluorescent staining in leprosy
SS Ghate and RS Dhurat Department of dermatology, LTM Medical college, Mumbai, India
Leprosy is a chronic disease. Diagnosis of leprosy is done by clinical examination and confirmed
with slit skin smear and histopathology. Fite Faraco stain is sensitive in detecting lepra bacilli.
Auramine stain is used to stain acid fast bacilli. Here, the same stain is being used to detect lepra
bacilli and compared with the conventional special stain. that is Fite Faraco. This pilot study was
conducted to study the use of Auramine stain for leprosy. In this study 5 patients (2femaes, 3 males)
were included.The age range was from 17 to 64 years. All of them presented with multiple red col-
ored plaques and nodules on the body. Few of them had diffuse infiltration of face. Sensory loss
was present in 2 patients only. Three out of 5 patients did not have thickened nerves. None of patient
had history of leprosy in other family members. All patients were clinically examined including
nerves. All were subjected to slit skin smear and skin biopsy. Slit skin smear were stained with AFB
stain. The biopsy sections were stained with H&E stain and Fite Faraco. All slides were stained with
Auramine stain (0.1%). The slit skin smears stained with AFB stain were positive in all patients except
one. The H&E section showed atrophic epidermis with Grenz zone. The entire dermis was infiltrated
with many foamy cells containing debris. Histopathology was compatible with Lepromatous lep-
rosy. Fite Faraco showed pink colored rod shaped bacilli arranged in globi. In some places frag-
mented bacilli seen with granular appearance. Auramine stained slides were examined under
immunofluorescence microscope. There was fluorescence in the dermis comparing the foamy cells
in H&E. Since the bacillary load was high so it was seen as diffuse fluorescence. In conclusion, our
patient’s slides stained with Auramine and Fite Faraco gave the same result. Auramine stain is good
alternative but it need expertise and immunofluorescence microscope. In future we want to enroll
the sufficient number of patients including Tuberculoid leprosy. Auramine stain will be a good
alternative.
1222
Hyper-inflammatory macrophage response delays wound healing and recovery of baseline
skin microbiome
MS Tuttle, DD Sprockett and KQ Lu Department of Dermatology, Case Western Reserve
University, Cleveland, OH
Chronic wounds are characterized by both high microbial bioburden and pro-inflammatory immune
responses that delay tissue repair. We have developed a hyper-inflammatory macrophage-mediated
mouse model of delayed wound healing to mimic chronic leg ulcers. This model combines the co-
administration of a PPAR-γ agonist and HMG-CoA reductase inhibitor with UVB irradiation to induce
prolonged M1 hyperactivation in macrophages responding to sterile surgical wounds on the dor-
sum of C57BL/6 mice. The inflammatory response from this treatment peaks 5 days after wound-
ing, followed by 3 days of stalled healing and 5 days of delayed healing relative to control mice.
We characterized changes in the microbiome of the wounds and intact dorsal skin of the hyper-
inflammatory mouse model and control mice over the 20-day healing course using next-generation
DNA sequencing of the V4 variable region of the 16S ribosomal RNA gene. The wound micro-
biome of the hyper-inflammatory mouse model was dominated by Acinetobacter immediately after
wounding and closely resembled that of intact skin (61.8% of the community), but then experienced
a distinct shift in community structure one day later, becoming dominated by Enterobacteriaceae
(44.1% of the community). The dominance of Enterobacteriaceae became most pronounced at the
peak of inflammation (56.6% day 5 after wounding), then persisted throughout the subsequent 10
days. In contrast, wounds of the control mice first became dominated by Staphylococcus one day
after wounding (47.9% of the community), but then returned more quickly to the pre-wounded
microbiome. Notably, a staphylococcal bloom also occurred in the intact skin 5 days after wound-
ing and persisted 10 days longer in the treatment group. These results suggest that a hyper-inflam-
matory innate immune response delays recovery of the baseline skin microbiome. Further under-
standing of the interaction between pro-inflammatory immune responses and the microbiome could
lead to novel alternative or adjuvant therapeutics to antimicrobial regimens for chronic wounds.
1220
Axillary bacterial transplantation and bacteriotherapy as a promising technique to treat
bromhidrosis
C Callewaert,1 T Plaquet,1 J Bostoen,2 T Van de Wiele1 and N Boon1 1 Laboratory of Microbial
Ecology and Technology, Ghent University, Ghent, Belgium and 2 Department of
Dermatology, Ghent University Hospital, Ghent, Belgium
In this research, we report a successful axillary bacterial transplantation / bacteriotherapy of the axil-
lary microbiota to treat bromhidrosis, in which offensive body odour emanated from the axillae.
Subjects with significant body odour were selected for treatment. Odour assessment was done by
a trained odour panel. Axillary samples were analysed by means of denaturing gradient gel elec-
trophoresis (DGGE). A first case study was performed on a monozygotic male twin who did not co-
habit, in which one twin had a significant body odour and the other one did not (p<0.05). Molec-
ular analysis showed that one twin had mostly corynebacteria, while the other twin mostly
staphylococci as dominant species in the axillae. Typically, the Corynebacterium spp. are known
to cause body odour. An axillary bacterial transplantation was executed from the non-odorous twin
to the odorous twin. Only one axilla was treated, whilst the other was used as a reference. Imme-
diately after treatment, hedonic values improved for the treated axilla. Three days after the treat-
ment, the non-treated axilla improved in hedonic values as well. The remarkable results were con-
firmed by DGGE as the improvements in hedonic values were associated with an increase in
abundance of staphylococci and a decrease in abundance of corynebacteria. Secondly, bacterio-
therapy was applied on two other subjects by means of a daily application of a pure Staphylococ-
cus strain (during three weeks). The treatment was not successful every day, however, where there
was a significant difference in hedonic value between treated and not-treated axilla, an increase of
staphylococci and a decrease of corynebacteria was noticed. When treatment stopped, the origi-
nal axillary microbial community was again noticed. Based on these initial results, with one per-
manently improved axillary community and two temporarily improvements, axillary bacteriother-
apy seems a promising technique to treat bromhidrosis.
1224
Novel fatty acid amide hydrolase inhibitors exert strong anti-inflammatory effects on human
keratinocytes
N Vasas,1 AG Szöllösi,1 J Papp,1 A Oláh,1 IL Szabó,1 E Lisztes,1 M Soeberdt,2 C Abels2 and T Bíró1
1 DE-MTA “Lendület” Cellular Physiology Research Group, University of Debrecen, Hungary,
University of Debrecen, Debrecen, Hungary and 2 Dr. August Wolff GmbH & Co. KG
Arzneimittel, Bielefeld, Germany
An increasing body of evidence argues for that endocannabinoids (eCBs) play an essential role in
the regulation of the skin immune system, and that the elevation of the cutaneous eCB tone, by the
inhibition of the eCB degrading enzyme fatty acid amide hydrolase (FAAH), results in anti-inflam-
matory effects. Therefore, in the current study, we aimed at exploring the putative anti-inflamma-
tory actions of two newly developed FAAH-inhibitors on primary and immortalized human epi-
dermal keratinocytes (KCs). By treating the KCs with various Toll-like receptor activators
(lipopolysaccharide, poly-I:C, and lipoteichoic acid [LTA]), we first established a “cellular pro-inflam-
matory model”. Moreover, we identified certain target genes (interleukin [IL]-1α, IL1β, IL6, IL8 and
pentraxin-3), whose expressional alterations specifically indicate the development of the cellular
inflammatory response of the KCs. By using this model, we found that both novel FAAH inhibitors,
as well as the commercially available inhibitor URB597, exerted remarkable anti-inflammatory
effects. Indeed, when applied at non-cytotoxic concentrations, the novel inhibitors were able to pre-
vent the “pro-inflammatory” actions of LTA to up-regulate the mRNA expressions of the above marker
molecules as well as the LTA-induced release of IL6 and IL8. Since these effects were effectively
abrogated by the inhibitors of CB1 and CB2 cannabinoid receptors, it can be proposed that they
indeed elevated the cutaneous CB tone. Taken together, our data indicate that the novel FAAH-
inhibitors are potent anti-inflammatory agents by targeting the “very first” players (i.e. the KCs) of
the cutaneous inflammatory responses. Therefore, our findings may encourage one to systematically
explore their impact in the treatment of various cutaneous inflammatory diseases, e.g. atopic der-
matitis.
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TLR2-dependent expression of Parathyroid Hormone-related Peptide (PTHrP) in the skin
B Muehleisen,1,2 LE French1 and RL Gallo2 1 Department of Dermatology, University Hospital
Zurich, Zurich, Switzerland and 2 Division of Dermatology, University of California, San
Diego, CA
In skin injury and skin infection, the vitamin D system is locally activated to induce expression of
the antimicrobial peptide cathelicidin, thus enhancing innate immune defense. In low vitamin D
situations, parathyroid hormone (PTH) is high. Recent data revealed that PTH or its related peptide
(PTHrP) in the skin are also able to induce cathelicidin, thus compensating for low vitamin D in
immune defense. However, the factors and mechanisms that control PTHrP expression are largely
unknown. We found high PTHrP expression in infected human skin by immunohistochemistry. Treat-
ment of normal human epidermal keratinocytes (NHEK) in culture with a panel of pathogen-asso-
ciated molecular pattern molecules (PAMPs) revealed that the TLR2 agonists LTA by S.aureus and
MALP-2 induced PTHrP mRNA expression significantly (4.2-fold, p < 0.01, and 1.3-fold p<0.05
respectively), whereas other PAMPs had no effect. This effect was cell type specific, since THP1
monocytes showed no response to LTA or MALP-2. To test the ability of TLR2 agonists to induce
cutaneous PTHrP in vivo, C57Bl/6 WT mice were injected s.c. with 50 ug LTA by S.aureus, result-
ing in a 12-fold increase in Pthrp (p < 0.01) and a corresponding 14-fold increase in cathelicidin
(Camp) mRNA after 24h. In summary, our results indicate that cutaneous PTHrP expression is
TLR2-dependent. Targeting the TLR2-PTHrP-cathelicidin axis might be a promising avenue to develop
novel therapies for cathelicidin-related diseases.
1226
Primary human skin culture experimentally infected with Bartonella henselae
P Velho,2 M Cintra,2 B Lania,2 A Almeida,2 S Nye,1 K Gupta3 and M Ericson1 1 Dermatology and
Center for Drug Design, University of Minnesota, Minneapoli, MN, 2 Dermatology, University
of Campinas, Campinas, Brazil and 3 Department of Vascular Biology Center, Division of
Hematology/Oncology/Transplantation, Department of Medicine, University of Minnesota,
Minneapolis, MN
Infection can induce angiogenesis. The mechanism by which this occurs is not well understood.
Bartonella is a unique bacterium genus able to produce human angio-proliferative lesions by direct
action. Bartonella spp. are re-emergent bacteria. They can cause chronic asymptomatic infection,
but they can also cause life-threatening diseases. Pets are often reservoirs for these bacteria. There
are no gold-standard tests to confirm Bartonella spp. infection and so improved diagnostic tests for
Bartonella spp. warrant attention. In our pursuit of a new diagnostic test option and a model to study
Bartonella angiopathogenesis we infected primary human skin cultures with different strains of B.
henselae. Supernatants were collected,The fragments were washed and incubated in DMEM+Glu
and a suspension containing B. henselae isolated from a cat, a bacteremic blood donor, or an
ATCC strain. All samples were run in triplicate. Controls with no B. henselae were also included.
Media was replaced every 24h. At 72h post-infection, supernatants were again collected and skin
fragments were fixed for electron microscopy (EM), confocal imaging and histology. Ultrathin (90nm)
sections from EM-fixed tissue were stained and examined. The 3rd set of skin fragments was stained
for H&E as well as a silver stain. Clumps of bacteria were found in all infected tissues by all these
methodologies. Supernatants analyses of 20 angiogenic factors and cytokines revealed differences
between IL6 and IL8 production in the culture infected with the blood donor strain and TIMP-2 (a
human gene, thought to be a metastasis suppressor) in the cat strain. Primary skin culture was able
to promote B. henselae proliferation that could be demonstrated 72h after experimental infection
and a significant production difference of IL6, Il8 and TIMP-2.
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